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Abstract 
 
During an immune response, dendritic cells (DCs) capture and process antigen, 
upregulate co-stimulatory molecules and migrate to lymphoid organs to maximise 
antigen recognition by rare T cell clones. A crucial step for successful T cell activation is 
cell-cell interaction at the immunological synapse (IS), the organised contact interface 
which allows optimal communication. IS formation requires the dynamic remodelling 
of the actin cytoskeleton to spatially distribute membrane areas with distinct protein 
compositions. While evidence exists for a role of the T cell cytoskeleton in this process, 
the driving force behind the specific organisation on the DC side is unknown.   
One important actin regulator is Wiskott-Aldrich Syndrome protein (WASp), expressed 
exclusively in immune cells. Using a murine model, we investigated the role of WASp in 
DC-mediated actin-dependent synapse formation. 
 
Utilising both confocal and electron microscopy (EM), we observed a disorganised, 
asymmetric interface between T cells and WASp-deficient DCs. Immunofluorescent 
staining shows reduced polarisation of certain synapse markers in WAS knock-out 
conjugates; while high resolution 3D EM reconstructions show severely impaired cell 
spreading and a reduced contact area. We have used fluorescence recovery after 
photobleaching (FRAP) to show reduced stability of the actin network in WASp DCs. 
Our experiments on supported planar bilayers have shown an unexpected interface 
organisation and highlight a novel role of the DC cytoskeleton in this process.  
 
Crucially, we have demonstrated reduced T cell activating capacity of WASp-deficient 
DCs, as measured by T cell proliferation, cytokine production and transcription factor 
expression. The results highlight the critical role of cytoskeletal regulation in DC-
mediated IS formation. Further, a second murine immunodeficiency model, Dock8 
deficiency, and two novel human primary immunodeficiencies were briefly 
investigated to examine the role of other actin regulators in normal DC function. 
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Chapter 1 – Introduction 
 
 
1. Actin 
Function of actin 
The actin cytoskeleton has a large number of diverse roles to support cellular function 
including structural integrity, movement, and the localisation, clustering and stabilisation of 
transmembrane proteins; which are crucial in biological processes such as cell division, 
motility, endocytosis and morphogenesis. These processes are achieved by highly regulated 
actin network assembly and disassembly (Pollard and Cooper, 2009, Dominguez and Holmes, 
2011). This delicately balanced process must depend on tight feedback mechanisms between 
the cell’s requirements, the actin network and its regulators, of which there are over 100. 
Actin’s participation in so many cellular processes is mediated by intimate and extensive 
interactions with the cell membrane (Doherty and McMahon, 2008). Further, actin can be 
coupled to transmembrane proteins, such as many immune cell receptors (Barda-Saad et al., 
2005), and the extracellular environment, for example through specialised adhesion structures 
called podosomes (Linder and Aepfelbacher, 2003). Thus dynamic polymerisation and 
depolymerisation of actin filaments and their anchoring to cellular structures can produce 
forces required for both whole-cell movements and intracellular transport of proteins, vesicles 
and organelles. Cells of the immune system are obligatorily highly mobile and thus require 
actin cytoskeletal regulation for correct spatial and temporal organisation both at cellular level 
and on a smaller scale, during cell-cell communication. The actin cytoskeleton therefore plays 
a pivotal role in nearly all stages of immune system function, including haematopoiesis, 
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migration and cell-cell interaction, which is crucial for initiation of innate and adaptive immune 
responses. 
Structure 
Actin is present in two states in almost all eukaryotic cells – free monomers, known as globular 
or G –actin, which polymerise to form filamentous or F-actin (Reisler, 1993). The monomeric 
subunit is around 42kDa and is bound to either ADP or ATP (Otterbein et al., 2001, Graceffa 
and Dominguez, 2003). During filament polymerisation, all actin monomers line up pointing in 
the same direction to form a filament with structural polarity. The end showing a subunit with 
an exposed ATP binding site is referred to as the (-) or “pointed” end, while the opposite end is 
the (+) or “barbed” end. These terms arose from myosin ‘decoration’ experiments 
investigating actin filament appearance by TEM (Begg et al., 1978). Actin hydrolyses ATP within 
the filament to produce ADP and a phosphate group (Pi). As the ADP-bound monomers remain 
bound in the filament for some time, this results in three different species of monomers being 
present in a filament – ATP-actin, ADP-Pi-actin and ADP-actin (Vavylonis et al., 2005). The 
proportion of each depends on the filament growth and depolymerisation rates.  
Both ends can undergo polymerisation, however, the critical concentration of actin monomers 
required for -end growth is 8 times larger than that for +end growth. Consequently, most 
polymerisation occurs at the +/barbed end while depolymerisation occurs at the opposite end 
(Bindschadler et al., 2004, Vavylonis et al., 2005). Polymerisation can occur at uncapped or 
severed filament barbed ends, or can be nucleated by several distinct types of proteins 
(Campellone and Welch, 2010). Although the concentration of actin-GTP in non-muscle cells is 
high, pure actin monomers do not readily form oligomers and begin elongation (Rosenblatt et 
al., 1995). The requirement for different nucleators also provides a mechanism for regulation 
and signal integration. The two main nucleation mechanisms are described below. 
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Arp2/3 nucleates branched actin networks 
The first and best characterised nucleator is the Arp2/3 complex (Welch et al., 1997, Mullins et 
al., 1998). This seven-subunit complex is able to nucleate branches from existing actin 
filaments (Volkmann et al., 2001, Egile et al., 2005, Pollard, 2007) and in doing so, it generates 
a branched network, which has been shown to play a crucial role at the leading edge of 
migrating cells (Pollard and Borisy, 2003). Arp2/3 contains two actin-related proteins (Arp2 and 
Arp3) and 5 additional subunits (ArpC1-Arp5C); and, like actin, is highly evolutionarily 
conserved. The complex requires ATP, pre-existing actin filaments and nucleation-promoting 
factors (NPFs) to initiate new filament growth at an angle of 78˚ from the mother filament 
(Mullins et al., 1998, Blanchoin et al., 2000, Achard et al., 2010). Arp2/3 in the cytosol is in an 
inactive conformation and its binding at a branch junction results in an active conformation, 
with Arp2 and Arp3 forming the first two subunits of the new daughter actin filament (Rouiller 
et al., 2008). 
The best-characterised NPFs are members of the WASp family, described below. The C-
terminal verpolin homology-central-acidic (VCA) domains of these proteins can bind both 
Arp2/3 and actin monomers and have been described to be both necessary and sufficient for 
WASp-mediated nucleation (Machesky and Insall, 1998, Miki and Takenawa, 1998, Machesky 
et al., 1999, Rohatgi et al., 1999). Many studies have investigated the interactions between the 
VCA and Arp2/3 and it has been suggested that the V region binds to actin monomers, the C 
region is able to bind to both actin and the Arp2/3 complex, while the A region binds Arp2/3 
only (Chereau et al., 2005, Marchand et al., 2001, Kelly et al., 2006, Kreishman-Deitrick et al., 
2005). The precise location of binding on individual molecules is still under debate. The 
conformational change induced in Arp2/3 by NPF binding has been shown in assembled 
junctions (Volkmann et al., 2001, Egile et al., 2005, Rouiller et al., 2008). More recently, Xu et 
al used electron microscopy to show that the precise conformational change is independent of 
the nature of the NPF and involves both a slightly twist within Arp2/3 and a further movement 
of Arp2 within the molecule (Xu et al., 2012). The authors also show that all NPFs observed 
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partially occluded the actin binding site on Arp2/3, suggesting further structural adjustments 
must be at play in the context of filament elongation (Xu et al., 2012). 
The VCA domain may play a role at several points during nucleation. First, single molecule 
imaging has confirmed that the VCA domain accelerates the association rate between Arp2/3 
and the mother filament (Smith et al., 2013a). Subsequently, there is evidence for a VCA-
mediated activation step after filament binding (Marchand et al., 2001, Beltzner and Pollard, 
2008, Smith et al., 2013a). Recently, it has been suggested that part of this activation may 
involve the release of Arp2/3 from VCA, thus coupling filament initiation and release from 
membrane tether constraints (Smith et al., 2013b). The authors use multi-wavelength single 
molecule imaging to follow branch formation over time and suggest that upon filament 
binding, the VCA is released from the Arp2/3 complex prior to filament elongation and that it 
cannot bind to Arp2/3 complexes in pre-existing branches (Smith et al., 2013b). However, the 
study used dimerised VCA constructs and it is yet unclear whether similar steps apply to 
monomers or oligomers of full-length NPFs. Furthermore, the model is incomplete as it does 
not take into account the conformational changes in Arp2/3, the role of membrane forces in 
dissociation of the VCA domain or the sequence of events for cytoplasmic, rather than 
membrane-bound NPFs. 
Formins nucleate longer unbranched actin filaments 
The formin family provides an example of another type of nucleation. Formins are also highly 
conserved and contain 2 formin homology domains (FH1 and FH2) (Castrillon and Wasserman, 
1994, Wasserman, 1998). FH1 binds profilin, a G-actin binding protein (Imamura et al., 1997, 
Watanabe et al., 1997); this has been shown to deliver actin monomers to the growing ends of 
filaments ((Sagot et al., 2002, Romero et al., 2004, Paul and Pollard, 2008); reviewed in (Carlier 
and Pantaloni, 1997). FH2 domains are sufficient to initiate actin nucleation; they act as 
homodimers, in an anti-parallel orientation, and abolishing dimerization abolishes actin 
nucleation (Li and Higgs, 2005, Copeland et al., 2004, Xu et al., 2004). Crystal structures of 
 Chapter 1 
21 
 
mammalian formins show that the dimers form a ring structure (Lu et al., 2007, Shimada et al., 
2004). 
 In contrast to Arp2/3, which effectively caps the pointed filament end, formins act as a 
processive, leaky cap on the barbed end, where they compete with capping proteins to 
regulate filament length (Harris et al., 2004, Moseley et al., 2004, Romero et al., 2004, 
Chesarone et al., 2009, Sagot et al., 2002). It is unclear whether this occurs before or after 
addition of new actin monomers (Otomo et al., 2005, Paul and Pollard, 2008). There is 
evidence to suggest that FH2 forms an open or closed ring conformation, which regulates 
advancement along the filament and actin monomer addition (Otomo et al., 2005). 
Among the nucleators, formins have a unique ability to directly regulate both the actin and 
microtubule cytoskeletons. In vivo, direct interaction with microtubules was first described for 
the mammalian formin, mDia, in a Rho effector screen; mDia was shown to aid stabilisation 
and orientation of microtubules (Palazzo et al., 2001). mDia1 and mDia2 have also been shown 
to interact with microtubules plus end tracking proteins to stabilise microtubules (Wen et al., 
2004, Lewkowicz et al., 2008). Further, epifluorescence and TIRF microscopy studies on mDia2 
mutants have shown that formins’ roles in actin and microtubule regulation can be genetically 
uncoupled (Bartolini et al., 2008). 
Formins play an important role in both nucleation and elongation of actin filaments. They have 
been shown to drive the formation of several cellular structures, including filopodia 
(Schirenbeck et al., 2005), lamellipodia (Yang et al., 2007), stress fibres (Tominaga et al., 2000) 
and phagocytic cup formation (Seth et al., 2006). In terms of cell-cell contact, formins are also 
required for the assembly of adherens junctions (Kobielak et al., 2004), which contain 
transmembrane adhesion proteins. Consequently, formins play crucial roles in many cellular 
processes such as motility, adhesion, morphogenesis and division.  
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Arp2/3, nucleation-promoting factors (NPFs) and Rho GTPases 
Arp2/3 is activated by NPFs to induce polymerisation; and the largest subgroup of NPFs are 
characterised by a C-terminal VCA domain (also called WCA; WASP homology 2/ connector/ 
acidic) (Stradal and Scita, 2006, Machesky and Insall, 1998, Miki and Takenawa, 1998). This 
family of proteins includes WASP, N-WASp (neural-WASp), WAVE1-3, WASH (WASP and SCAR 
homologue), WHAMM (WASp homologue associated with actin, Golgi membranes and 
microtubules) and JMY (junction-mediating regulatory protein). Despite the multiple domains 
present in each of these proteins, they have no intrinsic catalytic activity. Several of these 
proteins are regulated by autoinhibition in the cytosol (Kim et al., 2000), as described below. 
One of the mechanisms of releasing this autoinhibition is through the binding of small 
GTPases, such as Cdc42 and Rac1 (Rohatgi et al., 2000). Binding of Cdc42 and the weaker 
interaction of Rac1, to WASP was first described in yeast two-hybrid studies and overlay 
assays. Binding was linked to actin polymerisation and was shown to depend on GTP-bound 
conformations of the GTPase, although WASp did not activate the GTPase (Aspenstrom et al., 
1996, Symons et al., 1996, Kolluri et al., 1996, Abdul-Manan et al., 1999). 
The Rho family GTPases are well described regulators of many cellular processes, including 
cytoskeletal organisation (Nobes and Hall, 1994). They are often described as molecular 
switches due to their ability to cycle between an active GTP-bound and inactive GDP-bound 
state (Boguski and Mccormick, 1993). The switch is carefully regulated by a large number of 
activators (GEFs; guanine nucleotide exchange factors) and inactivators (GAPs; GTPase 
activating proteins) (Etienne-Manneville and Hall, 2002). The three best-characterised 
members of the Rho GTPase family are Rho (three isoforms- RhoA, RhoB, RhoC), Rac (three 
isoforms- Rac1, Rac2, Rac3) and Cdc42.  
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Actin-related structures and cell adhesion 
RhoGTPases, through a variety of different effectors, regulate assembly and disassembly of 
different actin structures, in response to a variety of different external stimuli (Etienne-
Manneville and Hall, 2002, Hall, 2005). Rac has been shown to promote the formation of 
lamellipodia and thus is important for promoting protrusions at the front of a migrating cell 
(Ridley et al., 1992, Small et al., 2002). Rho has been shown to regulate the formation of stress 
fibres; it can form contractile actin and myosin filaments and stimulates contractility to allow 
retraction of the rear of a migrating cell (Ridley and Hall, 1992). It also promotes acto-myosin 
contraction in smooth muscle cells (Fukata et al., 2001, Sakurada et al., 2001). Cdc42 promotes 
formation of filopodia (actin-rich, finger-like extensions) (Kozma et al., 1995, Nobes and Hall, 
1995) and has been shown to play a role in establishing polarity in yeast, C. elegans, 
Drosophila, epithelial cells and neurons (Etienne-Manneville and Hall, 2002). 
Rho GTPases are anchored to membranes, where they can initiate actin polymerisation to 
drive processes such as macropinocytosis, membrane-ruffling and migration (Ridley, 2006). As 
well as their roles in cell morphology and migration, the Rho GTPases are involved in other 
processes such as cell-cell interactions, phagocytosis, cell cycle progression, vesicle transport 
and secretion (reviewed in (Etienne-Manneville and Hall, 2002, Hall, 2005). 
Rho GTPases have been described as central regulators of podosome formation (Linder and 
Kopp, 2005). Podosomes are specialised cell adhesion structures containing an actin core 
surrounded by a ring of integrins, scaffold and actin-binding proteins (Linder and Kopp, 2005). 
Podosomes have mainly been described in myeloid cells in contact with the extra-cellular 
matrix, where they have a role in concentrating proteinases involved in matrix degradation 
(Linder, 2007). A podosome-based sealing zone is formed by actively bone-resorbing 
osteoclasts, highlighting the role of podosomes in cell adhesion (Destaing et al., 2003). The 
adhesion forces created by podosomes turning over behind the leading edge of a migrating cell 
are important for driving forward propulsion (Calle, 2006a). An example of these is shown in 
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Movie 4.6. Cdc42 localises to podosomes in macrophages and microinjection of mutated 
Cdc42 results in impaired podosome formation in macrophages and DCs (Linder et al., 1999, 
Burns et al., 2001). Conversely, constitutively active Cdc42 expression promotes the formation 
of podosome-like actin structures in HeLa cells (Dutartre et al., 1996). As described, Cdc42 
interacts directly with WASp, to promote Arp2/3 mediated actin polymerisation (Machesky 
and Insall, 1998, Millard et al., 2004). It has been suggested that this pathway plays a crucial 
role in podosome dynamics (Linder et al., 1999). WASp-deficient DCs and macrophages show 
severe defects in podosome formation on glass or fibronectin-coated coverslips (Linder and 
Kopp, 2005; Humphries et al., 2006). Disruption of Rac1 or RhoA has also been shown to lead 
to abnormal podosome formation (Burns et al., 2001, West et al., 2000, Ory et al., 2000). 
However, the precise effect of Rho GTPase disruption in each of these is complicated, 
suggesting that several Rho GTPases may be involved and the relationship between these in 
unclear. 
Other actin regulators 
Nucleation is just one aspect of actin regulation; indeed the actin cytoskeleton is not 
exclusively made up of actin but also includes many diverse actin-binding proteins resulting in 
the largest known network of protein-protein interactions (Dominguez, 2004, Pollard et al., 
2000). 
Profilin, for example, is a G-actin-binding protein, which sequesters actin monomers from the 
cellular pool (Carlsson et al., 1977). Profilin also has a 10-hold higher affinity for actin-ATP than 
the ADP-bound actin complex and this has been suggested to aid polymerisation of actin 
filaments in collaboration with both formin and WASp family members (Ferron et al., 2007, 
Paul and Pollard, 2008). Together with the diverse effects of the filament-severing protein 
cofilin (Van Troys et al., 2008), these two proteins can promote actin filament treadmilling. 
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Gelsolin, and other structurally similar severing proteins (Way and Weeds, 1988), acts to sever 
existing actin filaments. Its action is dependent on calcium concentration and it may have a 
role both intra- and extra-cellularly (Sun et al., 1999, Koya et al., 2000). 
Actin capping proteins also play an important role in the regulation of actin dynamics. Capping 
protein (CP) caps actin filament barbed ends, preventing elongation (Caldwell et al., 1989). 
Using a purified protein system, it has also been shown that CP can increase the frequency of 
Arp2/3 nucleation, thus affecting actin-mediated motility (Akin and Mullins, 2008). Further, a 
number of other proteins bind to and regulated CP, suggesting a diverse network able 
integrate several signals to control actin filament length in a range of processes (Cooper and 
Sept, 2008). 
Myosin motor proteins can organise the cellular actin network and produce forces promoting 
actin-mediated contraction. These are important both for cell adhesion and migration 
(Naumanen et al., 2008, Keren et al., 2009). Retrograde flow of actin filaments in migrating 
cells has been shown to be mainly powered by myosinII and the myosin inhibitor blebbistatin 
disrupts this flow (Naumanen et al., 2008). 
Another group of proteins regulating actin structure are the actin-bundling or crosslinking 
proteins. These include fascin, villin, filamin and α-actinin; and have been well-described 
particularly in cell adhesion (stress-fibre formation) or the formation of microvilli and filopodial 
protrusions (Nakamura et al., 2011, Khurana and George, 2011, Naumanen et al., 2008). 
Dorsal and ventral stress fibres attach to cell adhesion structures at one or both ends, they 
play roles in adhesion, contraction and cell motility and several types may be present in a cell 
at the same time (Pellegrin and Mellor, 2007, Naumanen et al., 2008). The adhesion structures 
themselves, such as focal contacts and podosomes, have been described as both adhesion and 
signal transduction organelles and are rich in integrin molecules (Riveline et al., 2001). 
Integrins mediate cell-cell and cell-ECM (extracellular matrix) adhesion and can be activated by 
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a large number of molecules through ‘inside-out’ and ‘outside-in’ pathways (Zhang and Wang, 
2012). Integrins play crucial roles in survival, migration, adhesion, proliferation and 
differentiation of immune cells and mutations can cause autoimmunity or immunodeficiency 
(Zhang and Wang, 2012). 
For most cells in the body, organisation in tissues and strict regulation of cell division or 
migration are crucial for correct function. For immune cells however, functionality is highly 
dependent on efficient migration, cell division, ability to cross barriers and to form different 
cell-cell contacts. 
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2. The Immunological Synapse 
The immunological synapse (IS) is the name given to the contact interface between cells of the 
immune system, which acts as a platform for communication between these cells. Although 
initially described between T cells and antigen presenting cells  (APCs; presenting peptide-
MHC) (Grakoui et al., 1999), the synapse is now known to form between a number of different 
cells, including natural killer (NK) cells (Davis et al., 1999) and B cells (Batista et al., 2001). The 
IS can also form between cells of varying activation status as part of secondary or ‘repriming’ 
activation, for example between activated T and B cells (Okada et al., 2005), or between two 
activated T cells (Sabatos et al., 2008). Although the activated T: B cell synapse has been the 
prototype for IS formation (Monks et al., 1998, Kupfer et al., 1987, Monks et al., 1997), it is 
now accepted that dendritic cells (DC), as the main professional antigen presenting cell type, is 
responsible for most primary activation. Formation of the immune synapse is vital for full 
immune response priming. 
 
On the DC side 
Dendritic cells are professional antigen presenting cells with a widespread distribution in 
peripheral tissues, as well as both primary and secondary lymphoid organs. Several subtypes, 
performing different functions, have been described which share generally related 
morphology. In steady state conditions, four types of DCs have been described in primary and 
secondary lymphoid organs (spleen and lymph nodes), which include CD4+, CD8+, double 
negative and plasmacytoid dendritic cells (Wu and Liu, 2007). These cells spend their life 
restricted to one lymphoid organ; they present foreign and self-antigens in that lymphoid 
tissue. CD8+ cells are concentrated in T cell areas of the spleen, while CD8- cells are found in 
the marginal zone though can be induced to migrate to T cell zones using microbial peptides. 
The plasmacytoid DCs (pDCs) are a relatively round, long-lived cell type, which upon detection 
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of viral or microbial compounds produce large amounts of type-I interferons (O'Keeffe et al., 
2002). 
Lymph nodes and peripheral tissues contain two more types of conventional DCs (cDCs) – 
Langerhans and dermal (CD11b+) DCs. These are migratory subtypes, which act as sentinels in 
the periphery and present antigens to T cells in the lymph nodes (Shortman and Naik, 2007). 
During infection or inflammation, further DC subsets develop, including monocyte-derived DCs 
and TNF-producing and inducible nitric-oxide synthase-producing DCs (Serbina et al., 2003). 
Although DCs were originally considered to have a myeloid origin, both common myeloid 
progenitors (CMPs) and common lymphoid progenitors (CLPs) have shown the potential to 
differentiate into various DC subsets both in vitro and in vivo (Traver et al., 2000, Manz et al., 
2001, Chicha et al., 2004). 
In vitro, mouse DC function has been investigated using several culture models for DC 
development. Splenocytes have been cultured in GM-CSF producing DCs with features 
reminiscent of inflammatory DCs (Berthier et al., 2000, Shortman and Naik, 2007). Mouse bone 
marrow (BM) cells have been cultured in GM-CSF or Flt3 ligand to produce conventional 
migratory DCs, though Flt3L additionally results in differentiation of pDCs (Inaba et al., 1992, 
Brasel et al., 2000, Gilliet et al., 2002). DCs derived from bone marrow or spleen express 
comparable levels of MHCII and costimulatory molecules and have been shown to induce 
similar levels of proliferation and IL-2 secretion by antigen-specific T cells using soluble peptide 
antigen (Garrigan et al., 1996). Using native protein antigens however, BMDCs maintain their 
capacity to process antigen longer and were shown to be 50 times better than splenic DCs at 
stimulating antigen-specific T cells (Garrigan et al., 1996). More recent experiments suggest 
that BMDCs are able to donate processed antigens to other cells, but unlike splenic primary 
cells, they are unable to acquire and present antigens from other DCs (Bedford et al., 2008). 
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As described in this section, it is known that DCs play a role in IS formation and T cell 
activation, however, the organisation, dynamics and driving forces behind the IS, as well as its 
importance for the DC have been neglected (Delon and Germain, 2000, Rodriguez-Fernandez 
et al., 2010).  
 
Molecular structure and cell morphology 
The immune synapse was first described in 1998 by Monks et al., as a complex structure 
formed at the interface between T and B cells, with distinct molecular clusters (Monks et al., 
1998). TCR/MHC pairs were shown to concentrate in the central supramolecular activation 
cluster (cSMAC). These are surrounded by outer rings containing LFA-1/ICAM-1 in the 
peripheral (p) SMAC, and CD45 in the distal (d) SMAC (Fig1). It has been suggested that this 
organisation is formed and stabilised by the actin cytoskeleton. The synapse structure was 
shown to be dynamic, with TCR initially engaged in the outer rings of the interface migrating 
towards the cSMAC in the centre (Grakoui et al., 1999). 
 
 
 
 
 
 
 
 
Figure 1.1. Immunological synapse organisation. 
Monks, C.R., et al., Three-dimensional segregation of supramolecular activation 
clusters in T cells. Nature, 1998. 395(6697): p. 82-6.  
 
 
 
TCR/ MHC 
LFA-1/ ICAM-1 
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The TCR-peptide-MHC complex is approximately 13nm long so in order to bring the 
components together and allow antigen-recognition, the opposing membranes of the T cell 
and DCs must come within this distance, forming a very intimate contact (Garcia et al., 1996, 
Garboczi et al., 1996, Shaw and Dustin, 1997). The spacing between apposed membrane may 
be involved in protein sorting and organisation at the interface (Davis et al., 2003, Shaw and 
Dustin, 1997). Indeed, altering the extracellular length of peptide-MHC complexes has been 
shown to affect TCR signalling (Choudhuri et al., 2005). A more recent study used a range of 
fluorescent particles to show that these were excluded according to size from the cSMAC of 
synapses formed between NK and B cell lines (Alakoskela et al., 2011). However, it is likely that 
other sorting mechanisms are also at play since exclusion of CD43 from the IS was shown to 
depend on interactions of its cytoplasmic tail rather than its extracellular size (Delon et al., 
2001).  
Other molecules also show very specific organisation. The phosphatase CD45 for example, is 
excluded from the central and peripheral SMAC; it has been suggested that this minimises 
premature signalling deactivation (Davis and vanderMerwe, 1996, Shaw and Dustin, 1997, 
Thomas, 1999, Leupin et al., 2000). 
As well as signalling and adhesion domains within the synapse, secretory domains in the form 
of clefts have also been observed in T: DC or cytotoxic T lymphocyte (CTL): target cell contacts 
(Brossard et al., 2005, Stinchcombe et al., 2001). These may be the target areas for directed 
secretion and may serve to restrict or concentrate signalling molecules. 
In vivo, DCs migrate fast in tissue and upon initial lymph node entry; they then slow down and 
form networks. T cells move rapidly in a random amoeboid manner, scanning the antigen 
repertoire present (Miller et al., 2002, Miller et al., 2003, Miller et al., 2004a, Lindquist et al., 
2004). Cahalan et al showed that as a result of fast T cell locomotion and extensive DC 
protrusions, each DC contacts up to 5000 T cells per hour, hugely increasing the chance of 
contacting rare antigen-specific T cell clones (Miller et al., 2004a). 
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Interactions between helper T cells and antigen-presenting cells may last over 6 hours and 
require continuous T cell receptor (TCR) engagement (Huppa et al., 2003); although some 
evidence, especially in vivo, has shown a much more dynamic nature with several short 
contacts before stable interactions are established (Mempel et al., 2004, Miller et al., 2002). 
There is evidence to suggest that the length of contact may be influenced by T cell intrinsic 
factors, such as presence of WASp (Sims et al., 2007), as well as the potency of activation, for 
example antigen dose (Skokos et al., 2007, Henrickson et al., 2008). 
One interesting question is how a highly motile T cell is able to arrest upon encounter of 
specific antigen-containing MHCII and how it is able to regulate different cytoskeletal systems 
to switch from a role in migration to one in stable adhesion. Such a stop signal has been 
proposed to occur early and in vitro studies suggest it may be dependent on intracellular 
calcium levels (Dustin et al., 1997, Donnadieu et al., 1994, Negulescu et al., 1996). Arrest of 
cells with high intracellular calcium (above 150µM) has also been observed in vivo (Wei et al., 
2007b). Complete early T cell arrest is still disputed and some in vivo studies have shown initial 
slowing of T cells, which is followed by arrest much later, around 24hours after antigen 
administration (Mempel et al., 2004, Miller et al., 2002, Miller et al., 2004a). The authors have 
noted that some events resulting from TCR triggering, for example CD69 upregulation, occur 
before full T cell arrest. This suggests that even a brief interaction with DCs is sufficient for this 
early level of activation. No cytokine secretion or CD25 (IL-2 receptor) upregulation was seen 
(Mempel et al., 2004). T cell arrest has also been suggested to correlate with antigen dose or 
potency (Henrickson et al., 2008, Skokos et al., 2007, Beemiller et al., 2012) implicating a role 
for TCR signalling in initiating arrest. Although full T cell arrest may not be required for TCR 
signalling (Beemiller et al., 2012, Moreau et al., 2012, Friedman et al., 2010), it is often seen 
during later activation stages (Mempel et al., 2004, Miller et al., 2004b, Hugues et al., 2004, 
Shakhar et al., 2005). 
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One model, built on electron microscopy data, proposed that synapse architecture is 
developed during 4 distinct stages in CD4 cells interacting with cognate-antigen expressing B 
cells (Ueda et al., 2011). The first stage (around 30 min) involves deep protrusions from the T 
cells into the interacting APC and the authors suggested that this could increase the surface 
area scanned by the T cells by around 10-fold. During the second and third stages (1-2hrs), the 
microtubule cytoskeleton is reorganised and the T cell MTOC repositioned beneath the contact 
zone. After around 4 hours, a flattening of the cell-cell interface and repositioning of the Golgi 
complex towards the IS, correlated with cytokine secretion,  are characteristic of the fourth 
stage (Ueda et al., 2011). Although it is unclear whether this mechanism of organisation is 
employed by other cell types in other contexts, this study does highlight the importance of 
dynamic synapse organisation and how dynamics could play an important role in regulating 
cell-cell communication.  
One in vitro study showed that after initial contact of T cells with DC, mature DCs were able to 
extend membrane protrusions and migrate their cell body towards the interacting T cell in a 
Rho GTPase-dependent manner; which immature DCs were unable to do (Benvenuti et al., 
2004a). The authors suggest this may be a specialised feature of the mature DC cytoskeleton in 
order to stabilise the DC: T cell contact.  
It is clear that formation of the IS between T cells and dendritic cells, requires the dynamic 
organisation of actin, described in the previous section, to spatially distribute activation 
clusters (Monks et al., 1998) with distinct protein compositions. 
Signalling 
Upon TCR engagement, the activation of tyrosine kinases and calcium mobilisation precede IS 
formation. Recognition of peptide-MHC promotes conformational changes within the TCR and 
TCR-bound CD3. Lck and Fyn (Src family kinases) phosphorylate tyrosine residues in the 
immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic CD3δ, ε, γ and ζ 
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chains, initiating downstream TCR signalling (Abram and Lowell, 2007). ZAP-70, another 
tyrosine kinase is recruited to the phosphorylated TCR (Chan et al., 1992) (see Figure 1.2, p48). 
ZAP-70 is also phosphorylated by Lck, and in turn phosphorylates LAT (linker for activation of T 
cells), allowing recruitment of PLCγ and SLP76. The former generates IP3 to induce calcium 
mobilisation; and DAG for membrane recruitment of downstream proteins including PKCθ 
(protein kinase C θ) and activators of the mitogen-activated protein kinase (MAPK) pathway 
(Huse, 2009). The latter, interacts with the kinase Itk, the guanosine nucleotide exchange 
factor (GEF) Vav-1 and the non-catalytic adaptor protein Nck (Koretzky et al., 2006). Nck 
interacts with several Arp2/3-regulating factors such as WASp and WIP to trigger actin 
polymerisation, perhaps initiating the retrograde flow discussed above. Vav-1 can activate 
Cdc42 to regulate WASp directed actin polymerisation (Reicher and Barda-Saad, 2010). 
Negative regulation is also present in these early signalling events. One example is the tyrosine 
phosphatase CD45, which can activate but also inhibit Lck by removing activating 
phosphotyrosine residues (Thomas and Brown, 1999). 
Several lines of evidence have led to the understanding that the majority of TCR signalling 
actually occurs in TCR microclusters, long before they reach the cSMAC. TCR signalling is 
initiated before formation of the cSMAC (Krummel et al., 2000, Lee et al., 2002) and the 
cSMAC itself has relatively low levels of activated Lck and ZAP-70 (downstream of TCR 
activation). By contrast, putative markers of TCR signalling, Lck and PKCθ, colocalise with the 
pSMAC (Lee et al., 2002). Using total internal reflection fluorescence microscopy, Campi et al 
demonstrated TCR microclusters generated after cSMAC formation arise in the periphery and 
contain around 10-17 TCRs (Campi et al., 2005). Further studies showed continuous formation 
of microclusters and the recruitment of SLP-76 and phosphorylated Lck and ZAP-70 (Yokosuka 
et al., 2005). Association with these molecules is lost towards the cSMAC, where TCR signalling 
appears to be terminated (Varma et al., 2006). Further, treating T cells with the Src tyrosine 
kinase inhibitor PP2, resulted in inhibition of Lck and Fyn – tyrosine kinases important for TCR 
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activation. This blocked ZAP70 recruitment to the IS but not microcluster formation, suggesting 
that microclusters are the sites of TCR signalling (Campi et al., 2005). 
With such experimental approaches however, it can be difficult to dissect the precise roles 
different synapse areas and the protein composition in these. Computational models can be 
useful to delineate the roles of separate processes by changing individual factors. Lee et al 
included the basic principles of TCR signalling; such as TCR phosphorylation, ZAP70 recruitment 
and phosphorylation, adaptor recruitment, basic feedback loops and receptor translocation; in 
a mathematical model of synapse interface organisation (Lee et al., 2003b). They were able to 
show that the cSMAC enhances TCR triggering by concentrating antigen, TCR and downstream 
signalling molecules but this increased receptor activation in turn leads to more complete 
phosphorylation and receptor degradation. The overall effect is to downregulate TCR signalling 
in the cSMAC over time, thus its initial role in receptor activation might have been overlooked 
by experimental analysis alone. Thus the cSMAC controls the balance between strong TCR 
signalling, sufficient for full T cell activation, and signal limitation, to protect T cells from 
overstimulation and apoptosis. 
The authors use a model of poor cSMAC formation to experimentally confirm computational 
findings. CD2AP, which interacts with the cytoplasmic domain of the adhesion protein CD2, is 
required for correct molecular patterning at the synapse and formation of a cSMAC (Dustin et 
al., 1998). CD2AP-/- T cells do not form clearly defined c- and pSMAC in cell-cell conjugates but 
show homogeneous distribution of TCR and integrins. These cells showed increased 
proliferation and IL-2 secretion; and due to such prolonged overstimulation, they also 
exhibited enhanced apoptosis compared to controls (Lee et al., 2003b). 
This model has further implications for TCR signalling cascades following high vs low affinity 
agonists. High affinity antigens may be able to induce signalling without cSMAC formation. The 
time necessary for receptor-ligand binding is short enough compared to the rate of 
dissociation that signalling complexes do not need to concentrate in the cSMAC. 
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Indeed, both mathematical models and experiments analysing T cells on lipid bilayers, suggest 
that clustering of fully activated and phosphorylated TCRs in the cSMAC favours their 
internalisation and degradation. Strong cSMAC signalling can be seen only upon blocking 
receptor degradation (Lee et al., 2003b). Mossman et al showed further support for this level 
of signalling regulation by using patterned substrates to reduce lateral protein mobility 
(Mossman et al., 2005). They showed that mechanically trapping TCR microclusters in the 
periphery of the synapse resulted in prolonged signalling in these clusters. 
TCR downregulation has been shown to involve internalisation of receptors and targeting to 
lysosomes (Valitutti et al., 1997). The concentration of multivesicular bodies in the cSMAC 
suggests that this is the site of receptor internalisation (Varma et al., 2006). Further, ubiquitin 
and the TSG101 protein, part of the ESCRT-I complex which sorts ubiquitinated substrates for 
degradation, are required for the formation of a cSMAC in T:B cell conjugates (Vardhana et al., 
2010). Studies of weakly binding MHC agonists provide support for the cSMAC receptor 
degradation paradigm. Transgenic T cells expressing reduced affinity TCRs are able to reduce 
cSMAC accumulation of TCRs and thus diminish receptor downregulation (Cemerski et al., 
2007). TSG101 is not recruited to the cSMAC of these synapses and does not alter the size or 
signalling capacity of TCR microclusters, suggesting it plays no role in early TCR signalling 
(Vardhana et al., 2010). 
The above studies suggest the cSMAC has an important role in detecting antigen strength/ 
potency as it can amplify signals from weak ligands while limiting those from strong ones. 
A recent study investigated how many of these synaptic components are recruited and 
involved in signalling at the immune synapse over time (Philipsen et al., 2013). The authors use 
antigen-specific B:T cell conjugates and show several distinct stages of synapse evolution and 
maturation. After initial T cell re-orientation, the cSMAC (containing CD3ε) began to appear 
after 10minutes of contact. Around 30-60minutes, co-stimulatory proteins such as CD86 and 
CXCR4 were recruited, suggesting structural reinforcement; while CD45R was excluded from 
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the synapse area. The authors have shown a gradual increase in pZAP70, pLAT and pSLP76, 
suggesting elevated signalling, which peaked between 60-120minutes. While these results are 
consistent with previous studies showing prolonged contacts and increased binding forces 
between T cell and APC (Hosseini et al., 2009), the authors imply that signalling gradually shifts 
from the pSMAC (peak at 60min) to the cSMAC (higher at 120min), which has not been 
described previously. 
There is also controversy surrounding the steady state stoichiometry of surface TCR-CD3 
complexes. One study has shown a mixture of single molecules and complexes of between 2-
20 TCR subunits (Schamel et al., 2005). The authors suggest that the coexistence of these 
species aids sensitivity and allows for distinction between high and low antigen 
concentrations. More recently, it has been suggested that TCR and LAT are located in separate 
‘protein islands’ on the surface of resting cells. Upon TCR engagement, these domains 
concatenate forming signalling microclusters (Lillemeier et al., 2010). Although this is a useful 
model combining levels of temporal and spatial regulation, the precise mechanism is likely to 
be more complicated. Vesicles carrying signalling molecules have been described as key 
players in correct spatiotemporal synaptic organisation (Soares et al., 2013). It has been 
suggested that two populations of pLAT clusters coexist at the synapse interface: one is pre-
existing round clusters, similar to resting cells, the other have an elongated shape which is the 
result of Rab27a-Rab37-Ti-VAMP- targeted vesicle fusion. Soares et al suggests it is the latter 
form of clusters which preferentially recruit pSLP76 and thus transduce TCR signalling. Exact 
LAT signalling localisation remains an area of active research. Some have suggested that the 
majority of signalling occurs as a result of phosphorylating plasma membrane LAT (with a small 
contribution from the vesicular pool) – (Houtman et al., 2006, Balagopalan et al., 2013). Others 
however, have shown evidence for SNARE-mediated LAT vesicles which dock at the synapse 
and it is this recruited population of LAT, rather than pre-existing surface LAT clusters, that is 
responsible for downstream signalling (Purbhoo et al., 2010, Williamson et al., 2011, Larghi et 
al., 2013). The precise organisation of TCR and downstream signalling molecules requires 
 Chapter 1 
37 
 
further analysis or confirmation; in particular, the use of new super-resolution microscopy 
techniques may provide more insights. 
 
Actin at the synapse 
The vast majority of studies point to a centripetal actin flow as the major driving force behind 
the specific organisation of the synapse (Barda-Saad et al., 2005, Billadeau et al., 2007, Kaizuka 
et al., 2007, Hartman et al., 2009, Yu et al., 2010). When T cells were treated with actin-
depolymerising drugs, TCRs failed to polarise and did not show free lateral diffusion (Krummel 
et al., 2000). TCR stimulation has been shown to induce dramatic cytoskeletal changes which 
mould the interface between the T cell and APC (Gomez and Billadeau, 2008). Actin 
polymerisation drives radially symmetric spreading to increase contact surface area with the 
APC. F-actin is then shaped into a peripheral ring, which has been suggested to regulate 
trafficking and clustering of synaptic components (Bunnell et al., 2001, Varma et al., 2006, 
Nguyen et al., 2008, Sims et al., 2007, Babich et al., 2012). 
Kaizuka et al showed robust, symmetric polymerisation-driven retrograde flow coupled to the 
flow of TCR and ICAM-1 microdomains (Kaizuka et al., 2007). In these experiments, the 
movement of TCR microclusters was reported to be at 40% of the speed of actin flow. Some 
elegant experiments using molecular mazes have provided further evidence for centripetal 
actin flow beneath the membrane, which translocates TCR microclusters towards the cSMAC 
(DeMond et al., 2008). The authors suggest that the size of the microcluster or its activation 
state may either initiate inward actin flow or induce coupling of the clusters to the actin 
network. DeMond et al were able to suggest an explanation for the uncoupling of 
translocation speeds seen previously, namely many weak, transient interactions between actin 
and individual receptors within a cluster, which maintain cluster attachment over time. 
Further, Ilani et al showed that TCR microcluster movement as well as signalling from these 
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clusters are dependent on myosin IIA (Ilani et al., 2009). This study however did not determine 
the site of action of myosinII or the precise organisation of F-actin in the IS. More recently, 
actin dynamics have been shown to affect the kinetics of interactions between TCR and MHC 
(Huppa et al., 2010, Huang et al., 2010), highlighting the importance of the actin network in 
TCR signalling. Conversely, laterally restricted TCR microclusters can slow down local actin 
cytoskeleton dynamics in a direction-dependent manner (Yu et al., 2010, Smoligovets et al., 
2012). 
Centripetal movement of actin is well-characterised – the actin network undergoes continuous 
polymerisation towards the leading edge (the distal SMAC, responsible for cell spreading over 
the APC), establishing a flow of existing actin filaments in the opposite direction. Retrograde 
flow is dependent on continued actin depolymerisation (Vallotton et al., 2004) and 
depolymerisation in the central region of the contact has been observed in T cell dynamically 
interacting with lipid bilayers (Beemiller et al., 2012). This organisation could be expected to 
depend on actin depolymerising proteins and regulators. Indeed disrupting cofilin function has 
been shown to interfere with IS formation and results in functional abnormalities in 
proliferation and cytokine secretion (Eibert et al., 2004). Beemiller et al suggest that while 
polymerisation is still the driving force behind actin flow (Varma et al., 2006, Kaizuka et al., 
2007), generating a lower viscosity region in the centre allows continuous movement of actin, 
which compresses the TCR microclusters into the central low actin region (Beemiller et al., 
2012). 
Although confocal imaging suggests clearance of actin from the cSMAC (Orange et al., 2003), it 
is unlikely that this is complete. Higher resolution structured illumination microscopy (SIM) or 
stimulated emission-depletion microscopy (STEDM) show residual actin across the centre of 
NK cell synapses (Brown et al., 2011, Rak et al., 2011). Rak et al in particular show granules 
surrounded by an actin network, which provides support for a role of actin and myosinII in 
exocytosis (Masedunskas et al., 2011, Nightingale et al., 2011). Further high-resolution studies 
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are required to understand the organisation of actin in the cSMAC and these would have to 
consider actin as a 3D structure, including networks running both parallel and perpendicular to 
the IS interface and their respective roles in IS formation. 
It has been proposed that the immunological synapse represents a symmetric version of the 
organisation present in a migrating cell, where the cSMAC corresponds to the uropod, the 
pSMAC corresponds to the lamellum and the dSMAC to the lamellipodium (Dustin, 2007). If 
this is the case, one can conclude that the myosinII-regulated contraction of transverse actin 
bundles seen in migration (Gardel et al., 2010), may co-operate with polymerisation-driven 
forces during the formation, organisation and long-term stabilisation of the synapse. Evidence 
for this was provided in a study by Yi and colleagues, who use fluorescently tagged actin and 
myosin to reveal a concentric ring of actomyosin arc contraction in the lamellum/pSMAC, 
surrounded by actin retrograde flow in the lamellipodium/dSMAC (Yi et al., 2012). Using 
different inhibitors the group was able to show that both actin-dependent forces are required 
for TCR clustering into the cSMAC. There is also evidence for a role of myosinIIA in calcium 
signalling and correct Zap-70 localisation (Yu et al., 2012). 
Cell polarity and MTOC translocation 
Lymphocyte polarisation plays a role in regulating their function. TCR signalling results in the 
mobilisation of the microtubule organising centre (MTOC) towards the IS (Gomez and 
Billadeau, 2008).  Further, during the formation of natural killer (NK) cell synapses, the NK cell 
adheres to its target and polarises its actin cytoskeleton. The MTOC then translocates towards 
the target cell, reminiscent of T cell synapses. In T cells interacting with immobilised, 
photoactivatable peptide-MHC, MTOC repositioning has been shown to occur within 2 minutes 
of activation (Huse et al., 2007, Quann et al., 2009). TCR stimulation and the early TCR 
signalling molecules, including Lck, ZAP70, LAT and SLP-76, have been shown to be important 
(Sedwick et al., 1999, Kuhne et al., 2003, Lowin-Kropf et al., 1998); indeed T cells contacting 
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several APCs are able to polarise towards that presenting most peptide-MHC (Depoil et al., 
2005, Huse et al., 2007), presumably by detecting level of TCR stimulation. 
MTOC polarisation, which also results in the migration of Golgi and endoplasmic reticulum 
(ER), has been proposed to allow recruitment of lytic granules and degranulation in CTL and NK 
cells specifically towards the target cell (Orange, 2008). Requirement for directional secretion 
has also been described in CD4 cells, which appear to utilise two distinct secretory pathways – 
a multidirectional chemokine pathway and a polarised cytokine secretion pathway which is 
crucially dependent on WASp function (Huse et al., 2006, Morales-Tirado et al., 2004). Another 
role of T cell MTOC polarisation may be the orientation of the T cell for asymmetric cell 
division, which may be involved in developing memory T cells (Chang et al., 2007). 
Microtubules are bipolar, similar to actin filaments, and their positive ends radiate outwards 
with negative ends capped at the MTOC. MTOC reorientation appears to depend on pulling 
forces created by minus-end directed microtubule motors (Huse, 2009). Dynein is one such 
microtubule motor; its localisation to the IS is still not completely understood though some 
evidence suggests it may interact with ADAP, which is recruited to the LAT-Slp76 complex 
(Combs et al., 2006). Accumulation of diacylglycerol (DAG) and a cascade of PKC isozymes at 
the synapse have also been linked with recruitment of dynein and MTOC polarisation (Quann 
et al., 2009, Quann et al., 2011). Ezrin, a protein acting as a bridge between the cytoskeleton 
and the plasma membrane has been suggested to regulate Discs-large homologue 1 (Dlg1) 
localisation (Lasserre et al., 2010). Depletion of Dlg1 itself reduced MTOC polarisation to the IS, 
which may implicate the Dlg1-containing Scrib complex, and its mutually inhibitory interactions 
with the Par (partitioning defective) complex, in immune cell polarisation and synapse 
formation (Nelson, 2003, Huse, 2011). Indeed, there is some evidence for a role of these 
polarity complexes in T cell polarity upon IS formation although this mechanism seems to 
develop later and may be involved in long-term maintenance rather than initiation of 
polarization (Ludford-Menting et al., 2005, Bertrand et al., 2010). In NK cells, VAV1 has been 
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identified as a regulator of both actin and microtubule dynamics required for cytotoxicity at 
the IS (Graham et al., 2006). In CD8 T cells, Cdc42 has been shown to play a role in MTOC 
reorganisation (Stowers et al., 1995). Further, the Cdc42-interacting protein 4 (CIP4) interacts 
with WASp, Cdc42 and tubulin and is required for full MTOC migration in NK cells (Banerjee et 
al., 2007).  
Although the precise molecular mechanism needs clarification, coupling to a functional actin 
cytoskeleton appears to be essential (Orange et al., 2002, Graham et al., 2006). F–actin 
clearance from the central synapse area (cSMAC) appears to be required for migration of the 
MTOC towards the IS and to allow lytic granules to reach the plasma membrane (Stinchcombe 
et al., 2006, Huse, 2012, Orange et al., 2003, Andzelm et al., 2007), though some residual actin 
appears to play a part in completing exocytosis (Brown et al., 2011, Rak et al., 2011). 
Coordination between the actin and microtubule cytoskeleton is also apparent in studies of 
casein-kinase I-δ (CKIδ) and IQGAP1, which interact with both actin- and microtubule-binding 
proteins, and when depleted in Jurkat cells or NK cell lines respectively, result in diminished 
MTOC polarisation (Zyss et al., 2011, Stinchcombe et al., 2006).  
A recent study challenged the motor-driven cortical sliding mechanism for MTOC relocation (Yi 
et al., 2013). Their optical trap experiments showed two distinct stages in the process – MTOC 
translocation and docking. Their imaging suggested that MTOC polarisation is the result of 
dynein-driven microtubule end-on capture-shrinkage directly to a point in the centre of the 
synapse (Yi et al., 2013). It would be interesting to see if evidence for this mechanism develops 
further. 
The role of integrins 
The integrin LFA-1 (CD11a/CD18) has been shown to play a crucial role in the organisation of 
the NK cell IS (Liu et al., 2009). Binding of LFA-1 to its ligand induces actin reorganisation and 
NK cell polarisation (Mace et al., 2009). Activation of LFA-1 separates the two cytoplasmic tails 
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of this integrin, allowing talin to bind to the β-chain (CD18) and stabilise the open, active 
conformation. Talin subsequently activates actin polymerisation by two separate pathways. It 
can recruit the actin nucleator Arp2/3 through association with vinculin. Talin can also recruit 
PIPKIγ (phosphatidylinositol 4-phosphate 5-kinase type I) to the activated LFA-1. The product 
of PIPKIγ, PIP2 (phosphatidylinositol-4,5-bisphosphate) in turn recruits WASp (Mace et al., 
2010). 
The first LFA-1 ligand identified was ICAM-1 (Dustin et al., 1986, Rothlein et al., 1986). LFA-1 
can be fully activated by cluster organisation through lateral mobility or increased force due to 
binding to ICAM-1 (Zhu et al., 2008, Dustin, 2009b). LFA-1 can also be activated through inside-
out signalling, the precise details of which are still elusive. TCR activation recruits Vav, which 
can itself recruit talin to directly interact with cytoplasmic integrin tails as discussed above 
(Gomez and Billadeau, 2008). The accumulation of DAG, following TCR signalling, also results in 
the recruitment of the Rap-1 GEF C3G (Krawczyk et al., 2002, Nolz et al., 2008). Rap-1 is 
thought to activate RIAM (Rap-GTP interacting adaptor molecule), which in turn allows 
recruitment of vinculin and talin (Nolz et al., 2007). Talin is required for LFA-1 mediated cell 
adhesion (Smith et al., 2005, Mace et al., 2009). Several studies have demonstrated the 
importance of LFA-1 in combination with an activated receptor for the symmetric organisation 
of the IS (Somersalo et al., 2004, Anikeeva et al., 2005, Markiewicz et al., 2005). 
Although clearly crucial for T cell: APC adhesion, there is also evidence for a role of LFA-1 is 
signal transduction (Abraham et al., 1999, Perez et al., 2003). An early report by van Seventer 
et al showed that engagement of LFA-1 by plate-bound ICAM-1 enhanced T cell activation 
following TCR/CD3 cross-linking (Vanseventer et al., 1990). LFA-1 engagement was also able to 
enhance total T cell activation induced by PMA and ionomycin, suggesting that the adhesive 
role of LFA-1 in this process was irrelevant. Abraham et al expressed a covalently coupled class 
II-peptide complex in order to increase the density of surface MHC/OVA compared to cells 
pulsed with exogenous peptide. They were able to show that increasing the density of 
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effective antigens by more than 10000 times, compared to the minimum required for naive T 
cell activation, does not induce T cell proliferation in the absence of ICAM-1 engagement 
(Abraham et al., 1999). Thus LFA-1 engagement affects both the quantity and quality of TCR 
signalling. The idea that integrins transduce signals is not novel (reviewed in (Dedhar and 
Hannigan, 1996, Parsons, 1996).  
In support of this idea, it has been shown that LFA-1 engagement results in activation of PKCδ, 
which phosphorylates the β2 chain of the integrin, promoting the release of JAB-1 (Perez et al., 
2003). JAB-1 (Jun-activating binding protein 1) has been shown to modulate the activity of the 
transcription regulating complex AP-1 (Bianchi et al., 2000). Perez et al demonstrated 
increased translocation of phosphorylated c-Jun to the nucleus in T cells with CD3, CD28 and 
LFA-1 stimulation compared to CD3/CD28 alone. Further, the authors identified cytohesin-1 as 
the mediator of Erk1/2 phosphorylation following LFA-1 activation. Erk1/2 activity leads to c-
Fos expression, which together with c-Jun forms AP-1, an early response transcription factor. 
Their results showed that these pathways promoted T cell activation (CD69, CD25 and IL-2 
expression) and proliferation. A combination of antagonists against both JAB-1 and cytohesin-1 
resulted in higher inhibition of IL-2 production than either antagonist alone. The authors also 
suggest that LFA-1 engagement polarises T cells towards a Th1 effector cell fate (discussed in 
chapter 5). 
Altogether these results suggest that LFA-1 activation can transduce signals independent of 
the TCR signalling pathway and thus fine tune T cell signalling. One unanswered question is 
whether different LFA-1 ligands result in distinct downstream signalling. In the above study, 
Perez et al use soluble ICAM-2 to activate LFA-1 and downstream JAB-1 and cytohesin-1. In 
their hands, soluble ICAM-1 did not induce phosphorylation of Erk1/2. They suggest that this 
may reflect a distinction in signal transduction, though it is unclear whether they tested the 
effect of different ICAMs on the JAB-1-c-Jun pathway.  
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Cytohesin-1, through its GEF activity, has been shown to play a role in chemokine-induced 
leukocyte arrest and trans-endothelial migration (Weber et al., 2001). If different LFA-1 ligands 
do result in distinct downstream signalling, it is easy to see how ICAM-2 and -3 may be more 
important in the process of extravasation, while ICAM-1 regulates LFA-1 signalling during other 
processes, such as immune synapse formation. Another possibility may be a difference 
between soluble, cell surface and immobilised LFA-1 ligands. For example, plate-bound ICAM-1 
has been shown to induce F-actin reorganisation downstream of LFA-1 (Porter et al., 2002).  
LFA-1 has an important function in vivo as blocking its adhesion (independent of ligand) using 
LFA-1 antagonists has been shown to inhibit delayed-type hypersensitivity (Winquist et al., 
2001) and suppress inflammation in a peritonitis model (Weitz-Schmidt et al., 2001). 
Like TCR microclusters, LFA-1 in the pSMAC is also highly dynamic (Sims et al., 2007, Kaizuka et 
al., 2007). This suggests that the IS represents a structure balancing many dynamic processes 
to produce a stable interaction, rather than employing more long-term adhesive forces. This 
may help to explain the similarities in the actin networks and regulators between the synapse 
and the motile T cell scanning structure dubbed the kinapse (Dustin, 2009b) (discussed in 
previous sections).  
Function of the synapse 
The role of the immune synapse is also still not fully understood. Many studies suggest it 
directs polarised release of cytokines in CD4 cells (Kupfer et al., 1991, Poo et al., 1988) or limits 
the area for secretion of perforin and granzymes by cytolytic cells to prevent bystander effects 
(Stinchcombe et al., 2001, Liu et al., 2009, Stinchcombe et al., 2011). While cytolytic molecules 
must be contained towards specific target cell, many chemokines for example need to be 
dispersed into the cellular environment. Huse et al have proposed that CD4 cells have 
directionally distinct pathways for exocytosis of different secreted factors (Huse et al., 2006). 
The authors show that Th1 cells secrete IL-2 and IFNγ directionally towards the synapse, while 
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TNF secretion is scattered and multidirectional. The two secretion pathways appeared to 
utilise distinct secretion proteins. This polarised secretion was also shown to be dependent on 
intact microtubule function. Further, the authors investigated cytokine secretion in Th2 and 
found IL-10 to be synaptically directed, while IL-4 localised to dispersed compartments 
throughout the cell (Huse et al., 2006). It is unclear whether similar bimodal secretion occurs in 
other T cell types or other immune cell lineages.  
The precise organisation of secretory modules is also controversial. Stinchcombe et al have 
suggested a split central region architecture, where secretion occurs alongside the cSMAC 
(Stinchcombe et al., 2001). More recent evidence in T cells suggests that secretion can occur in 
various parts of the synapse (Beal et al., 2009). Further, the cytolytic synapse formed by NK 
cells appears to be able to form several actin-poor secretory domains at multiple sites (Rak et 
al., 2011, Brown et al., 2011). 
Others have shown a very extensive, bidirectional communication involving gap junctions at 
the IS (Mendoza-Naranjo et al., 2011); and even trogocytosis – the intercellular exchange of 
membrane patches with different compositions (Ahmed et al., 2008). Crucially, cell 
polarisation and MTOC translocation described above can be expected to play a role in 
establishing a cell division plane parallel to the synapse interface in T cells, to allow asymmetric 
division seen upon specific antigen recognition (Chang et al., 2007, Oliaro et al., 2010).  
Synapses between different cells are likely to have different functions and although many of 
the molecular complexes may be similar, there is no reason to believe that formation and 
organisation will involve the same processes and final outcomes. Whatever the organisation or 
role of the IS between T cells and DCs, there is general agreement that it leads to optimal T cell 
activation through both receptor signalling and degradation (Lee et al., 2003b). Further, the 
role of the T cell actin cytoskeleton in this process is widely accepted (Gomez and Billadeau, 
2008, Dustin, 2009a). Most of our knowledge of synapses described so far comes from the 
more intensively studied T cell: B cell and T cell: lipid bilayer immune synapses. Although there 
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is evidence that the DC: T cell synapse forms a similar structure (Lee et al., 2002, Benvenuti et 
al., 2004b, Bouma et al., 2011) this has been controversial. Other groups, using fluorescence 
and electron microscopy, have suggested that DCs preferentially form a multifocal synapse 
(Brossard et al., 2005, Tseng et al., 2008). 
As discussed, T cells are able to endocytose and degrade spent TCRs at the cSMAC. It is unclear 
whether similar event downregulation occurs on the DC side of the synapse. One group has 
suggested that peptide-MHC complexes are internalised and rapidly recycled back to the 
surface in a pathway distinct from newly synthesised MHCII molecules (Walseng et al., 2008). 
It is still unknown whether this recycling to the surface is targeted to cell: cell contacts in 
mature, polarised DCs. 
 
Imaging the immune synapse 
 
Large scale in vivo imaging is useful in determining the cell: cell interactions at play in relevant 
immunological environments during a whole-organism immune response. Lindquist et al for 
example, combine fluorescent marker expressing transgenic mice and two-photon microscopy 
to visualise lymph node DC networks and compare mature and immature cells (Lindquist et al., 
2004). Multi-photon studies have revealed that T cells can migrate up to ten times faster than 
other cell types and arrest upon antigen encounter to allow activation (Stoll et al., 2002, 
Bousso et al., 2002, Miller et al., 2002, Mempel et al., 2004).  
 
On a smaller scale, imaging the IS interface requires increased speed and resolution, in a set 
imaging plane. Several techniques have been developed to allow imaging in the interface plane 
and avoid reconstruction from multiple optical sections. Oddos et al used optical tweezers and 
confocal microscopy to show CD3 clustered in the centre of a T cell: B cell interface, with 
microclusters being formed in the periphery and some fluorescence loss in the very centre 
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which could correspond to internalisation (Oddos et al., 2008). The intricate cell capture and 
alignment however, result in very low throughput in this type of imaging. 
 
Another system designed to induce IS formation in the horizontal imaging plane was 
developed by Biggs et al (Biggs et al., 2011). The group created PDMS micropits designed to 
capture single T cell: APC conjugates. The substrates allow analysis of multiple conjugates in a 
single imaging field thus significantly increasing throughput. Although this method proved 
useful for detailed analysis of an artificial APC system, it may be more difficult to maintain the 
interface plane when imaging cells of different sizes and shapes. 
 
Supported planar bilayers have become an extremely useful method of imaging and modelling 
the IS interface. Supported bilayers are commonly formed from phospholipid liposomes, which 
fuse together on clean glass coverslips. Signalling or adhesion related proteins can be anchored 
to the upper leaflet of the bilayer and remain laterally mobile (Groves and Dustin, 2003). 
Although a more artificial technique for T cell activation, presenting MHC-peptide complexes 
and costimulatory molecules in this way can fully recapitulate the SMAC pattern on the T cell 
surface, described initially by Kupfer and colleagues. The use of total internal reflection 
fluorescence (TIRF) microscopy to image supported planar bilayers has improved resolution 
and increased the signal-to-noise ratio observed. In TIRF, the laser beam is directed at the glass 
surface at an angle greater than the critical angle, resulting in total reflection. The sample is 
illuminated by an evanescent wave produced, which penetrates no more than 200nm into the 
cell (Groves and Dustin, 2003). The technique allowed several groups to follow the 
translocation of TCR microclusters from the periphery to the cSMAC over time and led to the 
discovery that signalling-competent microclusters are formed continuously in the periphery 
(Varma et al., 2006, Yokosuka et al., 2005). Patterned substrates have also been used to 
analyse the importance of microcluster translocation (Groves and Dustin, 2003, Yu et al., 
2010). 
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Single molecule fluorescence resonance energy transfer (FRET) combined with lipid bilayers 
has shown that F-actin networks beneath the synapse can regulate the TCR: MHC interaction 
by affecting the off-rate (Huppa et al., 2010). 
Single-molecule localisation microscopy, such as photoactivated localisation microscopy 
(PALM) or stochastic optical reconstruction microscopy (STORM), can provide information 
about the nanoscale organisation of molecules at the synapse. It involves cycles of 
photoactivation, detection and bleaching of a fraction of molecules to build up an image of the 
population of fluorophores. This overcomes the diffraction limit of most light microscopy and 
allows resolution of around 20nm. This type of microscopy has been used by two groups to 
resolve how TCR and LAT come together during the initial stages of signalling. Mark Davis and 
colleagues combined PALM with membrane sheet electron microscopy to suggest that TCR 
and LAT are segregated in ‘protein islands’ at steady state, which concatenate but do not mix 
during signalling (Lillemeier et al., 2010). Dan Davies and Katharina Gaus used optical tweezers, 
confocal microscopy and PALM, combined with a novel method for data analysis to 
differentiate between LAT in the plasma membrane or that located in sub-synaptic vesicles 
(Purbhoo et al., 2010, Williamson et al., 2011). They argue that this vesicle-associated LAT 
population is recruited and phosphorylated upon TCR activation, without vesicle fusion with 
the plasma membrane. The differences in findings between these studies may reflect 
difference in cell types, time points or T cell activation methods used. 
A recent study used STORM microscopy to examine the role of ITAM phosphorylation and 
suggested that this step was essential for induction of proliferation but dispensable for IL-2 
production in T cells (Guy et al., 2013). This is an elegant example of how super-resolution 
microscopy can be used to address functional questions. Furthermore, the study also 
suggested a link between surface TCR-Notch1 clusters and the actin cytoskeleton through 
interaction with Vav1. Further analysis of this pathways would be invaluable for understanding 
the role of F-actin in IS formation. 
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In NK cells, structural illumination microscopy (SIM) and stimulated emission depletion (STED) 
microscopy have been used to study the actin cytoskeleton and have provided evidence for 
remodelling of the actin meshwork upon activation to create holes for the release of lytic 
granules (Brown et al., 2011, Rak et al., 2011). 
Micromanipulation experiments have also shed light on interactions during T cell activation by 
analysing the affinity, kinetic rates and duration of TCR: MHC-peptide bonds between a T cell 
and a biomembrane force probe (BFP; bead attached to red blood cell). Initially it was shown 
that the strength, of an agonist bond correlated with a faster on-rate, unlike many other 
systems directed by off-rates (Huang et al., 2010). More recently, the same group used BFPs to 
show that force applied to the TCR:MHC complexes has differential effects on agonist and 
antagonist interactions. For agonists, force prolongs the lifetime of a single bond, described as 
a catch bond. For antagonists, force shortens the bond lifetime, resulting in a slip bond. The 
magnitude, duration and timing of the force applied, were all shown to affect T cell activation, 
highlighting a mechanosensory role for the TCR (Liu et al., 2014). 
Recent advances in microscopy have greatly improved our understanding of T cell activation, 
however, further developments in high-speed imaging and 3D super-resolution, as well as 
analytical methods are required for a complete picture of how the signalling, adhesion and 
cytoskeletal systems combine and are controlled over time to contribute to the induction of 
tolerance or immunity.  In particular, imaging events on the DC side would provide useful clues 
about how this contributes to IS organisation. Further adaptation of the supported planar 
bilayer system for DCs could be useful. In addition, super-resolution imaging techniques 
applied to cell: cell conjugates will be required to confirm findings in artificial bilayer systems. 
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3. The T cell side: TCR signalling, costimulation and cytokines 
T cell activation 
DCs are the most efficient antigen presenting cells (Mellman and Steinman, 2001). Antigen 
taken up by DCs is processed and presented by MHC class II to CD4+ T cells. Recognition of the 
antigen, along with expression and activation of costimulatory molecules results in activation 
of antigen-specific CD4+ T cells, leading to lymphoproliferation, cytokine secretion and 
upregulation of other activation markers (Caruso et al., 1997). 
T cell activation is commonly described as a three-signal process. Signal 1 involves TCR 
recognition of a cognate peptide-MHC complex. As described in the previous section, this 
results in phosphorylation of CD3 chains initiating a cascade which results in calcium 
mobilisation, activation of GEFs and eventually gene transcription (Haskins et al., 1984, 
Cantrell, 1996, Smith-Garvin et al., 2009). 
The second signal is provided by surface costimulatory molecules (Jenkins et al., 1990, 
Schwartz, 1992, Jenkins and Johnson, 1993). Interestingly, studies have suggested that the 
initial response of the immune system is similar for the first 3-4 days regardless of whether the 
eventual outcome is tolerance or immunity (Kearney et al., 1994). Such a late decision has 
been proposed to suggest that costimulatory signals must play an important role in 
polarisation of the immune response, rather than simply TCR antigen recognition (Gerard et 
al., 2013). This is supported by studies suggesting that TCRs can respond to multiple antigens, 
thus correct downstream activation may be dependent on other qualitative levels of 
stimulation (Colf et al., 2007, Felix et al., 2007). 
Costimulatory ligands CD80 and CD86, expressed primarily on APCs, interact with CD28 or 
CTLA-4 on T lymphocytes and play a role in regulating T cell responses (Linsley et al., 1991). 
CD80 and CD86 are type I transmembrane proteins, members of the immunoglobulin 
superfamily, with short cytoplasmic domains and extracellular domain similar to Ig variable 
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and constant region (Peach et al., 1995). The cytoplasmic domains have been implicated in T 
cell activation, thus highlighting the role of the dendritic cell cytoskeletal network in signal 
transduction (Tseng et al., 2005). Further, MHCII signalling has also been shown to induce 
surface B7 (CD80) upregulation (Nabavi et al., 1992) to provide increased costimulation for T 
cells.  
While CD28 appears to be expressed on a large number of T cells  (Gross et al., 1992), CTLA-4 
expression is restricted to activated T cells (Freeman et al., 1992, Linsley et al., 1992). CD28 
provides a positive costimulatory signal by enhancing production of IL-2, reducing the 
threshold of TCR triggering for activation and promoting organisation of the IS (Viola et al., 
1999, Wulfing et al., 2002). Transduction of B cell lines with B7 has been shown to provide 
sufficient costimulatory signal to induce T cell proliferation (Azuma et al., 1992, Norton et al., 
1992).  CD28 engagement was shown to be required for full activation of PKCθ, which in turn 
activates AP-1 and NF-κB transcription factors (Sun et al., 2000, Coudronniere et al., 2000, 
Huang et al., 2002). Upon ligand binding, tyrosines in the cytoplasmic tail of CD28 are 
phosphorylated by Src-family kinases and in turn recruit proteins such as PI3K, Grb2, Vav1 and 
ITK (Huse, 2009). Most of these downstream effectors are also recruited upon TCR activation, 
suggesting that CD28 enhances TCR signalling through similar pathways (Acuto and Michel, 
2003). 
CTLA-4 on the other hand plays an important inhibitory role by blocking IL-2 gene transcription 
(partly by inhibiting the nuclear translocation of NF-AT (nuclear factor of activated T cells)) and 
inhibiting T cell proliferation (Krummel and Allison, 1996, Brunner et al., 1999). Further, CTLA-
4-deficient mice show polyclonal T cell expansion resulting in lymphoproliferative disease with 
the majority of peripheral T cells exhibiting an activated phenotype (Waterhouse et al., 1995, 
Tivol et al., 1995). CTLA-4 deficiency also appears to result in preferential CD4 T cell expansion 
as depletion of CD8 cells in these mice has no effect on lymphoproliferation, while CD4 
depletion prevents lymphoproliferative disease (Chambers et al., 1997). CTLA-4 ligation also 
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results in tyrosine phosphorylation (Miyatake et al., 1998) which may recruit phosphatases to 
dephosphorylate local TCR signalling effectors (Huse, 2009). CTLA-4 also has a 10-fold higher 
affinity and 100-fold higher avidity than CD28 for binding to CD80 and CD86 (vanderMerwe et 
al., 1997, Metzler et al., 1997) which may allow it to compete CD28 off these ligands. 
More recently it was shown that CD80 localises to the IS in rings around central TCR clusters, 
where it is required for the synaptic accumulation of CD28, CTLA-4 and PKCθ in activated T 
cells. Deletion of the CD80 cytoplasmic domain abrogated synaptic organisation and led to 
reduced T cell proliferative response (Tseng et al., 2005). As the segregation of CD28 and TCR 
depends on the cytoplasmic tail of CD80, removal of this resulted in colocalisation of CD28 and 
TCR, correlating with reduced T cell activation. This provides strong evidence for the idea that 
segregation of some synaptic components is crucial for correct function. 
TCR activation alone, in the absence of costimulatory signals, was shown to induce a type of 
anergy or antigen tolerance in T cells, which could be rescued by addition of IL-2 or CD28 
stimulation (Jenkins et al., 1991, Schwartz et al., 1989, Finck et al., 1994). Though this is harder 
to show in vivo/ in primary cells (Chen et al., 1994, Shahinian et al., 1993). Furthermore, these 
interactions can affect signalling qualitatively, for example, CD80 and CD86 do not induce 
identical downstream signalling responses (Freeman et al., 1995, Bluestone, 1995). 
Signal 3 during T cell activation is provided by inflammatory cytokines and has also been 
described as the ‘danger signal’ provided to T cells in response to pathogens (Curtsinger et al., 
1999). Early studies suggested that adjuvants, such as CFA or LPS, when administered with 
antigen, result in greater clonal expansion and no induction of tolerance, most likely by 
inducing strong inflammatory cytokine responses (Pape et al., 1997). In the absence of signal 
three, T cells have been shown to become tolerant rather than activated (Curtsinger et al., 
2003). Cytokines can act directly on CD4 cells through T cell surface receptors (Dinarello, 1988, 
Weaver et al., 1988) or indirectly, by inducing increased costimulatory molecule expression on 
APCs (Liu and Janeway, 1991, McLellan et al., 1996, Yang and Wilson, 1996). Different types of 
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T cells require different cytokine stimulation, for example CD4 T cells have been shown to 
respond to IL-1, while CD8 require IL-12 for complete activation (Curtsinger et al., 1999). In 
order to respond correctly to a particular antigen, the immune system must also assimilate 
information about the nature of the antigen. Signal three can convey this information and, for 
example, polarise T helper cells towards the required subset (Scott, 1993). Each T cell subtype 
is then characterised by its cytokine secretion profile, which correlates with its function 
(Kapsenberg, 2003).  
Figure 1.2 summarises the three-signal model described above and the events that lead to 
actin mobilisation downstream of TCR activation. 
The three-signal model may be more complex than expected as some evidence suggests DC-
mediated Th1 polarisation requires IFNγ production by a third cell, such as a previously 
activated T cell, thus supporting a three-cell T cell activation model (Abdi et al., 2006, Corthay, 
2006). In this model NK cells, γδ T cells, mast cells, basophils and eosinophils could all 
contribute to Th cell polarisation (Corthay, 2006). 
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 Figure 1.2. T cell activation. The figure illustrates cell-cell contact between a T cell and an APC; and the three signals described to be involved in T cell 
activation – TCR triggering, costimulation and cytokine responses. ICAM-1 and LFA-1 represent a crucial adhesion mechanism for stable interaction. A brief 
summary of signalling downstream of the TCR is presented on the RHS. 
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T helper cell fate 
Activation of T helper cells directs them towards one of several differentiation pathways. At 
least 4 major types of T-helper cell have been identified – Th1, Th2, Th17 and Treg. Th1 cells 
produce predominantly IFNγ and play a role in responses to intracellular infections, 
culminating in activation of cytotoxic T lymphocytes. IL-12 is produce by DCs and polarises T 
cell to a Th1 response (Abdi, 2002). Th2 cells are critical for fighting extracellular parasites and 
produce a variety of interleukins including IL-4, leading to B cell differentiation into plasma 
cells (Mosmann and Coffman, 1989). Th17 cells, through production of IL-17a, IL-17f and IL-22, 
are involved in immune responses against extracellular bacteria and fungi (Miossec et al., 
2009). Tregs are important for regulating lymphocyte activation and function, and are thus 
crucial for maintaining immune tolerance (Vignali et al., 2008).  
Differentiation into each T-helper cell subset is controlled through the activity of master 
regulators (transcription factors) and is determined by the nature of the antigen, its affinity to 
the TCR and the cytokine milieu at the time of T cell activation. Cytokine receptors are non-
covalently bound to tyrosine kinases of the Janus kinase family. Ligation, dimerisation or 
clustering of the receptors brings the JAKs in close proximity and allows cross-phosphorylation. 
This leads to both recruitment and phosphorylation of signal transducers and activators of 
transcription (STATs). Phosphorylation results in a conformational change in the STAT protein 
leading to homo- or hetero-dimerisation. This allows dissociation from the receptor, nuclear 
translocation and regulation of transcription (Heim, 1999). Different STATs interact with 
different cytokine receptors and result in distinct transcription profiles. As reviewed by Zhu 
and Paul (Zhu and Paul, 2010), the relative amounts of cytokines and transcription factors 
determine the diversity and stability of the T helper cell subsets induced. The master 
regulators for the major subsets are described in Table1. 
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Master regulator CD4 lineage General pathway 
T-bet (TBX21) Th1 STAT1 activated by IFNγ induces further T-bet expression 
(Lighvani et al., 2001) 
GATA3 (GATA3) Th2 
STAT6 activated by IL-4 upregulates GATA3 expression 
(Kaplan et al., 1996), though GATA3 is involved in several 
step of CD4 development (Ho et al., 2009) 
RORγT (RORC) Th17 
IL-6, IL-21 and IL-23 are critical for STAT3 activation and 
induction of RORγT, critical for IL-17 production (Veldhoen 
et al., 2006, Korn et al., 2007) 
FoxP3 (FOXP3) Treg TGFβ, through Smad3, and STAT5 are critical for FoxP3 
induction (Davidson et al., 2007) 
 
Table1. The major transcription factors determining CD4 T cell fates. Gene names are given in 
brackets. 
 
As well as cytokine signalling, it has been proposed that co-stimulators and antigen dose may 
influence the final Th effector response (reviewed in (Murphy and Reiner, 2002)). Details of 
how each factor regulates the transcription pathways are unknown. It was shown that 
activation of the Th2 response through GATA3 requires CD28 co-stimulation (Rodriguez-
Palmero et al., 1999). Although the study does not consider the physiological relevance of this 
alongside the STAT6 pathway, the idea of additional Th response polarising mechanisms during 
cell-cell contact is gaining support. LFA-1 signalling was shown to have the opposite effect and 
was proposed to skew the CD4 response towards a Th1 type (Salomon and Bluestone, 1998, 
Smits et al., 2002). 
Another theory (Amsen et al., 2004) suggests that APCs express different Notch ligands to 
induce either Th1 or Th2 differentiation. A Th2 response is induced by Jagged-mediated Notch 
activation, which leads to conversion of RBPJκ from a transcriptional repressor to an activator, 
which in turn binds to a conserved region in the IL4 promoter allowing IL-4 (and thus GATA3) 
expression by bypassing STAT6. Conversely, the Delta ligand (the other family of Notch ligands) 
induced a Th1 response though the mechanism behind this is not understood. 
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There is also evidence pointing towards a role for the immune synapse in Th fate commitment 
(Maldonado et al., 2004). Maldonado et al show co-polarisation of IFNGR (IFNγ receptor) with 
TCR to the IS, leading to a Th1 response. IL-4 blocked the observed co-polarisation through 
STAT6 activation. The strength of the synapse may be an important regulating factor. Several 
groups have shown that varying the strength of the contact, either through antigen dose or 
antigen affinity for TCR, can alter T helper differentiation (Hosken et al., 1995, Constant et al., 
1995, Tao et al., 1997b). Tao et al for example, suggest that the importance of CD28 ligation in 
inducing IL-4-producing Th2 cells is dependent on the strength of primary signal stimulation 
(restricted to cases where T cells receive a low dose of TCR priming). 
More recently, Purvis et al showed that low-strength T cell activation through the TCR/CD3 
complex (using a lower CD3/CD28 bead: T cell ratio, in the presence of Th17 cytokines in 
culture) promotes an increased Th17 response, only in the presence of anti-CD28. Nuclear 
translocation of NFATc1 occurred following either high or low TCR signal strength activation, 
however binding of NFATc1 to the proximal region of the IL-17 promoter was only detected 
following low signal strength activation (Purvis et al., 2010). 
By contrast, Bouguermouh et al (Bouguermouh et al., 2009) showed that anti-CD28 
stimulation suppressed differentiation of anti-CD3-activated CD4+ T cells into IL-17-producing 
cells through an IL-2 and IFNy-dependent mechanism. This group used a soluble anti-CD28 
mAb instead of bead-mediated activation. It is unclear whether the variation in these results is 
due to different types of antibodies or TH17-polarising cytokine cocktails/milieu used. If indeed 
CD28 costimulation has an inhibitory role in Th17 differentiation, synaptic disorganisation 
leading to reduced CD28 stimulation could result in increased Th17 differentiation and 
therefore Th17-associated inflammatory responses.  
It is easy to envisage how disrupted expression of cell surface molecules or synaptic 
organisation of DCs may have an effect on tuning the Th fate induced. Organisation of 
 Chapter 1 
58 
 
integrins, cytokine receptors and co-stimulatory molecules may be crucial and an abnormal 
actin cytoskeleton can cause defects in this process. 
While there has been a lot of research on the T cell side of the conjugate, little is known about 
how the DC cytoskeleton affects synapse formation, though there is evidence for its 
involvement (Al-Alwan et al., 2001, Benvenuti et al., 2004a, Bouma et al., 2011). 
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4. Wiskott-Aldrich Syndrome and WASp 
Clinical characteristics and cellular defects 
Much of our understanding of the involvement of the actin cytoskeleton in immune cells 
comes from studying patients with actin-related immunodeficiencies. Wiskott-Aldrich 
syndrome (WAS) in particular has provided an insight into the importance of actin regulation 
for lymphocyte function (Nguyen et al., 2007). While fewer studies have focussed on the APC, 
it is likely that similar mechanisms may be involved. In this thesis, deficiency of the actin-
regulating Wiskott-Aldrich Syndrome protein was chosen as a model system to study the 
involvement of the DC actin cytoskeleton.  
Wiskott-Aldrich Syndrome is a rare but severe X-linked immunodeficiency affecting 2-4 live 
births per million. It is characterised by eczema, microthrombocytopoienia, autoimmunity and 
an increased risk of lymphoid malignancies (Thrasher, 2002, Ochs and Thrasher, 2006). The 
disease results from the loss of WASp expression/activity (Derry et al., 1994) and over 300 
unique mutations have been recorded with further mutations being identified regularly 
(Massaad et al., 2013, Safaei et al., 2012). Deletions and early terminations, which abolish 
WASp expression, result in severe disease. Missense mutations, which may reduce protein 
expression or function, cause milder forms of disease such as X-linked thrombocytopenia (Zhu 
et al., 1995, Albert et al., 2010). WASp activating mutations have also been described; these 
result in X-linked neutropenia (Devriendt et al., 2001, Ancliff et al., 2006). The increase in 
cellular actin caused by active mutants can cause cytogenetic abnormalities and defects in 
mitosis and cytokinesis (Moulding et al., 2007). 
Unlike N-WASp, another member of the WAS family of proteins, WASp expression is restricted 
to the immune system, where its mutation results in a range of actin-related abnormalities in 
many basic immune cell functions. These include myeloid cell defects, such as reduced 
migration, chemotactic responses and phagocytosis in macrophages and DCs; and lymphocyte 
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defects such as reduced cell surface protrusions, poor T cell proliferation and TCR capping, 
reduced marginal zone B cells and abnormal humoral responses (Notarangelo et al., 2005, 
Blundell et al., 2010, Thrasher and Burns, 2010).  
This broad range of defects results in a complex immunodeficiency due to cell-intrinsic and 
migration defects, as well as defects in cell-cell communication. One complex effect of this is 
autoimmunity and autoantibody production, which has been described both in patients 
(Schurman and Candotti, 2003) and murine models (Nikolov et al., 2010). Many factors have 
been described to contribute to this including increased apoptosis, reduced IL-2 secretion, 
chronic stimulation, impaired NK cell cytotoxicity and impaired phagocytosis (Schurman and 
Candotti, 2003, Blundell et al., 2010). Severe invasive infections, atopic eczema, colitis and 
hyper IgE found in WAS patients and murine models strongly indicate impaired Th1 and 
augmented Th2 responses (Imai et al., 2004). 
As well as its role in actin regulation, WASp may be involved in transcriptional regulation 
(Huang et al., 2005, Taylor et al., 2010). Independently of its actin polymerisation activity, 
WASp was shown to control the nuclear translocation of the transcription factors NFAT2 and 
NFκB (RelA) in NK cells (Huang et al., 2005). The same group showed WASp interaction with 
the proximal promoter locus of the Tbx21 gene and suggested that the reduced Tbet mRNA 
and protein levels in WASp deficient cells partly explain the Th1/Th2 imbalance in WAS (Taylor 
et al., 2010). Recently, Looi et al used ChIP and microarray assays to show interaction of WASp 
with RNA polymerase II and differential transcription profiles in myeloid cells expressing 
constitutively active WASp (Looi et al., 2014). The role of actin and its regulators in the nucleus 
is still not fully understood. 
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WASp structure and regulation 
WASp is a modular protein, containing an N-terminal EVH1 (also called WH1) domain, a GTP-
ase binding domain (GBD), a polyproline domain, and a C-terminal VCA (verpolin/cofilin/acidic) 
domain involved in autoinhibition (Kim et al., 2000). The presence of multiple domains and 
lack of enzymatic activity suggest that WASp can act as a scaffold to recruit a range of other 
adaptors, kinases and actin-binding proteins (Figure 1.3). This would suggest that WASp is an 
important platform with a role in signal integration from many molecular pathways to Arp2/3. 
Intramolecular interaction between the GBD and VCA domains results in a closed 
conformation, allosterically blocking VCA interaction with Arp2/3. WASp activators disrupt 
GBD-VCA interactions, relieving autoinhibition and allowing WASp to bind and activate Arp2/3 
(Kim et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.3. WASp domains and autoinhibition. Adapted from Bouma et al (Bouma et al., 2009) 
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In an active conformation, WASp binds Arp2/3 via its VCA domain (Figure 1.3). This complex 
initiates the formation of a new filament, branching from an existing one at a 70° angle 
(Mullins et al., 1998). The VCA domain also binds actin monomers, thus providing a 
concentrated local pool.  
Tyrosine phosphorylation at Y291 in human WASp (Y293 in murine WASp) has been proposed 
to play a critical role in WASp activation (Cory et al., 2002, Blundell et al., 2009). Numerous 
groups have shown that phosphorylation occurs both in vitro and in vivo and the residue is a 
target for several kinases, including Btk and Fyn, and the phosphatase PTP-PEST (Torres and 
Rosen, 2003). WASp has been shown to interact with the SH3 domains of Scr family kinases, in 
particular Fyn, in human and mouse hematopoietic cells (Banin et al., 1996, Sakuma et al., 
2012). Further evidence suggests specific phosphorylation and dephosphorylation by Fyn and 
PTP-PEST (interacting with WASp via PSTPIP1) respectively, are required for synapse formation 
and T cell activation (Badour et al., 2004). Phosphorylation may activate WASp through 
disruption of the autoinhibited conformation or stabilisation of the ‘open’ molecule. Tyrosine 
phosphorylation of WASp may also target the protein for proteasome-mediated degradation 
(Blundell et al., 2009), resulting in a self-limiting response. 
Binding of the lipid PIP2 or (the GTPase) Cdc42-GTP to WASp is also thought to destabilise the 
inactive conformation and allow binding of the Arp2/3 complex to the VCA domain. Higgs and 
Pollard show that WASp alone or in combination with Cdc42-GTP, is unable to stimulate actin 
nucleation by Arp2/3. (Higgs and Pollard, 2000) Their evidence suggests that addition of 
phosphatidylinositol 4,5 bisphosphate (PIP(2)) activates actin nucleation, which is then further 
increased by Cdc42. Purified N-WASp has also been shown to be activated by Cdc42 and PIP2 
(Rohatgi et al., 2000). 
During IS formation, it was shown that T cell CD28 engagement induced F-actin filopodia, 
which required Cdc42 activity (activated through Vav phosphorylation but independent of ZAP-
70) (Salazar-Fontana et al., 2003). Both Cdc42 and WASp are recruited to the IS in an antigen-
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dependent manner, following Zap-70 signalling (Cannon et al., 2001). Interestingly, Cannon et 
al show WASp recruitment to the IS is independent of Cdc42 but does require the WASp 
proline-rich region, which is necessary and sufficient for correct WASp targeting and may 
interact with SH3 domain containing proteins, such as Nck (Riverolezcano et al., 1995, Cannon 
et al., 2001). Nck has been shown to bind both SLP-76 and Vav-1 directly, which may provide a 
link between localisation and activation of WASp (Barda-Saad et al., 2010, Pauker et al., 2012). 
Grb2, another SH3 domain containing protein was also shown to interact with the polyproline 
domain of WASp family proteins, with a preference for their active confirmation (Carlier et al., 
2000). Binding was shown to be simultaneous with Cdc42 and the two proteins enhanced actin 
polymerisation by N-WASp synergistically (Carlier et al., 2000). 
Another player in the regulation of WASp is the WASp-interacting protein (WIP). Around 80% 
of WAS patients present mutations in the WIP binding site (Volkman et al., 2002). Possibly the 
best accepted theory is that WIP acts as a chaperone to prevent WASp degradation by the 
proteasome (de la Fuente et al., 2007). WIP was found to regulate both WASp localisation, in 
this case to DC podosomes, and calpain-mediated degradation (Chou et al., 2006). Indeed, 
both WIP and WASp tyrosine phosphorylation have been shown to regulate the stability and 
localisation of WASp to podosomes and consequently are critical for the maintenance of 
podosome turnover required for migration (Chou et al., 2006, Macpherson et al., 2012). 
Others have suggested that WASp exists as a complex with WIP in resting T cells, which acts to 
block activation by Cdc42. Upon TCR activation, WIP and WASp form a larger complex with 
ZAP-70 and the adaptor CrkL; the whole complex is recruited to lipid rafts at the IS, where WIP 
can be phosphorylated by PKCθ to release WASp from inhibition, while WASp is now in close 
proximity to Cdc42-GTP for activation (Sasahara et al., 2002). It is still unclear at what point 
WIP dissociates from WASp. This provides a very different model from the one discussed 
above suggesting recruitment by Nck; several different mechanisms for recruitment may be 
important for signal integration and transduction to the cytoskeleton. A more recent study, 
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investigating vaccinia virus actin-mediated motility, built on previous results showing 
interaction between WIP and Nck (Anton et al., 1998), showed that WIP contains two Nck-
binding sites and its interaction with N-WASp is essential for N-WASp recruitment to virus 
particles (Donnelly et al., 2013). 
One of the earliest direct observations of WASp kinetics came from Blanchoin et al, who used 
light microscopy to show relative rigid braches as a result of nucleation by Arp2/3, activated by 
WASp (Blanchoin et al., 2000). More recently however, the model has been challenged with 
the suggestion that WASp proteins may work as dimers to interact with both Arp 2 and Arp3 
subunits and bring 2 actin monomers into the complex (Padrick et al., 2011, Padrick et al., 
2008). While this is still controversial, it may prove to be a useful model of how WASp proteins 
integrate a large number of signals and what directs the orientation of the actin daughter 
filament.  
A recent paper has suggested a new model of temporal regulation of actin polymerisation by 
WASp (Smith et al., 2013b). The authors suggest that WASp dissociates form the nucleation 
complex prior to filament elongation and propose this as a mechanism of releasing the 
growing actin filament network from the membrane-bound nucleation promoting factor 
(Smith et al., 2013b). 
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WASp at the immunological synapse 
Wasp has a key role in transducing signals from cell surface receptors to the actin 
cytoskeleton. The cell-intrinsic role for WASp in immunological synapse formation has been 
well described. NK cells from WAS patients have decreased cytotoxicity due to impaired 
conjugate formation (Orange et al., 2002). Further, WAS NK cells show normal accumulation of 
Arp2/3, vinculin and talin downstream of LFA-1 but are unable to increase actin polymerisation 
and polarise the actin network towards the IS (Mace et al., 2010). In T cells, WASp has been 
proposed to play a role in lipid raft regulation (Dupre et al., 2002) or actin mediated synapse 
organisation downstream of CD2 (Badour et al., 2003). Several others have shown WASp to be 
a critical factor in T cell IS formation (Sims et al., 2007, Calvez et al., 2011). Sims et al showed 
that WASp and PKCθ have opposing effects at the IS; WASp promotes the symmetric formation 
of the IS, while PKCθ is involved in symmetry breaking and induces a migratory phase in T cells 
(Sims et al., 2007). 
A role for WASp in IS formation on the dendritic cells side is also emerging and has been shown 
to be important for activation of CD4 and CD8 T cells (Bouma et al., 2011, Pulecio et al., 2008).  
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5. WAS mouse model 
WASp-deficient murine model will be used to isolate bone marrow and produce bone marrow-
derived dendritic cells (BMDCs). Snapper et al disrupted the murine WASP gene in a TC-1 ES 
cell line with a targeted insertion of a neomycin-resistance gene in the reverse orientation into 
exon 7 (Snapper et al., 1998). The WASp-null ES clones were used to generate chimeric mice, 
which are bred to generate WASp-/- animals. The mice exhibit normal lymphoid development 
but reduced numbers of peripheral lymphocytes and platelets and abnormal T cell capping and 
proliferation responses (Snapper et al., 1998). Although originally based on the Sv/129 
background, these were crossed to the C57BL/6 (BL6) background, which were used in the 
following experiments. A second murine model, with a neomycin insertion in exon 4, also 
shows defects in lymphocyte development (Zhang et al., 1999). 
WASp is expressed exclusively in haematopoietic cells and appears to be more important for 
peripheral homeostasis than development and thymic production (Meyer-Bahlburg et al., 
2008, Bouma et al., 2009). WAS affects cells of both the innate and adaptive immune systems. 
It affects cells in a variety of ways, for example, macrophages show impaired phagocytosis, 
megakaryocytes produce fewer and smaller platelets, Tregs fail to proliferate and show 
reduced suppressive activity (Thrasher and Burns, 2010, Humblet-Baron et al., 2007). 
Osteoclasts and DCs from the Snapper mouse model exhibit defective chemotaxis (Burns et al., 
2001), homing (de Noronha et al., 2005) and formation of podosomes (Burns et al., 2001, Calle 
et al., 2004). WASp deficiency in DCs results in impaired T cell priming, not only as a result of 
inefficient migration, but also due to the formation of a spatially and functionally abnormal 
synapse (Bouma et al., 2007, Pulecio et al., 2008).  These results suggest that WASp plays a 
critical role in DC-mediated IS formation. As discussed above, DCs are involved not only in 
activation of CD4 cells but also in their commitment to a particular T helper subset. An 
imbalance in the induced lineages may explain some of the characteristic symptoms of WAS, 
such as eczema and autoimmune reactions. 
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6. DOCK8 
Similar to WAS, human mutations of other actin regulators have been described, which in 
many cases lead to severe immunodeficiencies, highlighting the crucial role of actin the 
immune system. One recently-described example is the DOCK8 deficiency. The last chapter of 
this thesis describes work performed to characterise this and two novel actin-related 
immunodeficiencies. 
DOCK8 structure, genetics and protein family 
Dedicator of cytokinesis 8 (DOCK8) is part of the Dock180-related family of atypical GEFs. As 
described above, GEFs activate Rho GTPases by facilitating the switch from a GDP- to GTP-
bound state; Rho GTPases in turn, integrate extracellular signals and transduce these to 
effector molecules (e.g. Cdc42 activation of WASp) to produce an appropriate cytoskeletal 
response (Miyamoto and Yamauchi, 2010). The original GEFs were described as a group of 
structurally related proteins containing a pleckstrin homology (PH) domain and a dbl homology 
(DH) domain with GEF activity. In contrast, the DOCK proteins have a distinct structure, lacking 
DH domains but containing two dock homology regions, DHR1 and DHR2 (also known as CDM-
zizimin homology (CZH1 and CZH2) domains). In most DOCK proteins, the DHR1 binds 
phosphotidyl-inositol triphosphate (PIP3), thus localising the protein to the plasma membrane; 
while the DHR2 interacts with Rho GTPases and contains the catalytic site for GEF activity (Cote 
and Vuori, 2007, Meller et al., 2005). The additional domains present on some family members 
have been used to segregate the Dock180-related group into several subfamilies (Meller et al., 
2005). DOCK8 belongs to the DOCK-C subfamily which is characterised by the absence of 
domains other than DHR1 and DHR2. Similar to other actin regulators, the DOCK180-related 
proteins are involved in a large number of diverse cellular processes including migration, 
phagocytosis, cytotoxic responses and polarisation. More specifically for immune cells, 
dysregulation in such actin processes can result in abnormalities in adhesion, activation of 
integrins, podosome formation and immunological synapse organisation. 
 Chapter 1 
68 
 
DOCK8 was isolated in a yeast two-hybrid screen for proteins interacting with Cdc42 (Ruusala 
and Aspenstrom, 2004); this has recently been confirmed by pull down experiments and has 
been shown to be dependent on the DHR2 domain (Harada et al., 2012).  
DOCK8 is a 1701 amino acid protein shown to localise to cell edges during lamellipodia 
formation (Ruusala and Aspenstrom, 2004). The 47 exon DOCK8 gene, spanning 190kb, was 
mapped to chromosome 9p24 (Griggs et al., 2008). DOCK8 mRNA is present throughout most 
tissues, with strong protein expression in haematopoietic cells and peripheral blood 
mononuclear cells (PBMCs).  
In a large scale study using genome-wide single nucleotide polymorphism (SNP) analysis and 
homozygosity mapping, Engelhardt et al showed that the majority of mutations identified 
(63%) were large deletions; the rest included small indels or point mutations resulting in in-
frame or out-of-frame nonsense mutations. These can result in a loss of DOCK8 expression due 
to nonsense-mediated mRNA decay (Engelhardt et al., 2009). 
Clinical characteristics and cellular defects 
In 2009, DOCK8 was independently described as the cause of severe immune deficiency in 
both humans and mice (Randall et al., 2009, Zhang et al., 2009, Engelhardt et al., 2009). Clinical 
characteristics include severe food and environmental allergies, middle ear infections, 
pneumonia or bronchitis and cutaneous viral infections, with the most common culprits being 
human papilloma virus (HPV), molluscum contagiosum virus (MCV), herpes simplex virus (HSV) 
and varicella-zoster virus (VZV) (Zhang et al., 2009, Chu et al., 2012). Systemic viral infections 
are rarely detected, suggesting antiviral immunity is defective locally within the skin 
(Engelhardt et al., 2009); though non-immune cells present in skin layers do not express 
DOCK8 protein (Su et al., 2011). Increased susceptibility to viral infections is seen in other PIDs 
such as WAS and “leaky” SCID (Modiano et al., 1995, Saijo et al., 1998, Artac et al., 2010). As in 
WAS this could be the result of a combination of factors including defective skin barrier, 
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reduced numbers of T cell, impaired T cell proliferation and antiviral cytokine production, and 
abnormal migration into infected tissues (Zhang et al., 2010). Pneumonia, caused by a wide 
spectrum of gram-positive and gram-negative bacteria and fungi, gastrointestinal tract 
infections, eczema, eosinophilia and IgE dysregulation have also been attributed to DOCK8 
deficiencies (Zhang et al., 2009, Engelhardt et al., 2009).  
On a cellular level, defects have been described in T cell homeostasis with reduced T cell 
numbers and impaired in vitro proliferation of CD8 (Zhang et al., 2009, Engelhardt et al., 2009)  
or both CD4 and CD8 populations (Engelhardt et al., 2009), similar to that seen in WAS. 
Dasouki et al used a T cell receptor excision circle (TREC) assay to show that the number of 
TRECs was very low or undetectable in 3 patients, suggesting impaired T cell production or 
efflux from the thymus (Dasouki et al., 2011). This defective thymopoiesis or efflux might help 
to account for the reduced numbers of T cells in patients. It may also result in a restricted T cell 
repertoire, contributing to the pathology. 
An imbalance of Th1/ Th2 CD4 subtypes has been suggested as several DOCK8 patients present 
with elevated levels of IL-6 and IL-10 (Dasouki et al., 2011). An increased Th2 response would 
increase isotype-switching in B cells and result in IgE overproduction. Increased serum IgE is 
also seen in Wiskott Aldrich syndrome, in which abnormal T cell function is a central player in 
disease pathology, further suggesting that variability in IgE levels may be the result of T cell 
dysregulation. 
Th17 cell differentiation and survival has also been shown to be impaired, as measured by 
production of IL-17 or expression of the Th17 master regulator RORγτ (Milner et al., 2010, Al 
Khatib et al., 2009). IL-17 and proinflammatory cytokines in turn have a role in inducing 
production of antimicrobial peptides by keratinocytes and bronchial epithelial cells (Minegishi 
et al., 2009); thus the reduced numbers of Th17 cells may explain the susceptibility to fungal 
infections in DOCK8 patients. 
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As in WAS deficiency, production of anti-viral cytokines IFN-γ and TNF-α by CD8 T cells is also 
decreased in DOCK8, although perforin content and cytotoxic granule release appear normal 
(Zhang et al., 2009). There is evidence for an essential role of DOCK8 in CD8 T cell survival and 
memory maintenance, whether due to loss of memory T cells or the development of an 
“exhausted” phenotype in circulating T cells (Lambe et al., 2011, Randall et al., 2011). It is still 
unclear to what extent defective TCR signalling, cytokine production and homeostatic 
proliferation of peripheral cells contribute to the overall T cell defects. The defective 
functioning of CD8 T cells, which normally assist in tumour surveillance, may contribute to the 
higher rate of malignancies in DOCK8 patients. Around 20% of patients develop at least one 
type of cancer and the most common malignancies are squamous cell carcinoma and 
lymphoma (Su et al., 2011). 
Similar to WAS, DOCK8 deficient mice exhibit a lack of marginal zone B cells (Randall et al., 
2009). Further, B cells show impaired immunological synapses due to a failure to concentrate 
the integrin ICAM-1 in the pSMAC; however, intracellular calcium flux and ERK phosphorylation 
were normal (Randall et al., 2009). 
Dendritic cell (DC) function is also affected in the absence of DOCK8. DOCK8 DCs were unable 
to induce T cell activation and proliferation, which was not a result of defective antigen uptake 
or presentation (Harada et al., 2012). Adoptive transfer experiments showed that migration of 
DOCK8 null DCs to draining lymph nodes was less that 25% of control levels and velocity of 
migration within dermal tissues was severely reduced. Further, DOCK8 DCs were unable to 
polarise and extend protrusions when migrating through 3D collagen gels. Two-photon 
microscopy provided evidence for defective intra-nodal DC migration as DCs failed to migrate 
into lymph node parenchyma for T cell priming (Harada et al., 2012). 
So far, there is one study of DOCK8-deficient natural killer (NK) cells, whose absolute numbers 
in patients appear normal. Unlike WAS NK cells, and total actin content of DOCK8 NK cells was 
indistinguishable from controls, however, patient cells were unable to polarise F-actin towards 
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the lytic synapse. Clustering of CD18 and polarisation of perforin and the microtubule 
organising centre (MTOC) were also impaired (Mizesko et al., 2013). Cytolytic activity of WAS 
deficient NK cells can be restored by IL-2 as the cytokine can bypass WASp to use the 
homologous effector WAVE2 (Orange et al., 2011). This was not the case for DOCK8 NK cells; 
IL-2 stimulation had no effect on NK cell functions in the absence of this upstream activator 
(Mizesko et al., 2013). 
Many of the symptoms described, such as rash, elevated IgE and susceptibility to 
autoimmunity, are very similar to those described in WAS (Thrasher and Burns, 2010). As an 
effector of the Rho GTPase Cdc42, WASp presumably acts downstream of DOCK8 and the 
similar clinical manifestations may reflect the overlapping signalling pathways. While WASp 
function may also be diminished in DOCK8 patients, this cannot explain the complete 
phenotype of DOCK8 patients. Unlike WAS, DOCK8 expression is not restricted to the 
haematopoietic system, it would be interesting to see whether reconstitution of the immune 
system would correct disease pathology. Similar to WAS, the disease pathology is likely to be 
the result of a combination of cellular defects including the inability of B cells to generate high-
affinity antibodies and sustain GCs; the absence of T cell memory; defects in DC migration and 
capacity to prime T cells; as well as reduced NK cell cytotoxicity. 
DOCK8 murine model 
Around the same time as the characterisation of the human disease, Randall et al identified 
two independent mutations (primurus(pri) and captain morgan(cpm)) in DOCK8 through an 
ethylnitrosurea (ENU) mutagenesis screen for mutations affecting antibody response 
maturation (Randall et al., 2009). DOCK8 mutation was shown to impair B cell immunological 
synapses and affect B cell ability to mature and contribute to the germinal centre subset. 
Diminished survival and selection of DOCK8 B cells resulted in severely reduced numbers of 
high affinity IgG+ B cells (Randall et al., 2009). Integrin interaction has been shown to play a 
role in lowering the threshold for B cell activation and allowing affinity maturation in germinal 
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centres, which is necessary for adaptive immunity (Carrasco et al., 2004, Cantor et al., 2009). 
ICAM-1 expression on follicular dendritic cells (FDCs) has been suggested to inhibit apoptosis 
of GC B cells so the failure of DOCK8 B cells or APCs to organise an immunological synapse may 
result in the loss of a survival signal in the form of integrin costimulus (Randall et al., 2009).  
The pri knockout model has also highlighted cell-intrinsic defects in DOCK8 CD8 cells after 
thymic development (Randall et al., 2011). CD8 cells had a shorter lifespan, produced a poor 
memory response and were unable to polarise LFA-1 towards the IS upon contact with DCs. 
In mice, Dock8 mutations replicate many of the cellular defects described in patients yet mice 
show no obvious clinical phenotype, similar to WAS knockout animals (Snapper et al., 1998, 
Zhang et al., 1999). This could be the result of maintenance in a pathogen-free environment.  
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AIMS 
This project aims to gain more insight into the role of dendritic cells in IS formation. Increased 
understanding of DC biology may contribute to the development of instruments for 
modulating immune responses and may help to advance treatment of WAS. The role of the DC 
in IS formation is under-represented and requires further investigation. 
It is hypothesised that impaired actin polymerisation in WASp DCs results in malformed IS, 
which is not sufficient to sustain intercellular signalling required for full T cell activation. 
Using a WASp-deficient murine model the project aims to investigate how defective 
cytoskeletal regulation in DCs affects: 
 The formation and organisation of the IS 
 The actin dynamics and structural stability of the IS over time  
 The functional consequences of IS formation between T cells and WASp-deficient DCs 
Further, the project aims to compare IS formation in WAS DCs with the more recently 
described DOCK8-deficient DCs, allowing a direct comparison of the function of each of these 
components of an actin-regulating pathway. 
Finally, basic immune cell functions will be investigated in two novel actin-related primary 
immunodeficiencies. 
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Chapter 2 – Materials and Methods 
 
2.1 Materials 
2.1.1 Media, Buffers and Solutions 
All media used were supplied by Gibco unless otherwise stated.  
Aprotinin Sigma Aldrich (A1153) 
AquaPoly Mount Polysciences, Inc. 
Avidin/ Biotin block  Invitrogen (004303) 
DNA (plasmid) isolation  QIAprep Spin Miniprep Kit (Qiagen) 
DNA loading buffer 0.25% bromophenol blue, 0.25% xylene cyanol, 30% 
glycerol, in dH2O. 
ELISA block buffer 1% BSA in PBS + 0.05% NaN3 
ELISA Reagent diluents 0.1% BSA, 0.05% Tween 20 in PBS, pH7.4 
ELISA stop solution 2N H2SO4 
ELISA wash buffer 0.05% Tween 20 in PBS 
Eα-GFP From Paul Garside, University of Glasgow 
Ficoll-Paque GE Healthcare (17-1440-03) 
Fixatives 4% PFA (confocal microscopy) 
4% PFA + 0.025% glutaraldehyde (immunogold) 
1% PFA + 3% glutaraldehyde (routine TEM and 3View) 
Freezing media 10% DMSO, 40% FCS, in DMEM or RPMI 
GM-CSF (human) Peprotech (300-03) 
GM-CSF (murine) Invitrogen, PMC2015 
Hybridoma media RPMI + 6%FCS +PenStrep + β-mercaptoethanol 
Isolation Kits CD4+ T cell isolation kit II, mouse – Miltenyi 130-095-248 
CD14 Microbeads, human – Miltenyi 130-050-201 
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IL-4 (human) Peprotech (200-04) 
LPS Sigma, L2654 
Luria-Bertani (LB) Broth/Agar Sigma Aldrich 
Lysis buffer 1% IGEPAL or NP40, 130mM NaCl, 20mM Tris-HCl pH7.4, 
1mM EDTA, 10mM NaF, 1% aprotinin, 10µM pepstatin, 
10µg/ml leupeptin, 50µM calpastatin and 1mM PMSF. 
MACS buffer (for magnetic cell 
separation) 
0.5% BSA, 2mM EDTA, in PBS 
Mouse IL-2 DuoSet ELISA 
Mouse IFNγ DuoSet ELISA 
Mouse IL-17 DuoSet ELISA 
R&D SystemsDY402 
DY485 
DY421 
Mouse IL-4 ELISA Ready-SET-Go  
Mouse IL-10 ELISA Ready-SET-Go 
eBioscience 
Normal mouse serum block DakoCytomation, X0910 (dilute to 2% in PBS) 
NuPAGE Tris-Acetate Mini Gels Invitrogen 
OVA323-339 Anaspec (27024) 
Ovalbumin Fluka, BioChemika, 05440 
PageRuler Prestained protein ladder Thermo Scientific (26616) 
PenStrep Added to culture media to final concentration of 100U of 
penicillin and 100µg of streptomycin per ml. 
Phosphate buffered saline 1x cell culture grade PBS (Gibco); 10x stock (Fisher 
Bioreagents) 
Pierce Crosslink Immunoprecipitation Kit Thermo Scientific (26147) 
Pierce ECL Western Blotting Substrate Thermo Scientific 
Platinum qPCR SuperMix-UDG with ROX Invitrogen, 11743-500 
Pluronic solution SigmaAldrich F-68 10% (P5556) 
Protein A+G Agarose Source Bioscience (PRAG25-AS-2) 
Reducing buffer NuPAGE Sample Reducing buffer NP0009 
Restriction enzymes and digest buffers; 
T4 DNA Ligase; Polymerase; Shrimp 
Alkaline Phosphatase; Klenow 
Commercially available enzymes from Promega, 
Fermentas and NEB. 
Reverse transcription reagents Invitrogen: DNaseI (18068-015);  
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Random primers (48190-011);  
10mM dNTP Mix (18427-013);  
RnaseOut ribonuclease inhibitor (10777-019);  
M-MLV reverse transcriptase (28025-013) 
RNA isolation Rneasy Mini Kit (Qiagen) 
RT-PCR primer/probe mix TaqMan Gene Expression Assays, Applied Biosystems 
Running buffers 
 
NuPAGE MOPS SDS 20x, NP0001-02 
NuPAGE MES SDS 20x, NP0002 
TE 0.05% Trypsin-EDTA, Gibco 
TMB Tetramethyl Benzidine chromogen solution; eBioscience 
(00-4201-56) 
Transfer buffer NuPAGE 20x, NP0006-1 
Western and IP blocking buffer 5% skimmed milk in PBS + 0.1% Tween 
Western and IP Loading buffer Laemmli buffer: 125mM Tris HCl, 4% SDS, 20% glycerol, 
10% 2-mercaptoethanol, 0.004% bromophenol blue. 
NuPAGE: Sample buffer (Invitrogen NP0007) + Reducing 
Agent (Invitrogen NP0004). 
Western stripping buffer Re-blot Plus Strong, Millipore 
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2.1.2 Antibodies and Cell Trackers 
Primary Antibody + Host species Clone Manufacturer 
α-tubulin mouse B-5-1-2 SigmaAldrich 
α-tubulin rat YL1/2 Santa Cruz 
Capping protein (CapZ) rabbit  Millipore (AB6016) 
CD11a-biotin (LFA-1) rat  I21/7  Leinco Technologies 
CD11c-eFluor450 armenian hamster N418 eBioscience 
CD3-PE-Cy5 rat 17A2 BD Pharmingen 
CD3e-PE armenian hamster 145-2C11 BD Pharmingen 
CD4-APC rat GK1.5 eBioscience 
CD4-FITC rat L3T4 eBioscience 
CD45 rat I3/2.3 Santa Cruz 
CD54 rat YN1/1.7.4 BioLegend 
CD54-biotin rat YN1/1.7.4 BioLegend 
CD62L-APC rat MEL-14 eBioscience 
CD69-PE Armenian hamster H1.2F3 BioLegend 
Ea52-68 peptide on I-Ab - biotin eBioY-Ae eBioscience 
γ-tubulin mouse GTU-88 Sigma Aldrich 
GAPDH 6C5 Santa Cruz 
I-Ab- biotin mouse KH74 BD Pharmingen 
Integrin-β2 mouse  Santa Cruz sc-8420 
MKL1 rabbit  Sigma HPA030782 
MKL1 N-terminus rabbit  Sigma SAB4502519 
MRTF-A goat  Santa Cruz sc21558 
N-WASp goat  Santa Cruz sc-10122 
Nck mouse 108/NCK BD Biosciences 
Nck-1 mouse NC-20 (same as 20B-1H9) GeneTex (GTX23215) 
Nck rabbit Y531 Abcam 
TCR a/b Armenian hamster H57-597 Caltag Laboratories 
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Vinculin mouse  Sigma V4505 
Vinculin rabbit  Abcam ab73412 
WASp rabbit  Cell Signalling Technology 
WASp mouse B-9 Santa Cruz 
WDR1 goat  Santa Cruz sc-160907 
WIP goat  Santa Cruz sc-16882 
   
Secondary Antibody   Manufacturer 
Anti-mouse IgG-Gold 10nm  Sigma Aldrich (G7652) 
Anti-rabbit IgG-Gold 10nm  Sigma Aldrich (G7402) 
Anti-mouse HRP  DAKO 
Anti-rabbit HRP  DAKO 
Anti-goat HRP  Santa Cruz sc-2768 
Anti-hamster Dylight549  Serotec 
Anti-mouse AlexaFluor488  Molecular Probes 
Anti-rabbit AlexaFluor405  Molecular Probes 
Anti-mouse AlexaFluor633  Molecular Probes 
Anti-rabbit AlexaFluor633  Molecular Probes 
Anti-rat Dylight405  Serotec 
Anti-rat AlexaFuor564  Molecular Probes 
Anti-rat Cy5  Jacksons ImmunoResearch 
Anti-mouse Cy5  Jacksons ImmunoResearch 
Anti-rat FITC  Jacksons ImmunoResearch 
   
Isotype Controls   
Armenian hamster IgG-PE   
Armenian Hamster IgG–Pe-Cy5   
Mouse IgG1-PE   
Mouse IgG2b – biotin   
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Rat IgG1-PE   
Rat IgG2b-FITC   
Rat IgG2b – PE   
   
Dyes, Stains and Trackers Manufacturer 
Amersham Cy5 Maleimide Mono-Reactive Dye GE Healthcare 
Cell Trace CFSE Cell Proliferation Kit 
Life Technologies, 
Molecular Probes (C34554) 
CellTracker Green CMFDA (5-Chloromethylfluorescein Diacetate) 
Life Technologies, 
Molecular Probes (C7025) 
CellTrace™ Far Red DDAO-SE 
Life Technologies, 
Molecular Probes (C34553) 
DAPI (4',6-diamidino-2-phenylindole)  
Phalloidin AlexaFluor 633 Invitrogen, A22284 
  
Other  
High Precision Microscope Cover Glasses (Deckglӓser 24x24m) 
Marienfeld Laboratory 
Glassware (01 070 52) 
FluoroDish (live imaging dishes) Dish 35mm; Glass 23mm; thickness 
0.17mm; Poly-D-Lysine coated 
World Precision Instruments 
FD35PDL 
Glass slides – Superfrost Thermo Scientific 
MicroAmp Optical 96-well Reaction Plate (QPCR) 
Applied Biosystems 
N8010560 
ELISA plates Nunc Maxisorb 
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2.1.3 Animals and Cells 
B017.10  Kindly provided by Dr.med. Stefan Porubsky, Heidelberg University, Germany.  
293T   Human Embryonic Kidney cell line, purchased from European Collection of Cell 
Cultures (ECCC).  
THP1  Human monocytic cell line, a gift from J Metelo, MIU.  
 
C57BL/6 wildtype mice purchased from Charles River. 
WAS and FYN: WAS knockout and Y293F phosphorylation-null knock-in mice were bred in 
house. The WAS KO was created by targeted insertion of neomycin resistance gene (neo) into 
exon 7 of the WASP gene, resulting in complete loss of RNA or protein expression (Snapper et 
al., 1998). The FYN strain contains a Tyr293Phe mutation in exon 9 of the WAS gene. 
OT-II transgenic mice (expressing OVA peptide-specific transgenic TCR) were bred in house. 
Dock8 strain was bred in house as homozygotes. These express a Ser1827Pro mutation in exon 
43 of the Dock8 gene. This was originally described by Randall et al and named primurus 
(Randall et al., 2009). 
All animals were housed in Individually Ventilated Cages (IVCs) and experiments were 
performed in accordance with Home Office legislation. 
 
Bone marrow dendritic cell (BMDC) cultures – BMDCs were generated by culturing bone 
marrow cells of BL6 or WAS mice in the presence of GM-CSF (20 ng/ml) for 7 days. Bone 
marrow was obtained by flushing the femur of mice, using a 25g needle, on day 0. The single 
cell suspension was then cultured at 4x106 cells per 10cm culture dish in 10ml of complete 
RPMI, supplemented with 20ng/ml recombinant murine GM-CSF. Fresh media supplemented 
with 20ng/ml GM-CSF was added on days 2 and 5. On day 7, cells were harvested using cell 
scrappers, washed in fresh media and pulsed with 100ng/ml LPS only (control – mature cells) 
or with LPS in combination with 100µg/ml ovalbumin or the OVA323-339 peptide (OVA-
presenting; for antigen-specific T cells). BMDCs were harvested for experimental use on day 8. 
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Isolation of CD4+ cells from OT-II mice  
CD4+ T cells were isolated from spleens and lymph nodes (inguinal, mesenteric and brachial) 
by negative selection using a Miltenyi Biotec CD4+ T cell Isolation Kit (130-095-248) as per 
manufacturer’s instructions. Briefly, a single-cell suspension was obtained by passing spleen 
and lymph nodes through a 40µm filter. Spleen suspensions were incubated in 10ml 1xRBC 
Lysis buffer for 5 minutes to lyse erythrocytes; this was quenched by adding 30ml PBS. Cells 
were counted, centrifuged at 300g for 10min and resuspended in 40µl/ 107 cells of MACS 
buffer. CD4+ Biotin Antibody Cocktail (containing CD8a, CD11b, CD11c, CD19, CD45R, CD49b, 
CD105, MHC and Ter-119 antibodies) was added to the cell suspension at 10µl/107 cells. This 
was incubated at 4˚C for 10min then diluted by adding 30µl/107 cells MACS buffer. Anti-Biotin 
Microbeads were added at 20µl/107 cells and incubated at 4˚C for 15min. Cells were washed 
by adding 2ml/107 cells of MACS buffer and centrifuged at 300g for 10min. Pellets were 
resuspended in 500µl for up to 108 cells and magnetic separation was performed on LS 
columns on a MACS MultiStand magnet. Column flow-through was collected, containing 
enriched, untouched CD4+ T cells. T cells were activated using Mouse T-Activator CD3/CD28 
Dynabeads (Invitrogen, 114.52D), or Concanavalin A (Sigma Aldrich, C5275) as positive controls 
for T cell activation and proliferation. 
Human peripheral blood dendritic cell cultures 
10-20ml of patient or control blood was diluted 1:1 with RPMI, layered onto an equal volume 
of Ficoll-Paque and centrifuged at 2300rpm (1000g) for 20minutes, without brake. Peripheral 
blood mononuclear cells (PBMC) were collected from the Ficoll/serum interface and washed 
twice in RPMI. CD14-positive cells were then magnetically labelled and positively selected on 
LS columns (Miltenyi Biotec). The column flow-through, representing the unlabelled 
lymphocyte fraction, was collected for further experiments. CD14 positive cells were eluted 
from the column as per manufacturer’s instructions and washed in RPMI. These were seeded 
on day 0 at 1x106 cells/well in 6-well plates in complete growth media (RPMI +10% FCS + 
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Pen/Strep) supplemented with 100ng/ml rhGMCSF and 25ng/ml rhIl-4. Fresh cytokines were 
added on day 3; cells were harvested for use on day 6 or 7. 
2.2 Methods 
2.2.1 Cell culture 
Adherent cell lines: 
293T cells were cultured in Dulbecco’s MEM-Glutamax, supplemented with 10% heat 
inactivated fetal calf serum (FCS) and 1% Penicillin/Streptomycin (Pen/Strep). Cell monolayers 
were grown in 75cm2 or 175cm2 culture flasks at 37˚C, 5% CO2. When confluent (90-95%) cells 
were washed in PBS to remove serum, and incubated in trypsin-EDTA for 5-10 minutes to 
detach the monolayer. Cells were split 1:10 using complete DMEM. 
 
Non-adherent cell lines: 
B017.10 were maintained in suspension in RPMI-GlutaMAX supplemented with 6% FCS, 1% 
Pen/Strep and 50μM beta-Mercaptoethanol. Cell were grown in upright 75cm2 flasks at 37˚C, 
5% CO2. Cells were passaged every 2-4 days. 
THP1 cells were cultured in suspension in RPMI-Glutamax supplemented with 10% FCS and 
Pen/Strep. Cells were maintained at 0.5-1x106 cells/ml. To split, cells were collected and 
centrifuged at 200g for 5 min, resuspended in fresh media and replated at 1:10. To 
differentiate into dendritic cells, THP1 cells were cultured in the presence of 10ng/ml rhIL-4 
(recombinant human interleukin-4) and 10ng/ml rhGMCSF (granulocyte-macrophage colony 
stimulating factor) for 6 days. 4x106 cells/well were plated in 12-well plates in 1.5ml of 
complete media with cytokines. Cells were split on days 2 and 5 with addition of fresh 
cytokines. On day 6 or 7, both adherent and suspension cells were harvested for use. 
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2.2.2 Constructs 
Maps were created and cloning strategies designed in VectorNTI. The following techniques 
were used in the creation of several vectors. Plasmid maps are included in the Appendix 1. 
LNT_LifeAct-mCherry 
LNT_Nck-ECFP 
LNT_Nck-Cerulean 
The following plasmids were acquired for further cloning or lentiviral preparation. 
Gift from M Blundell:  pHR_SEW 
pHRsincpptSEWWWT 
pHRsincpptSEWWE (Y291E) 
pHRsincpptSEWWF (Y293F) 
Gift from G Bouma: LNT_SFFV_ICAM-1-GFP 
Gift from D Moulding:  LNT_mCherry-Actin 
Bought from Clontech: pmCherry-N1 
pEGFP-C2 
pECFP-C1 
Gift from S Shetty: pNLS_Cerulean 
 
Cloning strategies 
Polymerase chain reaction: 1unit of Pfu polymerase was used for 200ng DNA in a 25ul 
reaction. The thermal cycler was set up as follows: 
2min at 95°C 
35 cycles of:  30s at 95°C 
30s at gradient*  
2min15s at 72°C 
10min at 72°C 
Hold at 4°C 
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Restriction endonucleases: 
Reactions were made up as per manufacturer’s instructions using Promega, NEB or Fermentas 
restriction enzymes. 1-4µ of DNA were digested for 1-2 hours in the optimal buffer and 
temperature recommended by the manufacturer. 
Blunting digested ends: 
If required, Klenow DNA polymerase I was used to fill in 5’ or digest 3’ overhangs. The reaction 
is performed at room temperature for 15 minutes with the addition of Klenow and 2mM 
dNTPs.  
DNA dephosphorylation: 
Shrimp alkaline phosphatase (SAP) was used to remove phosphate groups after digestion and 
prevent vector re-ligation. DNA was incubated with 1µl of enzyme at 37°C for 1hr, followed by 
heat inactivation at 65°C for 15 minutes. 
Ligation: 
After manipulation, DNA was run on a 1% agarose gel to resolve digested fragments. Bands 
were excised and purified from the agarose using a Qiagen gel extraction kit. Compatible 
digested and purified fragments were mixed with T4 DNA ligase and incubated at 14°C 
overnight. Vector and insert fragments were mixed in proportions calculated by the following 
equation, using 100ng of vector and a 3: 1 insert: vector ratio: 
           
         
         
                  
        
         
         
              
 
Preparation of chemically competent bacteria 
500ml LB was inoculated with DH5α E. Coli and incubated at 37°C with agitation until the 
culture reached an optimal density of 0.4 at 600nm (1cm pathlength). The culture was spun 
down at 5000rpm (2000g) for 10 minutes at 4°C. The pellet was gently resuspended in 125ml 
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ice cold 100mM MgCl2 and centrifuged at 4000rpm (1200g) for 10 minutes. The pellet was 
resuspended in 250ml of ice cold 100mM CaCl2 and incubated on ice for a minimum of 20 
minutes. The bacteria were spun down again and resuspended in 10ml of ice-cold, sterile 
85mM CaCl2 containing 15% glycerol w/v. 100µl aliquots were snap frozen in liquid nitrogen 
and stored at -80°C. 
Transformation of competent bacteria 
Competent E. Coli DH5α were mixed with 500ng of plasmid DNA and incubated on ice for 30 
minutes. A heat shock at 42°C for 45seconds was applied, followed by a further 2 minutes on 
ice. 200μl of sterile LB broth was added and the bacteria were allowed to recover in a 37°C 
shaking incubator for 1 hour. Cultures were then plated on an agar plate with the appropriate 
antibiotic selection and incubated overnight at 37°C to allow growth of colonies derived from 
single bacteria. Colonies were then selected for inoculation of 5ml LB cultures. 
Isolation/ purification of plasmid DNA  
5ml cultures were pelleted and plasmid DNA was isolated using QIAprep Spin Miniprep Kit 
according to manufacturer’s instructions. DNA was eluted in 30-50μl distilled water. The DNA 
was digested and resolved on a 1% agarose gel to confirm the presence of the correct plasmid 
construct. 
Large scale plasmid production 
500ml of LB with the appropriate antibiotic was inoculated with 500µl bacteria and incubated 
overnight at 37°C. The bacteria were pelleted by centrifugation at 5000g for 15 minutes and 
plasmid DNA was extracted using QIAprep Spin Maxiprep Kit according to manufacturer’s 
instructions.  
  
 Chapter 2 
86 
 
2.2.3 Lentiviral preparation 
Transforming the packaging cell line 
The transfection mixture comprises 40µg vector construct (pHR_LNT), 10µg pMD.G2 (vector 
containing envelope genes) and 30µg pCMV-dR8.74 (vector containing gag/pol packaging 
genes) added to 5ml Optimem media per flask. This was filtered (0.22μm) filter and added to 
5ml Optimem with 1μl 10mM polyethylenimine. The transfection mixture was incubated at 
room temperature for 20minutes. 10ml were added to each 175cm2 flask of 293T cells, seeded 
at 1.5x 106 cells/flask 24hours previously. After 4 hours, the transfection mixture was removed 
and replaced with fresh complete DMEM. 
Virus harvesting and concentration 
After 48hours the culture medium was collected, filtered through a 0.22µm filter and 
ultracentrifuged at 23 000rpm (50000g), for 2hours to pellet the virus particles. These were 
resuspended in 150μl PBS and incubated on ice for 1 hour to allow virus resuspension. Virus 
aliquots were stored at -80°C. 
Titration of virus suspension 
293T cells were seeded at 50 000 cells per well in a 5-fold serial dilution of virus from 1/100 to 
1/106. After 72 hours, the cells were harvested and analysed by flow cytometry to determine 
the percentage of positive cells. The virus titre was calculated by multiplying the number of 
cells seeded by the dilution and the percentage positive cells. 
Infection of primary DCs 
BMDCs were cultured in GMCSF as previously described. On day 5, before feeding, cells were 
harvested, counted and replated at 5x105 cells per well (12-well plate) in 500μl of conditioned 
media. Cells were allowed to settle for 30min at 37°C before addition of virus at an MOI = 5 
(multiplicity of infection). This was incubated for a further 30min, followed by addition of 
1.5ml of fresh complete media supplemented with 20ng/ml GMCSF. Cells were harvested on 
day 8 for further experiments. 
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Infection of THP1 cell line 
Stable cell lines of control (SCR shRNA) or knockdown (e.g. MKL-1, WDR1) THP1 cells were 
created by infecting THP1s with a lentivirus expressing the appropriate shRNA construct using 
a protocol identical to that for primary DCs. 24 hours after infection, THP1 cells were spun 
down and resuspended in complete RPMI media supplemented with 0.6µg/ml puromycin 
(selection for resistance gene encoded in construct). 
 
2.2.4 Western blots and Immunoprecipitation 
Cell pellets were resuspended in ice-cold lysis buffer (50μl per 1x106 cells) and lysed on ice for 
10 minutes. Lysates were centrifuged to pellet cell debris; supernatants were transferred to a 
new eppendorf tube and mixed with an equal volume of 2x loading buffer and heated at 70°C 
for 10minutes. Cell lysates were separated on 12-14% NuPAGE Bis-Tris gels loaded with 30μl 
sample per well. Fermentas PageRuler Prestained Protein Ladder was included as size marker 
and gels were run at 160V for 1-1¼ hours. 
Blots were transferred onto Millipore Immobilon P membrane (activated in methanol for 5 
minutes) at 18V for 45minutes. 
Membranes were blocked using 5% skimmed milk in PBS-tween (0.1%) and antibodies were 
used at 1/1000 in 5% milk with 0.1% Tween 20. Secondary antibodies (anti-mouse and anti-
rabbit HRP conjugated) were also used at 1/1000 dilution.  
Peroxidase activity was detected using SuperSignal West Femto Chemiluminescent Substrate 
(Thermo Scientific). 
To analyse protein interactions, cells were lysed and one of three methods for 
immunoprecipitation was followed. 
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A. Cell lysates were pre-cleared using normal mouse IgG1 and A/G PLUS-Agarose beads 
for 1 hour at room temperature to remove non-specifically bound proteins. Cleared 
lysates were incubated with anti-Nck (BD) or anti-WASp (SantaCruz) antibodies 
overnight, then pulled down with Protein A/G PLUS-Agarose beads. 
Immunoprecipitates were collected by centrifugation, washed in PBS, resuspended in 
reducing buffer and boiled. Immunoblots with anti-WASp and anti-Nck were carried 
out on the polyvinlidene difluoride (PVDF) membranes. 
B. Antibodies for IP (e.g. anti-Nck, BDBioSciences) were crosslinked to agarose beads 
using the Pierce Crosslink Immunoprecipitation Kit, according to manufacturer’s 
instructions. Lysates were then added to columns containing the labelled beads and 
incubated at 4°C on a rotator overnight. The bead suspension was washed and 
immunocomplexes eluted and analysed for protein content on Immobilon membranes 
as above. 
C. Primary antibody (WASp, B9) was conjugated to Protein G Dynabeads as per 
manufacturer’s guidelines. Samples were incubated with the Dynabeads on a rotator 
for 2 hours at room temperature. Dynabead-Ab-Ag complexes were washed in PBS 
three times and transferred to a new tube. Denaturing elution was performed in 
NuPAGE Sample Buffer+ Reducing Agent, for 10minutes at 70°C. 
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2.2.5 Conjugate formation 
Conjugate adhesion by FACS: 1x106 DCs (LPS only or LPS/OVA pulsed) were resuspended in 
2ml complete RPMI and CMFDA dye (Molecular Probes, Invitrogen) was added to a final 
concentration of 0.2uM. 1x106 CD4+ T cells per sample were resuspended to 1x106/ml in 
complete RPMI and labelled in 1ug/ml DDAO. Both cell types were stained for 30min at 37˚C, 
then washed and resuspended in complete RPMI for 30min at 37˚C. DC T cells were mixed 1:1 
in round-bottom polystyrene tubes in a total volume of 250µl; and centrifugated at 400rpm 
(30g) for 5min to encourage conjugate formation. Suspensions were incubated at 37˚C for 1 
hour and conjugate adhesion was analysed by flow cytometry. CMFDA was detected in the 
FITC channel; DDAO in APC channel. 
Slides for confocal microscopy: Ovalbumin-pulsed or LPS control only DCs were harvested on 
day 8 and mixed with CD4+ OT-II cells at a ratio of 1:5 (typically 80 000DCs and 400 000T cells) 
in a small volume (typically 200μl) and spun gently (400rpm (30g) for 5 min) to enhance 
contacts between cells. The suspension was incubated at 37°C for 10-100min (see individual 
experiments) to allow conjugate formation. The loose pellets were resuspended gently and 
pipetted onto poly-L-Lysine-coated glass slides. Incubation at room temperature for 2-
5minutes allowed cells to settle onto the coated slides, which were then washed and the cells 
fixed in 4% PFA at room temperature for 20 minutes. 
Pellets for electron microscopy: DCs and OT-II cells were mixed at cell ratios of 1:3 (typically 
1x106 DCs+3x106 T cells). These were centrifuged and incubated as above. Fixation was 
performed in suspension by adding an equal volume of 4%PFA supplemented with 0.05% 
gluteraldehyde. Suspensions were centrifuged and the fixative removed. Cell pellets were 
resuspended in 50μl of PBS, followed by addition of 50μl of 2% low-gelling temperature agar 
(above 37°C). 
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2.2.6 Antigen presentation assays 
Eα-GFP: Immature BL6 and WAS BMDCs were pulsed with varying concentrations (0.01 – 100 
μg/ml) of Eα-GFP protein (a gift from P Garside, University of Glasgow) in combination with LPS 
(as above), on day 7. Eα presentation was detected 24hours later by flow cytometry using an 
antibody specific for the Eα peptide in context of MHC class II peptide (Yae; see antibody list).  
T cell proliferation: Isolated CD4+ T cells were stained in a final working concentration of 
10μM CFSE diluted in serum-free media for 10 minutes at 37°C. Staining was quenched by 
adding 5 volume of ice-cold complete RPMI and incubating on ice for 5 minutes. Cells were 
pelleted and washed by resuspending in fresh media twice. CFSE-stained T cells were 
cocultured with BL6 or WAS DCs (pulsed with LPS with or without OVA) at ratios of 1:1 and 1:5. 
Three days later, cells were harvested and immunostained for CD4. CFSE staining was analysed 
by flow cytometry, gating on CD4-positive cells only. 
IL-2 production: Unlabelled CD4+ T cells were cocultured with DCs for 48hours, as above, at 
DC: T cell ratios of 1:1 and 1:5. Plates were centrifuged, supernatants collected and IL-2 
content determined by ELISA as per manufacturer’s instructions.  (R&D systems: Mouse IL-2 
DuoSet DY402) 
2.2.7 Enzyme-linked immunosorbent assay (ELISA) 
Cytokine secretion was measured from 24 and 48hr DC: T cell coculture supernatant using R&D 
systems Duo Set ELISA kits, as per manufacturer’s instructions. Briefly, high protein-binding 
capacity 96-well plates (Nunc MaxiSorb) were coated with capture antibody against the 
selected cytokine at 4°C overnight. These were washed and blocked (see ELISA solutions in 
table) and supernatants were added at pre-determined dilutions. Plates were incubated for 
2hours at room temperature, washed and biotinylated detection antibody was added and 
incubated for a further 2 hours. Unbound antibody was washed off and streptavidin-bound 
horseradish peroxidise (HRP) added for 30min. 1x TMB solution was added as a substrate for 
 Chapter 2 
91 
 
HRP and incubated at room temperature for 15-30minutes. Sulphuric acid stop solution (2N 
H2SO4) was added and absorbance at 450nm was measured on an Optima FLUOStar plate 
reader. 
2.2.8 Q-PCR 
DC: T cell suspensions, cocultured at 1:5 ratio for 48hrs in a 96-well plates, were pelleted and 
lysed. Total mRNA was isolated using the RNeasy Mini Kit (QIAGEN, 74104). DNA 
contamination was removed by a 15-minute incubation at room temperature with DNaseI. 
RNA strands are split by addition of random primers and incubation at 65°C for 5 minutes. 
Reverse transcription was carried out at 37°C for 2 hours using MMLV-RT, followed by heat 
inactivation at 70°C for 15 minutes. 1μl of this reaction volume containing cDNA was used for a 
25μl RTQ-PCR reaction, using TaqMan primer/probe mix and Platinum qPCR SuperMix-UDG 
with ROX. Samples were set up in triplicates for each experiment. ΔCT values were calculated 
against murine GAPDH controls. Briefly, CT values were averaged for all replicates. ΔCT values 
were calculated (CT(gene of interest) -CT(GAPDH). ΔΔCT values were calculated by dividing the 
ΔCT value of each experimental sample by the BL6 LPS control value for the respective gene. 
Fold change from BL6 LPS was calculated as 2(-ΔΔCT). Results were averaged across 5 repeat 
experiments. 
2.2.9 Microarray analysis 
T cells were isolated from DC:T cell cocultures 48hours after culture. RNA was extracted and 
DNA contamination removed as above. RNA quality and concentration were determined on 
2100 Bioanalyser. An Affimetrix GeneChip Mouse Genome 2.0 Array was used to analyse over 
39000 transcripts. An average for each condition was calculated and fold change (FC) analysis 
performed in the GeneSpring software. Data was consequently imported into Ingenuity 
Systems IPA8, which was used to create Figures 5.13 and 5.14. 
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2.2.10 Dynabead assays 
Matured DCs were incubated on ice in a 1:1 mix of anti-MHC (I-Ab)-biotin and anti-ICAM-1-
biotin antibodies for 40 minutes. Antibodies were used at a dilution of 1/100 in PBS, and 50μl 
per 106 cells. After 40minutes, cells were washed in PBS and resuspended in Dynabeads M-270 
Streptavidin, at a cell: bead ratio of 1:3. The suspension was incubated at 37°C for 30-
40minutes and cell-bead complexes were separated using a Dynabead magnet. 
These were used for immunofluorescent staining and confocal analysis or lysed for 
immunoprecipitation as described above.  
2.2.11 DC adoptive transfer 
DCs were pulsed with LPS only and LPS/OVA overnight, then labelled with CFSE as described in 
section 2.2.6 above. 4x106 labelled cells were injected into the tail vein of OT-II mice. Three 
mice were used per condition in each experiment. Two days post injection, spleens and lymph 
nodes were collected and CD4+ cells were isolated using a Miltenyi Biotec kit. 5x105 CD4+ cells 
per well were added to 96-well plates in 200μl in media supplemented with PMA (10ng/ml), 
ionomycin (1.5μM) and brefeldin A (1μg/ml) for 5hours. CD4+ cells were then washed and 
stained for FACS analysis as described below. 
 
2.2.12 Immunocytochemistry and Immunostaining for FACS 
Coverslips (Deckglӓser 24x24mm): Cells were allowed to adhere onto poly-L-lysine coated 
slides or coverlips and fixed in 4% paraformaldehyde (PFA) for 30minutes. Cell membranes 
were then permeabilised in 0.1% triton for 5minutes. To block Fc receptors, cells were 
incubated in PBS with 5% serum from the secondary antibody host (mouse, goat, rat or rabbit) 
for 20minutes. If necessary, endogenous biotin was blocked using an Avidin/Biotin block kit 
(Invitrogen) as per instructions. 
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After washing off blocking agents, the primary antibody was added at 1/50-1/100 dilution for 1 
hour at room temperature. This was washed off with 3x 5 minute washes in PBS and secondary 
antibody was added at a dilution of 1/100-1/200. Other staining agents, such as DAPI (DNA) 
and fluorescently-tagged phalloidin (F-actin), were also added at this stage. After 45minutes, 
the washing was repeated and coverslips were mounted using AquaPolymount. 
For analysis of podosomes, coverslips were coated with fibronectin (10µg/ml) for 1hour at 
37˚C or overnight at 4˚C. Coverslips were washed in PBS and primary DCs or THP1 cells were 
seeded for up to 2hours at 37˚C. Once adhered, cells were fixed and stained following the 
protocol above. 
FACS: Cells were washed in complete media and stained for surface markers (e.g. CD3, CD4, 
CD11a/c, CD69) using fluorophore-conjugated antibodies at 1/100 dilution in PBS-BSA (1%) for 
45minutes. Cells were washed in PBS twice and fixed in 4%PFA for 15minutes, followed by any 
permeabilisation or intracellular stain required (e.g. cytokine stain in T cells from DC adoptive 
transfer). Conjugated antibodies were also used for intracellular stains, diluted to 1/50 in PBS-
BSA (1%) for 1 hour.  
 
2.2.13 Live Imaging and Fluorescence Recovery After Photobleaching (FRAP) 
Conjugates were formed between T cells and lentivirus-infected DCs as described above. These 
were allowed to settle in a glass-bottom dish for 20minutes at 37°C. All imaging was 
performed using the Zeiss LSM710 system with a 63x oil objective. Fluorophores were excited 
using 488nm and 561nm lasers for EGFP and mCherry constructs respectively. 
For FRAP, conjugate suspensions were also seeded in glass imaging dishes. Successful 
conjugates were chosen for FRAP on the basis of sufficient fluorescent construct expression. 
For the basic analysis, images were acquired every 100ms, at a digital zoom x8 and a 
63xmagnification objective. 1.5x3μm rectangle region of interest (ROI), in the synapse, cortex 
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or cytoplasm of the DC, was bleached.  Pre-bleach images were acquired for 2s, followed by 
bleaching of the ROI with 5 iterations of 100% laser power with 488 and 561nm lasers. 
Fluorescence recovery was measured for 30s after the bleach. Recovery curves were 
normalised and averaged. Halftimes were calculated according to the time taken for 
fluorescence to reach half of the final intensity. 
To separate the actin networks involved, only imaging parameters were changed. Images were 
acquired every second with a digital zoom of 27x (5x5μm area). Pre-bleach images were 
acquired for 5s, followed by bleaching of a 1x1μm circular ROI. Fluorescence recovery was 
measured for 2minutes after the bleach. 
2.2.14 Micropits preparation 
Coverslips containing the micropits (kind gift from M Biggs, Columbia University) were affixed 
to 6-well plates, in which the bottom of the dishes was cut out, using an even layer of vacuum 
grease to prevent leakage. The wells were filled with 3ml serum-free media and placed inside a 
DNA SpeedVac. Air pressure was slowly decreased to around 20-25 Torr to extract air from the 
micropits. From this point on the pits remained completely submerged in liquid to prevent 
contact with the atmosphere which would reintroduce air, preventing cell seeding. The 
coverslips were incubated in 10% pluronic acid solution for 30minutes at 37°C to prevent 
protein adsorption. The micropits were washed in PBS to remove residual pluronic acid; and 
buffer exchanged with serum-free media. For cell seeding and imaging conditions see results 
section 4.2.5. 
 
2.2.15 Electron Microscopy 
Conjugates were fixed in 1% PFA + 3% glutaraldehyde or Karnowski fixative for 20min at room 
temperature. Samples were pelleted and resuspended in low gelling temperature agar 
(TypeVII, 2-Hydroxyethylagarose; Sigma, A4018). The agar was allowed to set at room 
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temperature. The agar blocks were post fixed in osmium tetroxide, followed by dehydration in 
increasing percentages of ethanol (70-100%). Conjugates were embedded in epoxy resin, 
which was polymerised at 60°C. Samples were sectioned with an ultramicrotome using a 
diamond knife and sections were loaded onto 300mesh grids. Uranil acetate was used as a 
positive stain to provide contrast.  
 
2.2.16 Gatan 3view sample processing 
DC: T cell conjugates were fixed in 2% PFA+2% gluteraldehyde for 1hour at room temperature. 
These were set as above into 2% low gelling temperature agar. The resulting gel was cut into 
small pieces (<2x2mm) using a razor blade. The samples were washed 5 times for 3 minutes 
each in cold 0.15M cacodylate buffer containing 2mM calcium chloride. (Each wash referred to 
below comprises 5 x 3min washes.) These were then incubated for 1hour on ice in 0.3M 
cacodylate buffer with 4mM calcium chloride combined with an equal volume of 2% aqueous 
osmium tetroxide (EMS) and 3% potassium ferrocyanide. After the heavy metal incubation, 
samples were washed in dH2O and placed in filtered thiocarbohydrazide solution for 20min. 
Sample were washed and placed in 2% osmium tetroxide in dH2O for 30min for a second 
osmium stain. After washing, samples were incubated in 1% uranyl acetate at 4°C overnight. 
On the following day, Walton’s en bloc lead aspartate staining was performed for 30min, as 
previously described (Walton, 1979). Finally, samples were washed and dehydrated 
sequentially in ice-cold solutions of 30%, 50%, 70%, 90%, 100% and 100%(anhydrous) ethanol. 
Samples were placed in a viscous embedding agent (Fluka Durcupan) on a rotor overnight. 
Finally, these were embedded in a fresh, thin layer of resin, which was polymerised in a 60°C 
oven for 48hours. 
For imaging, resin block were cut to the size of each sample, mounted onto cryo pins using 
cyanoacrylate glue and trimmed further to created clean edges. Samples were coated in gold 
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palladium for 5min under argon. Cutting and imaging are performed under variable pressure, 
at a magnification of 50,000x and a Z step of 100nm. 
2.2.17 Supported planar lipid bilayers 
Glass coverslips were cleaned in Pirahna solution (3:1 mixture of sulphuric acid and 30% 
hydrogen peroxide). These were dried under Argon flow and glued to chamber slides (Sigma, 
C7182). When set, lipids (a gift from C Nowosad, Tolar lab, NIMR) were added in 250µl to each 
chamber. 1,2-Dioleoyl-snGlycero-3-Phosphoethanolamine-N-(cap Biotinyl) (DOPE-cap-biotin) 
was mixed at a molar ratio of 1:100 with 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DOPC; 
both from Avanti Polar Lipids) in choloform, and used to produce planar lipid bilayers as 
described previously (Tolar et al., 2009). Following washing, 5µg/ml of streptavidin in PBS was 
added for 15mins. Following washing, chambers were incubated with 0.5µg/ml biotinylated 
antigen (anti-MHCII-Cy5 and/or anti-ICAM-1 antibodies) in PBS for 30min. Chambers were 
washed in HBSS, to allow complete buffer exchange; and pre-incubated at 37˚C prior to 
addition of cells. 
2.2.18 Image Processing and Data Analysis 
Post-acquisition image processing and intensity quantification were performed using ImageJ 
(NIH, USA). FACS data was analysed using FlowJo. Gatan data was processed using 
DigitalMicrograph and Amira. GraphPad Prism 5 and Microsoft Excel 2010 were used for 
graphical representation and statistical analysis. Unless otherwise stated, a paired or unpaired 
t-test was used as appropriate, to determine significance between two separate groups. CT 
values from QPCR results were analysed using 7000 System SDS Software by Applied 
Biosystems. Origin Lab was used for FRAP analysis as described in recent publications 
(Fritzsche et al., 2013). GeneSpring and Ingenuity Pathway Analysis were used for analysis of 
microarray data in Chapter 5. 
 Chapter 3 
97 
 
 
Chapter 3 – Deregulated actin results in 
abnormal synapse formation 
 
 
3.1 Introduction 
 
Although the T cell actin cytoskeleton has been shown to be important for the formation of 
the immunological synapse ((DeMond et al., 2008, Ilani et al., 2009, Yu et al., 2010, Krummel et 
al., 2000)), the role of the dendritic cell actin network has not been studied in such detail. To 
elucidate its role in immunological synapse formation, the murine model of Wiskott Aldrich 
syndrome was used as a model for cytoskeletal dysfunction. Several characteristics of 
successful synapse formation were compared between WAS and control DC: T cell conjugates 
in vitro. 
The T cell integrin, LFA-1 (also known as CD11a/CD18 and αLβ2), is involved in the adhesion 
between DCs and T cell, initially establishing the interaction through weak binding and later to 
stabilise this during formation of a mature synapse (reviewed in (Dustin, 2009a, Hogg et al., 
2011, Kinashi, 2005). T cell LFA-1 has been shown to polarise towards the DC upon stable 
immunological synapse formation (Lub et al., 1997, Wulfing and Davis, 1998). 
Integrins are important for leukocyte trafficking and function in the immune system. In 
addition to their crucial role in cell-cell adhesion, data is emerging to support the idea that 
integrins can also act as bidirectional transmembrane receptors and transduce biological 
signals. As previously discussed, it is difficult to elucidate the exact pathways in T cells, in 
particular for outside-in signalling, due to the blurred distinction between direct LFA-1-
mediated signalling and the effects of prolonged or augmented signalling from other 
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receptors. Despite this, evidence increasingly points to a role of LFA-1 in signal transduction 
(Abraham et al., 1999, Weber et al., 2001, Perez et al., 2003). Furthermore, it has been shown 
that LFA-1 binding to its ligand ICAM-1 results in the accumulation of the adaptor protein talin, 
which in turn recruits vinculin and Arp2/3. Through its association with type I 
phosphatidylinositol 4-phosphate 5-kinase (PIPKI), talin recruitment results in elevated levels 
of PIP2 at the site of LFA-1 ligation, leading to recruitment of WASp and subsequently 
increased actin polymerisation (Mace et al., 2010). Although these experiments were 
conducted in NK cells, they provide a clear mechanism which links integrin activation and 
cytoskeletal rearrangement.  
In this chapter, several methods were used to study DC: T cell adhesion and the characteristics 
of successful synapse formation. As well as LFA-1, these studies also focused on its dendritic 
cell ligand, ICAM-1. ICAM-1/LFA-1 interactions have been shown to occur in the pSMAC 
(Monks et al., 1998). 
Another parameter reflecting correct DC: T cell interaction is T cell MTOC polarisation and 
docking. This was first documented over 30 years ago (Geiger et al., 1982), though the 
signalling pathways regulating MTOC docking are still unclear. It has been suggested that 
MTOC polarisation is driven by localised accumulation of diacylglycerol (DAG) at the IS and 
DAG-dependent activation of PKC (Quann et al., 2009). MTOC docking has also been linked to 
Lck signalling (Tsun et al., 2011), L-plastin phosphorylation (De Clercq et al., 2013b) and cdc42 
(Pulecio et al., 2010). 
Serial block face electron scanning microscopy was used to further probe the general structure 
of a synapse. This technique, originally developed in the field of neuroscience for imaging of 
whole tissue sections, involves sample sectioning with an ultra-microtome, followed by 
imaging of each consecutive block face by collecting the backscattered electron image (1 see 
                                                 
1
 http://www.gatan.com/knowhow/knowhow_15/3view.htm 
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footnote for reference). The technique was optimised for samples of DC: T cell conjugates in 
suspension. 
This chapter aims to establish the validity of WAS DCs as a model for actin-deficiency in 
synapse formation; to consolidate the previously suggested role for the DC actin cytoskeleton 
at the IS; and to examine the morphological differences in synapse formed between CD4+ T 
cells and control or WASp-deficient DCs. 
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3.2 Results 
3.2.1 T cell isolation efficiency 
To create an antigen-specific system, T cells were isolated from OT-II mice, expressing a 
transgenic TCR which recognises ovalbumin (OVA) in the context of MHC class II. CD4+ T cells 
were isolated using a Miltenyi Biotec negative selection kit and purity was checked by flow 
cytometry using an anti-mouse CD3-FITC conjugated antibody. Over 95% efficiency was 
achieved. The untouched, enriched CD4+ T cells were used for experiments.  
  
Figure 3.1. T cell isolation purity. Red histograms represent isotype control stain. Blue 
histograms represent anti-CD3 or anti-CD4 labelled cells. 
 
CD3-FITC 
FITC iso APC iso 
CD4-APC 
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3.2.2 Bone marrow-derived DCs and comparison of WAS DC markers 
BMDCs of control (BL6), WASp deficient (WAS) and WASp phospho-null mutant (FYN) mice 
were cultured for 7 days in the presence of GM-CSF and matured overnight with the addition 
of LPS. Figure 3.2 shows surface expression of CD11c, in immature and LPS-matured DCs, 
which is upregulated during myeloid differentiation (Corbi and Lopez-Rodriguez, 1997). 
 
 
 
 
 
 
 
 
 
Expression of MHCII, CD80 and CD86 was checked to ensure DCs were of comparable 
maturation status. Figure 3.3 shows upregulation of all three markers upon maturation of DCs. 
Further, surface expression levels are similar in cells from all three strains, suggesting a similar 
level of maturation. 
 
 
 
 
 
Figure 3.2 CD11c expression. Grey-filled histograms represent immature DCs; black lines 
represent LPS-matured cells; black dashed, filled histograms represent isotype controls. 
Bars quantify percentage of cells stained positive above isotype control for each DC type. 
C57BL/6 WAS FYN 
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Figure 3.3. BMDC maturation status. DCs were stained on ice with fluorophore-conjugated 
antibodies and analysed by flow cytometry. Grey-filled histograms represent immature DCs; 
black lines represent LPS-matured cells; black dashed, filled histograms represent isotype 
controls. Bars quantify percentage of cells stained positive above isotype control. 
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Figure 3.4. Total polymerised actin network. The CFSE-stained C57BL/6 and unstained 
WAS or FYN populations are gated separately in the FITC dotplots (left column). 
Polymerised actin in these is then compared – in the middle column histograms 
represent WAS or FYN; right column represent C57BL/6. Bars (“actin high” gate) 
quantify the percentage of each population which shows a strong phalloidin stain.  
CFSE 
Phalloidin-647 
WAS/ FYN BL6 
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Loss of expression or function of WAS is predicted to affect actin polymerisation as a result of 
reduced Arp2/3-mediated nucleation. The total polymerised actin network was measured by 
staining with phalloidin. As this stain is very sensitive to any variation in staining protocol, 
including cell number and permeabilisation, staining was performed in mixed population 
samples. CFSE-labelled control DCs were mixed with unlabelled WAS or FYN DCs. These were 
then permeabilised and stained together. Fig3.4 shows C57BL/6 DC populations contain a 
larger proportion of cells with highly polymerised actin (larger percentages of ‘actin high’ cells 
in the BL6 histograms). Similar results were obtained when either WAS or FYN DCs were CFSE-
labelled and mixed with unlabelled C57BL/6 DCs, confirming that the difference in actin is not 
a result of the additional stain in control cells. The experiment confirms that WAS and FYN DCs 
are impaired in actin polymerisation and thus show a decreased total F-actin network. 
 
 
3.2.3 Antigen presentation 
Presentation of particulate antigen has previously been shown to be defective in WASp-
deficient DCs (Westerberg et al., 2003). To confirm that differences in synapse formation were 
not a result of poor antigen presentation, an Eα-GFP antigen presentation assay was 
performed. BMDCs were matured with LPS and cultured in varying concentrations of Eα-GFP 
(0.1-100µg/ml). The DCs normally take up this antigen, process it by cleaving off the GFP tag 
and present the Eα peptide on MHC II molecules at their surface. Eα in the context of MHCII is 
then recognised by the Yae antibody (Rudensky et al., 1991, Ghimire et al., 2012). No 
significant difference in surface Eα presentation was seen between control and WAS DCs at 
any of the concentrations tested (Figure 3.5). This confirms previous reports that soluble 
antigen, unlike particulate antigen (Westerberg et al., 2003), is taken up, processed and 
presented normally in WAS DCs. 
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Figure 3.5 Antigen presentation. Proportion of Yae positive cells (expressing Eα peptide on 
MHC class II). DCs were cultured overnight with LPS and a range of Eα peptide 
concentrations. Cells were then stained for surface Eα using the Yae antibody. Positive cells 
are characterised as those showing fluorescence higher than the isotype control for each 
cell type. FACS plots show one representative experiment. Means values from 4 separate 
experiments are plotted in the graph on the right. 
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3.2.4 DC: T cell conjugate formation 
To investigate the ability of WAS DCs, compared to BL6, to form stable conjugates CMFDA-
stained DCs and DDAO-stained T cells were cocultured for 1 hour and conjugate adhesion was 
analysed by FACS. Stable conjugates were detected as double positive events. Figure3.6 shows 
representative dotplots indicating the percentage of double positive conjugates. The 
proportion of successful conjugates was very low, suggesting that many of the synapses may 
be disrupted as a result the sample preparation technique.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Conjugate formation - FACS. CMFDA-DCs and DDAO-T cell were cocultured 
for 1 hour at 37˚C. Conjugates were gently resuspended and analysed by flow cytometry. 
Double positive events (in Q2) represent DC: T cell conjugates. 
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Therefore, conjugate formation was also studied by immunofluorescence to quantify the 
number of synapses formed more accurately. DC and T cells were cocultured at a 1:3 ratio for 
45minutes and seeded on poly-L-lysine slides at room temperature for a further 10min. Cells 
were fixed and stained for specific surface markers. Successful conjugates were characterised 
as those showing an extensive, intimate contact between the DC and T cell, as shown in Fig 3.7 
(white arrows). The graph in Figure3.7 shows the percentage of DCs which had engaged T cells, 
out of the total DC population. 
 
 
 
 
 
 
 
 
 
The proportion of synapses is reduced in samples with WAS-deficient DCs or DCs expressing 
inactive WAS protein (FYN) compared to control. 
 
  
TCR
CD4
5 
LFA-1 DIC  
Figure 3.7. Conjugate formation - microscopy. DC: T cell cocultures, seeded on poly-L-lysine 
slides, were stained for LFA-1, CD45 and TCR. DCs forming conjugates (white arrows) where 
quantified as a percentage of total DC number. 
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3.2.5 Cell surface markers accumulating at the IS 
There is evidence for polarisation of several cell surface markers towards the contact interface, 
as discussed in the introduction. Immunofluorescent stains were performed to investigate 
whether these polarise correctly in WAS DCs. To allow quantification of T cell markers, such as 
TCR and LFA-1, the T cell cortex was split into two areas of similar size – the side contacting the 
DC and the opposite side. Fluorescence in each cortical half was measured and the synapse 
side was divided by the opposite side to obtain a polarisation ratio (Fig 3.8). 
 
 
 
 
 
 
 
This analysis was performed for cell surface molecules that are known to accumulate in 
different regions of the IS. CD45 was analysed as a marker for dSMAC, LFA-1 is present in the 
pSMAC, and the TCR gathers in the cSMAC. Polarisation of these markers is quantified in the 
scatter plots in Figure 3.9.  
There is evidence for TCR polarisation in productive synaptic contacts (Alarcon et al., 2011, 
Biggs et al., 2011, Hashimoto-Tane et al., 2011). TCR polarisation shown in Fig 3.9 appears very 
modest; and no significant difference in TCR polarisation was detected between T cells 
contacting BL6, WAS or FYN DCs using an unpaired t test. However, a one-sample t-test against 
a hypothetical value of 1.0 reveals a significant difference between this and the calculated 
polarisation ratios for BL6 and FYN DCs conjugates (BL6 p=0.0023; FYN p=0.0288). This was not 
Figure 3.8. Measuring polarisation of synaptic markers. Yellow line represents division of T 
cell parallel to the plane of the cell-cell interface. Blue area (5.196μm2) represents T cell half 
facing the contact, green area represents opposite side. 
A = 5.196μm
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the case for WAS (p=0.0637), suggesting that the polarisation ratio of TCR molecules in T cells 
interacting with WAS DCs was not significantly different from 1.0. 
 
 
 
 
CD45 is a distal SMAC marker apparently excluded from the central region of the IS (Graf et al., 
2007). CD45 shows slight polarisation towards the synapse in T cells contacting BL6 DCs, which 
is partially or severelly reduced in FYN and WAS respectively. 
LFA-1, the integrin implicated in synaptic organisation, localise to the pSMAC (Graf et al., 2007, 
Cambi et al., 2006, Jo et al., 2010). LFA-1 was also found to polarise towards the IS in T cells 
contacting control but not WAS or FYN DCs. 
As WASp absence was restricted to DCs, any difference in the polarisation of T cell markers 
must be induced by the DC. As LFA-1 showed the largest polarisation defect, polarisation of its 
ligand on the DC surface, ICAM-1, was investigated by immunofluorescence. ICAM-1 has 
previously been shown to direct specific synaptic organisation in cytotoxic immune synapses 
(Liu et al., 2009). Total surface ICAM-1 levels were similar between mature, OVA-pulsed BL6, 
WAS or FYN DCs. (Fig 3.10a). However, while BL6 DCs polarise ICAM-1 towards the T cell 
Figure 3.9. Polarisation of synaptic markers. DC: T cell conjugates were fixed and 
immunostained for TCR, CD45 and LFA-1. Polarisation of these markers towards the 
synapse was analysed as described in Figure 3.8. Significance levels:  
* p = 0.05-0.01;  ** p = 0.01-0.001;  *** p < 0.001 
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synapse; the polarisation ratio was significantly reduced in WAS DC conjugates. FYN DCs 
showed intermediate polarisation ratios. 
 
 
 
 
 
To confirm these findings, primary DCs were infected with a lentivirus containing an ICAM-1-
GFP construct (Bouma et al., 2011). DC: T cell cocultures were formed as above and incubated 
for 30, 45 or 60 minutes to form conjugates; then seeded and fixed as above. In control DCs, 
ICAM-1-GFP was strongly polarised towards the T cell. WAS DCs showed a significant reduction 
in ICAM-1 polarisation at all time-points tested (Fig3.11). The number of cells showing 
polarised ICAM-1 with a polarisation ratio >1.25, quantified in Figure 3.11b, was significantly 
reduced in WAS DC cocultures. FYN DCs were not significantly different from control BL6. 
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Figure 3.10. ICAM-1 polarisation on the DC side. Histogram shows similar levels of surface 
ICAM-1 in mature OVA-pulsed BL6 (BO), WAS (WO) and FYN (FO) DCs. DC: T cell conjugates 
were immunostained for ICAM-1. Polarisation was measured as described in Figure 3.8, by 
splitting the DC, rather than the T cell, into 2 roughly equal-sized opposing sides. A 
minimum of 10 conjugates were analysed for each strain in 3 separate experiments. 
Significance level: ** p = 0.0026. 
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Figure 3.11. ICAM-1-GFP polarisation in lentivirus infected DCs. Conjugates were seeded on poly-L-lysine slides and fixed at different 
timepoints. Scale bars = 10μm. Cells with polarisation ratio >1.25 were quantified. Cell percentages were converted into arcsin values to 
account for the variation limits of percentages. T tests were then performed to compare the different cocultures. BL6 vs WAS p=0.028; BL6 vs 
FYN p=0.075; WAS vs FYN p=0.044. 
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Polarisation of the T cell MTOC towards the DC: T cell interface has been reported to occur as 
part of IS formation (Pulecio et al., 2010) and suggests a role for the microtubule cytoskeleton. 
Immunofluorescent staining for γ-tubulin, a nucleating component of the MTOC, shows 
polarisation in T cells synapsed with normal DCs.  This appears defective in T cells synapsed 
with WAS DCs (Fig 3.12), as the MTOC appeared to be located randomly in each T cell. FYN DCs 
induce an intermediate phenotype, significantly different from both BL6 and WAS. No 
polarisation of the DC MTOC was observed in either strain.  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.12 T cell MTOC polarisation found in dendritic cells. DCs were cocultured with T 
cells for 1hour, placed on poly-L-lysine coated microscope slides and stained for γ-
tubulin. The distance between the T cell MTOC and the DC was measured in ImageJ by 
drawing the shortest possible straight line between the MTOC and the DC surface. 
Representative BL6 and WAS conjugates are shown above. White arrows highlight the 
position of the T cell MTOC. Scale bar = 10μm. A minimum of 20 cells were analysed in 3 
separate experiments and an unpaired t test was used to compare populations. 
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3.2.6 High resolution and 3D imaging of conjugates 
To increase imaging resolution, several electron microscopy (EM) techniques were utilised, the 
importance of which has been recognised by a number of groups (Williams et al., 2007, Ueda 
et al., 2011). 
First, similar to immunofluorescence MTOC stains, EM studies confirmed that no DC MTOC 
polarisation was seen towards the synapse; the DC MTOC was often observed in detail in the 
centre of most DCs (Fig3.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
EM images of control DC conjugates often showed very intimate contacts between the T cell 
and DC. One method to analyse this further was electron tomography, a technique which 
Figure 3.13 Electron microscopy synapse imaging. Arrow denotes position of MTOC. Scale 
bar = 2μm. 
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involves tilting the electron beam at incremental angles through the centre of the sample, on a 
transmission electron microscope (TEM). Although this technique proved useful for visualising 
some level of 3D detail, it was not sufficient to build up a complete 3D image of conjugates and 
allow quantification of membrane contacts. 
Serial block face scanning electron microscopy allows us to produce 3D reconstructions of EM 
data. Using the Gatan-3view technology (Denk and Horstmann, 2004), samples are sectioned 
with an ultra-microtome and each consecutive block surface is imaged. Figure 3.14 shows 
representative slices through conjugates of T cells with BL6, WAS or FYN DCs on the left; and 
illustrates the analysis performed to calculate the conjugate contact area (right). The individual 
slices show the very close apposition of the T cell and DC membranes across the whole 
synapse site in BL6 conjugates (top). FYN DCs appear to induce similar contacts (bottom). WAS 
DCs however, appear to interact in a much less intimate way, through a smaller contact 
interface (middle panel). 
The process illustrated on the right, involves creating a stack of the individual slices and 
drawing each cell outline on each slice. Several tools in the Amira software allow detection of 
pixels belonging to each cell, making the process more objective and reliable. Amira uses the 
selection on each slice to reconstruct a 3D model (Isosurface reconstruction) of the DC: T cell 
conjugate. 
 
 
 
 
 
 Chapter 3 
116 
 
Figure 3.14 TEM and 3-view. BL6, WAS and FYN 
conjugates were imaged by TEM (left) or serial 
block face SEM (right). Images were acquired in 
Digital Micrograph; Isosurface reconstructions 
were produced in Amira. Scale bars = 5µm 
BL6 
WAS 
FYN 
Slice through BL6 conjugate 
DC and T cell area labels 
3D Isosurface reconstruction 
BL6 
WAS 
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By outlining the perimeter of each cell on each slice imaged, a detailed 3D isosurface was 
created, allowing the measurement of contact area between the two cells and comparison 
between the mouse strains. 
During conjugate formation, BL6 DCs induce T cell spreading, thus increasing the contact 
surface area. They also seem to undergo cytoskeletal rearrangement to allow the T cell to 
settle in a ‘pocket’ on the DC surface (Fig 3.16 top). Minimal T cell spreading was seen when T 
cells formed conjugates with WAS DCs, while FYN DCs induced an intermediate state. The 
difference can be seen clearly in Movies 3.1-3.3. The contact area for each conjugate was 
quantified as a percentage of the total T cell surface area and this is shown in Figure 3.15. As 
OT-II T cell for all conjugates were identical, the differences in T cell spreading observed must 
be a result of the differential expression or function of WASp in the DCs. This highlights the 
crucial role of the dendritic cell actin cytoskeleton in correct synapse formation. 
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Figure 3.15 DC: T cell contact surface area. After isosurface reconstruction, contact area 
was measured using the ‘Measure patches’ function in the Amira software. Contact area 
was normalised relative to T cell size so is presented as a percentage of total T cell 
surface area. A minimum of 10 conjugates of each DC type was analysed. An unpaired t 
test was used to test significance between DC types. 
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Figure 3.16 3D reconstructions of EM serial slices. In BL6 conjugates, the T cell (blue) 
appears to spread out and to lie in a ‘pocket’ on the DC (orange). Representative WAS 
and FYN conjugates are shown. Transparent T cells shown in the top panel are removed 
to visualise the surface contact site on the DC (bottom panel). Images were acquired in 
Digital Micrograph; Isosurface reconstructions were produced in Amira. 
BL6 
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3.3 Discussion 
 
Firstly, it is important to highlight that the antigen-specific T cells used for conjugate formation 
expressed WASp normally and were of the same origin throughout all experiments. 
Consequently, the differences in their responses reflect a DC-intrinsic dysfunction, resulting 
from WASp deficiency, which abrogates the DCs ability to induce normal synapse formation. 
Upon stimulation with LPS, WAS DCs show a similar maturation status, as measured by surface 
expression of MHCII, CD80 and CD86; and similar levels of surface CD11c expression (Fig 3.2 
and 3.3). This suggests that any synapse differences are not due to abnormal dendritic cell 
phenotype or poor maturation. Further, antigen uptake, processing and presentation of 
soluble antigen were found to be normal in WAS DCs, as previously described (Westerberg et 
al., 2003). 
WAS DCs contain less total polymerised actin (Fig 3.4). Actin plays a crucial role in cell integrity, 
transmembrane protein clustering, membrane organisation and mechanosensing. Thus, 
reduced actin polymerisation, or a reduced total F-actin network, may mean the cell is less 
responsive to external physical cues, less able to form precise structures; and less able to 
transport, concentrate or stabilise many transmembrane proteins.  
This appears to be the case for ICAM-1, the LFA-1 ligand with a previously described role in 
synapse organisation (Graf et al., 2007, Liu et al., 2009, Jo et al., 2010). Although the surface 
levels of ICAM-1 were similar between BL6 and WAS DCs, ICAM-1 polarisation towards the IS 
was defective in WAS DC contacts (Fig 3.10). It has been proposed that an active actin-
cytoskeleton dependent mechanism is responsible for membrane ICAM-1 translocation 
towards the synapse and reduced ICAM-1 polarisation in WAS DCs is compatible with this 
mechanism (Jo et al., 2010). Jo et al however, also suggest uptake and recycling of ICAM-1, 
which is directed to the IS through adhesion to LFA-1 (Jo et al., 2010). Experiments presented 
here cannot exclude the possibility that a feedback mechanism from the T cell LFA-1 exists to 
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reinforce ICAM-1 clustering on the DC surface. However, the fact that LFA-1 polarisation 
towards the interface was abnormal in T cells contacting WAS DCs (Fig 3.9), suggests that DC-
mediated ICAM-1 polarisation provides the driving force for this process. 
A similar idea has been described for the localisation of CD80 and its T cell ligands CD28 and 
CTLA (Tseng et al., 2005). The cytoplasmic domain of CD80 was shown to be critical not only 
for its own organisation at the synapse, but also for that of its ligands CD28 and CTLA and the 
downstream kinase PKCθ. 
A defect in integrin polarisation towards the synapse, and therefore reduced integrin density, 
would result in reduced adhesion, which could explain the reduced number of stable 
conjugates of WAS DCs seen in Fig 3.7. This supports previous studies showing that blocking 
LFA-1 function abolishes interaction forces in T cell: APC conjugates, as measured by atomic 
force microscopy (AFM) (Hosseini et al., 2009). Reduced integrin binding at the synapse could 
also account for the reduced contact interface seen in EM and 3View experiments (Fig3.14 and 
3.15), by essentially minimising or eliminating the pSMAC in WAS DC conjugates. It would be 
interesting to directly observe LFA-1 or ICAM-1 localisation at high resolution by performing 
immunogold labelling for EM. AFM comparing BL6 and WAS DC conjugates would also provide 
supporting data. 
In addition to defective integrin polarisation, CD45 translocation was also observed to be 
impaired. A defect in CD45 polarisation towards the synapse could have an effect on 
downstream signalling. CD45 is a protein tyrosine phosphatase, which is essential for TCR-
mediated T cell activation (Altin and Sloan, 1997). In T cells, CD45 regulates Src family kinases 
such as Lck and Fyn (Chan et al., 1994). For example, it is known to dephosphorylate the 
negative regulatory tyrosine residue Y505 on Lck (Wang and Johnson, 2005, Duplay et al., 
1996, Seavitt et al., 1999). It may also have other targets at the IS, including TCR and ZAP-70 
(Furukawa et al., 1994, Mustelin et al., 1995). CD45 organisation or concentration at the 
synapse may be crucial for maintaining the correct pTyr signature for the correct association of 
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synapse components and activation or inhibition of signalling pathways. It is easy to see how in 
T cells contacting WAS DCs, defective CD45 polarisation towards the synapse may result in 
altered signalling. Further experiments are required to investigate whether this is directly due 
to the instability of the actin network or indirectly due to integrin adhesion defects, as has 
been proposed for CD45 exclusion from the cSMAC (Graf et al., 2007). 
MTOC polarisation may also be linked to integrin adhesion. Early studies into MTOC 
polarisation suggested the process was dependent on TCR signalling. Sedwick et al showed 
that when a T cell simultaneously contacted cells expressing either peptide-MHC complexes or 
ICAM-1, the T cell MTOC polarised mainly towards the cell expressing MHC (Sedwick et al., 
1999). In addition, there is evidence for the requirement of several downstream signalling 
proteins, including tyrosine kinases (Lck and Zap70) and scaffolding proteins (Slp76 and LAT) 
(Lowin-Kropf et al., 1998, Kuhne et al., 2003). Although initially it was thought that LFA-1 did 
not play a role, more recently evidence has shown that it is required for complete, robust 
MTOC polarisation (Yi et al., 2013). Yi et al also show that the driving force behind MTOC 
repositioning can cause deep membrane invagination at the contact surface of “frustrated” 
conjugates thus implicating a strong force anchored at the IS. If LFA-1 does play a role in MTOC 
migration, it is easy to see how this would by perturbed in T cells contacting WAS DCs, where 
LFA-1 polarisation is abrogated.  
Recently, LFA-1 localisation and activation have been linked to L-plastin phosphorylation 
(Wang et al., 2010, Wabnitz et al., 2010). L-plastin is an actin-crosslinking protein that allows 
formation of tight actin bundles (Morley, 2012). Blocking L-plastin function results in abnormal 
IS formation, cytokine secretion and MTOC docking (De Clercq et al., 2013b). If LFA-1 plays a 
role in T cell MTOC polarisation, other mechanisms affecting LFA-1 organisation can be 
predicted to have effects similar to L-plastin. This supports results presented in this chapter 
showing that lack of WASp in DCs results in poor LFA-1 polarisation on the surface of T cells, 
which in turn affects T cell MTOC relocation. However, the results cannot rule out an LFA-1-
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independent mechanism which may be defective during induction by WAS DCs. Further 
investigation into signal transduction between actin or LFA-1 and the microtubule cytoskeleton 
is required. 
The exact mechanism of MTOC polarisation is still controversial. Until recently, it was thought 
that a complex containing the microtubule motor dynein and the adaptor protein ADAP was 
responsible for pulling the MTOC towards the synapse in a sliding motion (Combs et al., 2006, 
Billadeau et al., 2007). However, as mentioned earlier, a recent model suggests end-on 
microtubule capture and depolymerisation provides the main driving force behind microtubule 
organisation (Yi et al., 2013). The link between the microtubule and actin cytoskeleton in either 
model is not completely understood and research into this could provide important clues 
regarding loss of MTOC polarisation both in T cells intrinsically lacking WASp and wildtype T 
cells contacting WAS DCs. Further, although the exact role of MTOC polarisation in CD4 cells is 
unclear, if this is similar to its role in polarised secretion in CD8 and NK cells (reviewed in 
(Billadeau et al., 2007)), perturbed cytokine secretion in CD4 T cells could affect T cell 
activation, or the cytokine milieu produced. However, there is evidence to suggest that 
polarised cytokine release in CD4 cells requires actin polymerisation downstream of Cdc42 but 
not MTOC polarisation (Chemin et al., 2012).  
Contrary to previous observations by Pulecio et al, no polarisation of the DC MTOC was seen in 
BL6 or WAS DCs by confocal or electron microscopy (Pulecio et al., 2010). However, another 
recent publication also highlighted the importance of intact DC function for IS formation but 
found no DC MTOC polarisation towards the synapse (Bouma et al., 2011). 
The FYN DCs showed an interesting phenotype throughout all of these experiments. 
Expression of the phospho-null Y293F WASp results in recovery of ICAM-1 polarisation in DCs, 
and consequently LFA-1 polarisation on the T cell (Fig 3.9, 3.10, 3.11). This suggests that 
phosphorylation of WASp is not essential for either of these – ICAM-1 localisation, or its 
ligation to LFA-1. This may point to a different regulator of WASp at the synapse (such as 
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Cdc42 binding, WIP or dimerisation). Alternatively, it may suggest that WASp activation and its 
role in actin polymerisation are not crucial for ICAM-1 localisation, for example WASp may be 
involved in stabilising the actin network at the IS, rather than active polymerisation.  
Further, contact area, as measured in 3D conjugate reconstructions, is increased to normal 
levels in FYN, compared to WAS DC conjugates. FYN DCs are able to induce T cell spreading 
over their surface and form the ‘pocket’ described for BL6 DCs (Fig 3.16). This provides support 
for the adhesion hypothesis described above, suggesting that LFA-1 polarisation and 
interaction with ICAM-1 are important for pSMAC organisation and stable, intimate synapse 
formation.  
Polarisation of the T cell MTOC however in FYN, although improved compared to WAS, is still 
significantly different from the close apposition seen in the BL6 IS (Fig 3.12). As previously 
discussed, this may be due to an LFA-1 –independent mechanism involved in MTOC relocation, 
which is deficient in WAS and perhaps dependent on WASp phosphorylation.  
Several questions remain unanswered. It would be interesting to compare the mechanisms 
and regulators behind ‘pocket’ formation in DCs and phagocytic cup formation, which has 
been shown to be abnormal in WAS (Leverrier et al., 2001, Lorenzi et al., 2000, Tsuboi and 
Meerloo, 2007). Interestingly, formation of the phagocytic cup has been compared to IS 
formation, in particular downstream of Dectin-1 receptor ligation to particulate β-glucans (for 
example, yeast) (Goodridge et al., 2011). Dectin-1 is able to differentiate between soluble and 
particulate β-glucans; and downstream of the latter, it is able to induce cytoskeletal 
remodelling, phagocytosis and exclusion of the phosphatases CD45 and CD148, as has been 
described in T cell synapses (Cordoba et al., 2013). Questions remain about whether all of 
these structures involve some initial mechanosensing to determine the function and 
organisation of the final structure; or whether the phagocytic cup is a kind of evolutionary 
precursor for the mechanisms developed in the formation of the IS. In terms of the role of 
WASp however, Tsuboi and Meerloo, suggest the phosphorylation of WASp is important for 
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phagocytic cup formation in macrophages (Tsuboi and Meerloo, 2007), which does not seem 
to be the case for ‘pocket’ formation in FYN DCs seen in Fig 3.16. 
Further, it would be interesting to study whether WAS deficiency in DCs affects T cell calcium 
influx, DAG and PKC signalling, as well as the localisation of PAR3-PAR6-aPKC complex, which 
have all been implicated in MTOC polarisation (Quann et al., 2011, Quann et al., 2009, Dustin 
et al., 2010, Merino et al., 2012, Huse, 2012).  
In summary, results presented in this chapter showed significant differences between WAS 
and BL6 DCs in a number of physical IS characteristics, including integrin polarisation and 
induction of T cell MTOC relocation. Consequently, there may be significant differences in cell: 
cell adhesion, synapse organisation over time and T cell activation, which may contribute to 
the immunological defects seen in WAS patients. 
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Chapter 4 – Dynamics of synapse 
formation 
 
 
4.1 Introduction 
 
The immune synapse has been described to last for several hours (Huppa et al., 2003) with 
constant contact between the two cells. The physiological relevance of this remains elusive. It 
has been suggested that the long-lived cSMAC provides increased local concentration of TCR 
and pMHC, which may slow down disengagement or allow re-engagement (Lin et al., 2005). 
The precise mechanism behind this lasting contact is unclear though there is strong evidence 
for the involvement of actin and integrins (Sims and Dustin, 2002). Despite this stability, the 
synapse is a highly dynamic structure.  
First, at a macrostructural level, the morphology of the synapse undergoes several changes 
through distinct stages (Ueda et al., 2011). It has been suggested that there are at least 4 
distinct stages in CD4+ T cell synapse formation, starting with T cell pseudopodia penetrating 
deeply into the APC, followed by centriole positioning close to the contact site and 
enlargement of the Golgi complex with membrane activity becoming polarised towards the 
APC (Ueda et al., 2011). Furthermore, observations of T cell activation in lymph nodes suggests 
T cells make multiple contacts with APCs and are thus able to break and reassemble the IS 
structure several times (Mempel et al., 2004, Miller et al., 2002).  
As well as whole cell movements and adhesion, the dynamic nature of the synapse is also 
crucial for movements on a much smaller scale – the movement of transmembrane proteins, 
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such as TCR/pMHC, costimulatory molecules and integrins, in the plane of the cell-cell 
interface; as well as the endocytosis of proteins from the synapse, by either cell, as part of the 
recycling process (Lee et al., 2003a, Grakoui et al., 1999). 
The main determinants of cortical actin’s structural integrity and mechanics are the length 
distribution of actin filaments, the cross-link nature and the density of the actin network 
(Gardel et al., 2004, Kasza et al., 2010, Bai et al., 2011). In steady state, actin assembly, 
disassembly and cross-linking are balanced so that the thickness, structure, composition and 
mechanical properties of the cortex remain constant. During processes such as cell migration 
or cell-cell interaction, these parameters of the actin network must be changed to build a 
cortical actin network more suited to the precise function/process. This is achieved by actin 
regulatory proteins, which control the delicate balance between a dynamic and stable 
network.  
As actin has been shown to play a key role in synapse organisation (Chapter 3 and (Bunnell et 
al., 2001, Campi et al., 2005, Mayya and Dustin, 2010, Monica Gordon-Alonso, 2010)), it is 
predicted that actin’s ability to form stable yet dynamic networks underlies the long-lasting 
and flexible synaptic structure. Disturbing the function of actin regulators in DCs, such as 
WASp, would be expected to result in abnormal cellular actin dynamics and the formation of 
less stable and poorly organised IS. 
This chapter aims to investigate any differences in duration of stable contacts between control 
and WAS DC synapses using live imaging; examine the dynamic organisation of synapses in the 
plane of the cell-cell interface; investigate the stability of the actin network at the IS; and 
determine the degree to which different actin properties are affected resulting in poor synapse 
formation by WAS DCs. 
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4.2 Results 
 
4.2.1 Synapse quantification 
In Chapter 3, conjugate numbers were quantified after a set incubation time of 45 minutes. To 
follow the number of conjugates formed over time, a similar experiment was conducted as a 
time course of 10-100 minutes. Figure 4.1 shows that WAS DCs formed fewer conjugates, 
compared to BL6; and this was consistent at every time point. Linear regression analysis shows 
the change over time (slope) between BL6 and WAS in significantly different. FYN DCs showed 
a smaller reduction in the number of conjugates formed. At initial time points they appear 
similar to WAS, while later efficiency of conjugate formation increases. Consequently, linear 
regression shows the slope of the FYN data is similar to BL6, while the total number of 
conjugates (the elevation) is reduced.  
 
 
 
 
Comparison Slope Elevation/ 
Intercept 
BL6/WAS p=0.0001 * 
BL6/FYN p=0.2545 p=0.0033 
WAS/FYN p=0.0109 * 
Figure 4.1 Conjugate formation over time. DC: T cocultures were seeded on poly-L-lysine 
slides at given intervals after coculture (10, 20, 30, 45, 60 and 100minutes). Conjugate 
numbers were quantified as in Figure 3.7 (left). A linear regression fit was performed on the 
resulting data; fitted lines are shown in the graph on the right. Statistics are summarised in the 
table.  
*Due to difference in slopes, it is not possible to test whether the intercepts differ 
significantly. 
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4.2.2 Live imaging 
To assess the stability of the DC: T cell conjugates formed, synapse formation was followed in 
real time. Mature, OVA-pulsed DCs expressing LifeAct-mCherry (Riedl et al., 2008) and ICAM-1-
GFP were transferred to glass-bottomed imaging dishes on day 7 of the BMDC differentiation 
culture. OT-II CD4+ cells were added just prior to imaging to focus on the initial contacts. The 
montages below represent live imaging in Movies 4.1 and 4.2. 
BL6 DCs formed stable, long-lasting contacts, which on average last over 30 minutes and 
results in a slight rounding of the DC. In contrast, WAS DCs rarely formed such stable contacts 
with T cells. In Figure 4.2, two T cells come into view, make brief contacts with the WAS DC and 
appear to ‘bounce off’ it several times before migrating away (blue arrows in WAS montage). 
C57BL/6 
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WAS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The blue arrow in the BL6 montage highlights the start of a stable contact and the DC and T cell 
remain in a conjugate for the rest of the imaging period. The arrows in the WAS montage show 
brief contacts in between which the T cell appears to roll along the DC surface but not form a 
stable synapse. A longer live imaging period would be beneficial for both the BL6 and WAS 
samples. This type of imaging however does not allow enough resolution to study the subtle 
molecular changes at the synapse. 
 
 
Figure 4.2 DC-T cell contacts are shorter or less stable with WAS DCs. The montages 
above are taken from live-imaging data over 45minutes. Images are taken at intervals of 
around 1.5minutes, starting 5 minutes after addition of T cells. Each image represents a 
maximum projection of 3 slices of the z-stack (10 slices total). LifeAct (actin) is shown in 
red and ICAM-1 in green. Time is given in minutes. Blue arrows highlight contacts, as 
described in the text. Scale bars = 10μm. 
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4.2.3 Fluorescence Recovery After Photobleaching 
In addition to live imaging, an analysis of the stability of the actin cytoskeleton at the synapse 
site would be beneficial. To investigate molecular changes at the synapse, FRAP was used to 
study actin dynamics. BL6 and WAS BMDCs were transduced on day 3 with a vector expressing 
Actin-mCherry to allow fluorescent imaging of actin. 
An area of the Actin-mCherry expressing DC was selectively photobleached using 5 iterations 
of 100% laser power with 488 and 561nm lasers. Fluorescence intensity was measured for 
between 15 and 30s after the bleach. After bleaching, recovery of fluorescence occurs as a 
result of repopulation of the area by non-bleached molecules.  Binding of actin to other 
proteins or immobile structures in the cell, including incorporation in stable low-turnover 
filaments, results in slower recovery of fluorescence. 
The graph in Figure 4.3 shows a typical normalised recovery curve and highlights the different 
parameters that can be derived from the data. The two most important parameters taken into 
account for basic analysis are the half-time, which is the time taken for fluorescence to recover 
to half of the final intensity; and the immobile fraction, which reflects the difference between 
pre-bleach and final intensities giving us a measure of the proportion of actin that cannot be 
replaced. 
 
 
 
 
 
 
 Figure 4.3 Recovery curve calculations.  
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Each of three areas was bleached independently – synapse, cortex or cytoplasm. Post-bleach 
intensity dropped to around 20-30% of pre-bleach value. The images above are single slices 
through a conjugate, representing an example of a synapse ROI bleach. 
As expected, recovery of cytoplasmic actin is much faster and more complete, compared to 
the cortex or synapse areas (Fig4.5). The lower proportion of polymerised actin in the 
cytoplasm, compared to cortex and synapse, allows faster diffusion of actin monomers back 
into the bleached area. Turnover of actin polymers itself, although more rare in the cytoplasm 
compared to the cortex, may be much faster due to a higher concentration of free actin 
monomers and a lower concentration of actin bundling and cross-linking proteins.  
 
   
Actin pre-bleach Actin post-bleach DIC 
cytoplasm 
cortex 
synapse 
DC 
T cell 
Figure 4.4 Actin-mCherry bleach at 3 different areas. 
Red dashed outline indicates region of interest (ROI) 
bleached. DIC image shows that this is a synapse ROI 
at the DC: T cell interface. 
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Further, WASp-deficient DCs consistently show faster recovery than control BL6, consistent 
with the idea that the WASp DC cytoplasm may be less dense due to a lower proportion of 
polymerised actin. (Figure 4.6) 
Since actin-mCherry is overexpressed from the same promoter in BL6, WAS and FYN DCs, 
unless WAS-deficiency has an effect on actin post-translational regulation, we can assume 
there is a similar level of total actin in both cells. Consequently, the fact that WASp-deficient 
cells contain less polymerised actin (Fig 3.4), suggests there may be a higher proportion of 
actin monomers. An increased concentration of actin monomers would allow faster diffusion 
and polymerisation. This faster treadmilling is reflected in the shorter half-time of fluorescence 
recovery and, indirectly, the lower immobile fraction in WASp-deficient DCs (less polymerised 
actin at a given time).  
Figure 4.5 Actin dynamics in different areas of a cell. Recovery of actin-mCherry 
fluorescence is plotted against time for each different ROI. Fluorescence is normalised 
against pre-bleach value and an average of 15 curves is plotted. 
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Decreased recovery half-life suggests increased turnover of actin filaments and therefore 
reduced overall polymerisation. The lower immobile fraction in the WAS DCs shows that more 
of the actin can be replaced post-bleach, perhaps suggesting a reduced stability of the actin 
network in the WAS DC compared to control.  
The differences between the control and WASp-deficient DCs appear exaggerated at the 
synapse. This confirms the difference in protein composition between the synapse and the rest 
of the cell cortex, highlights the involvement of actin in this structure and implicates an 
additional regulatory mechanism at the synapse. The longer half-time and higher immobile 
fraction, suggest greater stability of the actin cytoskeleton at the synapse of normal DCs. 
(Figure 4.7) 
Interestingly, actin-mCherry in FYN DCs recovers normally in the cortex and cytoplasm, 
resulting in recovery curves similar to BL6. This would suggest that the presence of WASp 
alone, even as a phosphorylation-dead mutant, is sufficient for normal actin dynamics in the 
cortex. One possible explanation is that in the cortex and cytoplasm, WASp is activated mainly 
through mechanisms other than phosphorylation. Alternatively, in these areas WASp may have 
a role independent of its Arp2/3 binding function, for example by acting as a scaffold for other 
proteins. At the synapse however, FYN DCs show actin recovery similar to WAS-deficient DCs. 
This suggests that at the synapse, phosphorylation of WASp is crucial for its role in regulating 
actin dynamics. 
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Figure 4.6 Fluorescence recovery appears much faster in WASp-deficient DCs.  
Normal or WAS DCs expressing Actin-mCherry were incubated with T cells for 40 
minutes. The cell suspension was then added to a glass-bottomed 35mm imaging dish 
and allowed to settle for 20 minutes. Conjugated DCs were chosen on the basis of 
sufficient Actin-mCherry expression and no drift within the field of view. Three areas 
were bleached for comparison. The curves shown here are averages of normalised, 
background-corrected data for at least 15 cells. 
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Figure 4.7 Fluorescence recovery in WAS DCs is augmented at the synapse.  
Comparison with other areas bleached in the conjugated cells (cortex or cytoplasm) 
shows a bigger difference in half-time and immobile fraction of actin between control 
and WAS at the synapse.  
↑polymerisation = ↓ turnover = ↑ half life 
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Although this basic analysis was useful in highlighting some of the differences between control 
and WAS DC synapses, several parameters were altered to improve the FRAP set up and allow 
for more sophisticated calculations. First, the area of the bleached region was reduced to a 
circle of 1µm diameter (2x5µm rectangle previously) to allow fast, symmetric diffusion of actin 
monomers into the bleached area from all directions. Given the fast rate of diffusive recovery, 
D≈ 20μm/s (Fritzsche et al., 2013), and the small size of the bleached region, this also 
minimises the diffusion component of the FRAP recovery curve. Further, the total area imaged 
was reduced to 5x5µm in order to increase imaging speed. Once the validity of these 
parameters was confirmed, the temporal resolution of imaging was reduced to 1 frame per 
second. This allows enough resolution to detect actin recovery through polymerisation but 
minimises the photo-damage caused during imaging. At higher frame rates, many actin 
monomers are bleached and the detected recovery is much lower than actual filament 
recovery.  
A recent paper described reactive recovery (that resulting from association/dissociation rather 
than diffusion of proteins) in terms of first-order reaction kinetics. 
F (t) ≈ [1- exp (-tωd)]F0, where F0 represents pre-bleach fluorescence and ωd is the rate of 
turnover, which is linked to half-life calculated from FRAP experiments (t1/2 – ln2/ωd). This 
exponential function would describe the simplest recovery, resulting from one type of 
reaction. It is likely that several molecular reactions contribute to cortical actin turnover and it 
has been suggested that fluorescent recovery can be represented as the sum of several 
exponential functions (where each one represents a different molecular turnover process) 
(Fritzsche et al., 2013). Thus, by separating the components of the recovery curve, the rates 
and proportions of the separate actin networks contributing to recovery can be calculated. 
As before, OVA-pulsed Actin-mCherry-expressing DCs from either BL6, WAS or FYN mice were 
used to form conjugates with OT-II T cells. FRAP was performed using the parameters 
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described above. The recovery curves of actin at the cortex or synapse of BL6, WAS and FYN 
DCs are shown in Figure 4.8. 
The fitting parameters, R2 and χ2 for first-, second- and third-order exponentials are shown in 
Table 4.1. Second-order exponential fit described the curves best, suggesting that two 
different actin networks contribute to actin recovery.  Rates of recovery and proportions of 
each actin network are shown in Table 4.2. 
  
Figure 4.8 Background-corrected mean fluorescence recovery plotted against time. Error 
bars represent SEM. Red solid line represents second order exponential fit. Dotted line shows 
fluorescence loss due to imaging. Mean values from 10 curves are presented. 
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Table 4.1 Exponential fitting parameters. 
Table 4.2 Second-order exponential fit recovery rates. 
The analysis revealed the presence of two distinct actin subpopulations in DCs, as previously 
described in cell lines (Fritzsche et al., 2013). The rate of the first network (ωd,1) describes a 
fast-recovery network which comprises short branched filaments with a fast turnover rate. The 
slower network, described by ωd,2, comprises longer actin filaments, nucleation and 
stabilisation of which may be mediated by formins (Fritzsche et al., 2013, Kovar et al., 2006). 
The proportion of each subpopulation is represented by F1 and F2. In BL6 DCs, around 78% (f1 
column) of actin recovery occurred through the fast, Arp2/3-depended network. In the steady-
state cortex, rate of this recovery was 1.28 ± 0.1s-1. In the synapse, the proportion of this fast, 
branched network was increased, however its rate of recovery decreased to 1.02 ± 0.1s-1, 
which is significantly different to the cortex. This shows there is some level of stabilisation 
(decreased recovery rate) of the actin network during synapse formation, and may also 
suggest a more densely branched network (increased proportion of short branched filaments). 
Multi 
exponent fit 
R21st Χ
2
1st R
2
2nd Χ
2
2nd R
2
3rd Χ
2
3rd N 
C
o
rt
ex
 
C57BL/6 0.9 0.09 0.97 0.03 0.97 0.03 10 
WAS 0.9 0.09 0.97 0.03 0.97 0.03 11 
FYN 0.89 0.111 0.95 0.05 0.95 0.05 10 
Sy
n
ap
se
 C57BL/6 0.89 0.06 0.96 0.02 0.96 0.02 10 
WAS 0.94 0.1 0.97 0.04 0.97 0.04 8 
FYN 0.89 0.2 0.92 0.14 0.92 0.14 13 
Multi 
exponent fit 
ωd,1 (s
-1) p-value f1 ωd,2 (s
-1) p-value f2 N 
C
o
rt
ex
 
C57BL/6 1.28 ± 0.1 - 0.78 ± 0.08 0.14 ± 0.04 - 0.22 ± 0.02 10 
WAS 1.28 ± 0.1 0.99 0.78 ± 0.08 0.14 ± 0.04 0.99 0.22 ± 0.02 11 
FYN 1.42 ± 0.1 <0.01 0.82 ± 0.08 0.24 ± 0.04 <0.01 0.18 ± 0.04 10 
Sy
n
ap
se
 C57BL/6 1.02 ± 0.14 <0.01 0.81 ± 0.08 0.13 ± 0.04 0.99 0.19 ± 0.05 10 
WAS 1.68 ± 0.3 <0.01 0.81 ± 0.06 0.27 ± 0.04 <0.01 0.19 ± 0.02 8 
FYN 1.84 ± 0.1 <0.01 0.81 ± 0.1 0.28 ± 0.04 <0.01 0.19 ± 0.08 13 
 Chapter 4 
139 
 
The longer formin-mediated filaments contribute to around 22% (f2 column) of actin recovery 
at the cortex, at a rate of 0.14 ± 0.04s-1. In the synapse, the rate of recovery of this network 
does not change, though the overall proportion of it is slightly decreased. This is most likely to 
be a result of increased short branched actin, rather than a decrease in the absolute amount of 
long filaments. 
According to this analysis, the WAS DC cortex is similar to BL6, suggesting that WAS function is 
not required for maintenance of cortical actin in steady state. This conflicts with data 
presented in Fig 4.7, highlighting the difference in sensitivity between the two techniques. At 
the synapse, lack of WASp results in increased recovery rates of both networks compared to 
BL6 DCs, similar to previous basic analysis (Fig4.6, 4.7). The increased recovery of the fast 
network may result from an inability to stabilise actin and provide a platform for the IS. Loss of 
stability suggests more diffusion and random motion of both G-actin and different filament 
subpopulations, resulting in more fluidity beneath the membrane. Furthermore, the recovery 
rate at the WAS synapse is increased even compared to the WAS cortex. This could be the 
result of increased local actin monomer concentration or short-filament polymerisation 
through other pathways, as a result of the external signals provided at the synapse to increase 
actin polymerisation. 
It is interesting that the rate of the second, slow-recovery network is also increased in the WAS 
synapse. If the actin network does become polarised towards the synapse through 
mechanisms independent of WASp, but then cannot be organised and stabilised due to the 
lack of WASp, this could provide more building blocks (in the form of short actin filaments), 
which could be annealed to form longer formin-dependent filaments. It has been shown for 
example that this is the case at the leading edge of some migrating cells (Mejillano et al., 2004) 
– short branches can anneal end to end to form long filaments. Alternatively, if short-filament 
polymerisation or stabilisation is reduced, while the rate of filament severing is unaffected, 
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this would also result in an increase in the fast, branched network, which would then be 
translated into an increase in the long-filament network. 
Unexpectedly, actin in FYN DCs recovers faster after bleaching in the steady state cortex. 
Although the results from WAS DCs suggest WASp is not required for cortical actin 
maintenance, its presence in a non-functional state may result in a dominant negative effect. 
Phosphorylation-dead WASp may still interact with several proteins, such as the SH3-domain 
containing Nck and Itk. As this inactive WASp cannot then interact with Arp2/3 and polymerise 
actin, it may effectively render other proteins inactive by sequestering them away from 
potential compensatory pathways (which, as discussed, may be acting in the WAS DC cortex). 
Similarly at the synapse, both the fast and slow network recovery rates are increased, 
suggesting that the actin network is even less stable than in WAS DC synapses. 
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4.2.4 Bull’s-eye IS pattern 
The stability and organisation of the actin network is likely to affect clustering and localisation 
of transmembrane proteins within the synapse as observed in Chapter 3. A bull’s-eye pattern 
interface has been described in T cells (Monks et al., 1998). Although one could expect the 
interacting APC to mirror this organisation, it is still unclear whether DCs form a similarly 
organised interface. The bull’s-eye pattern described contains areas with distinct protein 
compositions: cSMAC (TCR-red), pSMAC (LFA-1-blue) and dSMAC (CD45-green). Figure 4.9 
shows that WAS DC conjugates form irregular and asymmetric interfaces compared to BL6 
control. Though the synapse exhibits a concentrated TCR area, it does not form the typical 
bull’s-eye pattern, highlighting that WASp is an important regulator during this process. 
 
 
 
 
 
 
 
 
  
BL6 
2μm 
WAS 
2μm 
 
 
 
TCR/ MHC 
LFA-1/ ICAM-1 
CD45, CD43 
Figure 4.9 Synapse organisation appears to be abnormal in WAS DCs. 3D 
reconstructions of stacks of serial fluorescent images allow us to view the synapse across 
the Z plane and thus to image the interface between the two cells. Representative 
reconstructions for BL6 and WAS DCs are shown. 
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4.2.5 Micropits 
Given that the maximum Z-plane resolution with the confocal system is around 0.5μm, which 
is 2-3 times worse than resolution in the xy dimension, imaging the synapse in the plane of the 
interface would improve the level of detail acquired. One attempt to achieve this was using 
novel micropit technology. 
Micropits have been developed using a silicon master mould to transfer arrays of pits (40μm 
deep with a diameter between 15-23μm) onto a PDMS-coated coverslip. DCs and T cells are 
sequentially loaded into these pits to form conjugates with an IS interface in the imaging 
plane. This would allow faster imaging and greater resolution, with the possibility of following 
synapse-formation in live cells. 
 
 
 
 
 
 
 
 
 
The micropits (a gift from M Biggs) were previously optimised for cell lines of different, less 
variable sizes compared to the primary DCs used in these experiments. In order to achieve the 
high-throughput imaging expected by this method, seeding and imaging conditions had to be 
optimised. Micropit preparation is described in Materials and Methods section 2.2.12 and 
Silicon master mould 
PDMS 
cover glass 
Micropit substrate 
Figure 4.10 Making micropits. This illustrates the process of producing the master mould 
(by photolithography and reactive ion etching) and using this to create the pits in the 
PDMS substrate. Adapted from Biggs et al (Biggs et al., 2011). 
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briefly summarised in Figure 4.11a. The DCs used expressed ICAM-1-GFP introduced by 
infection with a lentiviral construct. Micropits were imaged using a scanning laser confocal 
microscope, combining fluorescence and DIC (differential interference contrast) modalities. To 
optimise cell seeding, parameters such as incubation time, cell number, volume and micropit 
diameter were adjucted. A volume of 500μl was found to be sufficient to completely cover the 
micropits and 5x105 DCs was enough for seeding without an excess of uncaptured cells. The 
best DC seeding was seen after incubation at 37°C for 1hour. 
To investigate the optimal micropit diameter, pits ranging from 15-23μm across were designed 
and cell seeding in each was quantified (Figure 4.11 b and c). The largest number of DCs were 
captured in 19 or 20μm micropits. DC seeding was also high in 22 or 23μm pits, however, these 
allowed entry of multiple cells and cell movement within the pit, and were thus not optimal for 
imaging. 19-20μm diameter pits were chosen for further experiments. 
Although less prevalent at smaller diameters, on many occasions multiple T cells enter one pit, 
as seen in Figure 4.11 e. Many of these do not form stable contacts with the DCs, however, 
they are not washed off during the cell seeding stages, perhaps due to the depth of the 
micropits. These do not allow accurate imaging of cell-cell interfaces so other imaging 
techniques were sought to investigate interface organisation.  
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Affix coverslip 
SpeedVac to 
remove trapped air 
Pluronic acid 
treatment 
Washing 
DC seeding 
T cell seeding 
Figure 4.11 Micropit grid and optimal seeding 
diameter. A) Flow chart summarising micropit 
preparation. B) Grid with varying pit diameters. C) 
Barchart shows quantification of cell seeding at 
different diameter pits. D) ICAM-1-GFP positive DCs at 
optimal seeding. E) Multiple T cells in each micropit, 
each indicated with an orange arrow. 
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4.2.6 Planar Lipid Bilayers 
Glass-supported planar lipid bilayers allow imaging of synapse formation with high spatial and 
temporal resolution (Groves and Dustin, 2003). The aim of these bilayer experiments was to 
investigate the differences in IS organisation over time between BL6 and WAS DCs in the plane 
of the interface. Unless otherwise indicated, all bilayer images represent single section in the z-
plane capturing the contact interface. 
Most studies into synapse formation have investigated the interaction of T cells with an MHC-
peptide-loaded bilayer. A previous student in the lab, in collaboration with a group in New 
York (M Dustin, New York University), used a novel lipid bilayer system to observe DCs in an 
investigation of gamma-chain function (C Beilin, in process of submission). Experiments 
presented here use a different set up and a pilot experiment was designed to validate the 
system for analysis of DC interactions. Bilayers were loaded with biotinylated anti-MHC and 
anti-ICAM-1 antibodies. These are linked to the biotinylated bilayer using a streptavidin bridge. 
The antibodies spread evenly and are laterally mobile (tested by FRAP) allowing the formation 
of an immune synapse. The biotinylated anti-MHCII antibody was labelled with Cy5 (Amersham 
Cy5 Maleimide Mono-Reactive Dye) and separated by gel permeation chromatography on a 
Sephadex G25 column. The anti-ICAM-1 antibody was not conjugated to a fluorescent dye; 
instead DCs were infected with a lentiviral vector containing an ICAM-1-GFP construct.  
Figure 4.12 shows BL6 and WAS DCs interacting with a planar lipid bilayer containing anti-
MHCII and anti-ICAM-1. BL6 DCs formed a condensed MHCII cluster in the centre of the 
synapse area, surrounded by a ring of ICAM-1, reminiscent of cSMAC and pSMAC in the 
previously discussed bulls-eye organisation. WAS DCs showed a more diffuse MHCII pattern 
and disorganised, asymmetrical ICAM-1.  
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DCs added to chambers containing empty streptavidin-only lipid bilayers did not form stable 
interactions with the bilayer. Very few cells were present in chambers after fixation and 
washing, for both BL6 and WAS DCs. Further, those that were present remained rounded and 
did not form the surface MHCII patterns seen previously (Fig 4.13). The biotinylated anti-MHCII 
antibody stains the lipid surface uniformly. This suggests the ‘synapse’ organisation seen in 
Figure 4.14 is not an artefact of DCs interacting with the lipid bilayer or streptavidin molecules 
but is result of MHCII and ICAM-1-specific ligation. 
 
 
 
 
 
 
 
 
Figure 4.12  
ICAM-1-GFP expressing 
DCs interacting with 
bilayers. Anti-MHCII-Cy5 
is in red, ICAM-1-GFP in 
green.  The antibodies 
were added to final 
concentration of 0.5 
µg/ml. Chambers were 
fixed 30mins after 
addition of DCs. Scale 
bars = 5μm. 
Figure 4.13 Empty bilayer. Chambers were fixed 30mins after addition of DCs. Cells were 
permeabilised and stained with DAPI, phalloidin-488 and anti-MHCII-Cy5. Scale bars = 
10μm. 
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To dissect the roles of different synapse components during IS formation, and investigate the 
contribution of each to the defect seen in WAS synapses, anti-MHC and anti-ICAM-1 were 
added to lipid bilayer chambers separately. 
 
Anti-MHCII only 
On bilayers containing anti-MHCII only, BL6 control DCs appeared to form a progressively more 
organised cSMAC over time. Cells fixed 5 minutes after addition to chambers showed many 
peripheral microclusters of MHCII; whereas those fixed at 30 or 60min formed a much larger, 
rounder, more intense, central MHCII cluster. WAS DCs appeared to organise this structure 
much more slowly and the resulting cSMAC was often asymmetrical and less complete 
(Figure4.14). 
Interestingly, there were also differences in cell morphology, as illustrated by phalloidin-
stained outlines (Figure 4.15). Although both BL6 and WAS DCs spread on the bilayer at 5min, 
by 15min around 60% of BL6 DCs formed radial spiked protrusions. Significantly fewer WAS 
DCs formed similar structures (around 25%). Some WAS DCs presented a partial phenotype, 
where half of the cell formed protrusions (‘half spikes’). 
At 30 and 60 minutes, around half of BL6 DCs formed a distinct actin-rich structure in the 
centre of the synapse. This was on average 1.5-3μm in diameter. Only around 25% of WAS DCs 
formed these actin dots. The role of these previously undescribed structures is unclear. It is 
unknown whether they occur in T cell: DC synapses or are artefacts resulting from DCs 
interacting with a non-deformable substrate. 
 
 
 
Figure 4.14 (next page) Anti-MHCII bilayer. Cy5-labelled anti-MHCII antibody was added to 
the chambers at 0.5μg/ml. After washing, BL6 or WAS DCs were added to the chambers and 
these were fixed at set timepoints (5, 15, 30, 60min). Cells were stained with Phalloidin-488 
and imaged. BL6 DCs are shown on the left; WAS on the right. Scale bars = 5μm. 
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Figure 4.15 DC morphology over time. At each time point over 200 cells from 2 separate experiments from each strain were 
counted and analysed. At 15minutes, these were classed as cells forming spikes or no spikes. At 30 and 60minutes, cells were 
scored as containing an actin-rich ‘dot’ or not. Significance values are based on a two-way ANOVA analysis with paired BL6 and 
WAS observations across experiments. 
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Figure 4.16 Actin and MHC surface area and intensity. Images of single DCs on an anti-MHCII bilayer (see Figures 4.15 and 4.16) 
were analysed. Parameters were measured in Fiji for 15-20 cells of each strain at each timepoint. Significance was calculated using 
a paired t-test at each timepoint. *p=0.01-0.05; **p=0.001-0.01; ***p<0.001. 
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Other parameters were measured to further characterise differences between BL6 and WAS 
synapse organisation with time (Figure 4.16). Cell spreading was analysed by measuring total 
actin area in contact with the bilayer. The average actin intensity over that area was also 
measured. Similarly, the area of MHC was analysed by selecting all pixels above a threshold 
and measuring the total size and average intensity within this selection. MHCII area is 
presented as a percentage of the total cell area. The number of microclusters per cell and the 
circularity of the synapse are also plotted against time.  
Cell spreading and contact area appear to be similar between BL6 and WAS DCs at all 
timepoints tested. Average actin intensity also shows little difference, perhaps reflecting the 
fact that this method of phalloidin staining and imaging is not sensitive or reliable enough for 
direct comparison of separate samples with small differences. 
Total MHC area as a percentage of the contact area was significantly larger in BL6 DCs 
compared to WAS at 15minutes. This may reflect the greater number of microclusters formed 
in BL6 cells or a larger cSMAC formation. Initially, both types of cells form similar numbers of 
MHCII clusters (around 70 per cell). In BL6 DCs, the number of these microclusters appears to 
be maintained at 15minutes. This may reflect maintenance of pre-formed clusters for longer or 
continued microcluster formation over a larger time frame compared to WAS DCs. By 30 and 
60 minutes, the number of MHCII clusters is considerably reduced in both BL6 and WAS DCs. 
MHC intensity on the other hand increases with time, implicating continued recruitment and 
concentration of MHCII to the contact interface. Synapse roundness was the final parameter 
quantified using the Fiji Measure feature. The significantly higher roundness in BL6 synapses at 
5 and 30minutes reflects more symmetrical contact interfaces. By 60 minutes, WAS DCs 
appear to reach a similar level of circularity. The spikes formed by BL6 cells at 15minutes are 
evident in both the actin and MHCII stains and manifest in a drop in synapse roundness at 15 
minutes. 
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Anti-MHCII and anti-ICAM-1 
To reconstitute cell-cell synapse formation more fully, anti-ICAM-1 was added to the bilayer. 
Mathematical models predict that addition of ICAM-1 to lipid bilayers should allow a cSMAC to 
form more readily in T cells on planar bilayers compared to contacting APCs (Lee et al., 2003a, 
Qi et al., 2001). These suggest that the higher ligand mobility in bilayers compared to APCs and 
the fact that only one of the interacting membranes is deformable, both result in easier 
reorganisation of membrane proteins. Several lines of evidence point to a role for ICAM-1 in 
organising the synapse interface, by concentrating TCR, antigen and downstream kinases in 
the cSMAC. Enhanced receptor activation in the cSMAC results in increased receptor 
degradation, thus resulting in an intense yet self-limiting activation response. To test the role 
of ICAM-1 on the dendritic cell during synapse formation, biotinylated anti-ICAM-1 was added 
to the bilayer and cell interactions were assessed as before. 
In agreement with the above studies, control DCs formed a compact MHCII cSMAC faster when 
interacting with bilayers containing both anti-ICAM-1 and anti-MHCII compared anti-MHCII 
alone (compare Figures 4.17 and 4.14).  
BL6 DCs were able to mobilise MHC molecule and form a concentrated central area faster than 
WAS DCs. This can be seen in Movies 4.3 (BL6) and 4.4 (WAS). 
Figure 4.17 (next 4 pages) Anti-MHCII and anti-ICAM-1 bilayer. Anti-ICAM-1 
and Cy5-labelled anti-MHCII antibodies were added to the chambers to a final 
concentration of 0.125μg/ml and 0.5μg/ml respectively. After washing, BL6 or 
WAS DCs were added to the chambers and these were fixed at set timepoints 
(5, 15, 30, 60min). Cells were stained with Phalloidin-488 and DAPI and 
visualised by confocal microscopy. BL6 DCs are shown on the left; WAS in the 
right panel for each time point. Scale bars = 5μm 
 Chapter 4 
153 
 
  
D
A
P
I 
p
h
al
lo
id
in
 
A
n
ti
-M
H
C
II
-C
y5
 
M
H
C
II
-p
h
al
lo
id
in
  
o
ve
rl
ay
 
D
IC
 
BL6 5min 
 Chapter 4 
154 
 
 
 
 
  
BL6 15min 
D
A
P
I 
p
h
al
lo
id
in
 
A
n
ti
-M
H
C
II
-C
y5
 
M
H
C
II
-p
h
al
lo
id
in
  
o
ve
rl
ay
 
D
IC
 
WAS 15min 
 Chapter 4 
155 
 
BL6 30min 
D
A
P
I 
p
h
al
lo
id
in
 
A
n
ti
-M
H
C
II
-C
y5
 
M
H
C
II
-p
h
al
lo
id
in
  
o
ve
rl
ay
 
D
IC
 
WAS 30min 
 Chapter 4 
156 
 
 
BL6 60min 
 
 
 
 
 
WAS 60min 
D
A
P
I
Fe
n
d
 
p
h
al
lo
id
in
 
A
n
ti
-M
H
C
II
-C
y5
γ-
M
H
C
II
-p
h
al
lo
id
in
  
o
ve
rl
ay
 
D
IC
 
 Chapter 4 
157 
 
Total actin area
5 15 30 60
0
200
400
600
800
BL6
WAS
*
*
Time (min)
A
c
ti
n
 a
re
a
 (

m
)
% MHC area
5 15 30 60
0
10
20
30
40
BL6
WAS
***
**
*
Time (min)
%
 M
H
C
 a
re
a
Actin intensity
5 15 30 60
0
10
20
30
BL6
WAS
* ***
***
***
Time (min)
A
v
e
ra
g
e
 a
c
ti
n
 i
n
te
n
s
it
y
MHC intensity
5 15 30 60
0
20
40
60
80
100
BL6
WAS
*
Time (min)
A
v
e
ra
g
e
 M
H
C
 i
n
te
n
s
it
y
No of microclusters
5 15 30 60
0
20
40
60
BL6
WAS
Time (min)
N
o
 o
f 
m
ic
ro
c
lu
s
te
rs
/c
e
ll
Average synapse roundness
5 15 30 60
0.45
0.50
0.55
0.60
0.65
0.70
0.75
BL6
WAS
*
Time (min)
A
v
e
ra
g
e
 r
o
u
n
d
n
e
s
s
*
***
 
  
Figure 4.18 Actin and MHC surface area and intensity. Images of DCs on an anti-MHCII and anti-ICAM-1 bilayer (see Figures 4.18) were analysed. 
Parameters were measured in Fiji for 15-20 cells of each strain at each timepoint. Significance was calculated using a paired t-test at each timepoint. 
*p=0.01-0.05; **p=0.001-0.01; ***p<0.001. 
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Compared to the anti-MHCII only bilayer, the total actin area (total contact area) for BL6 cells 
this time is increased, suggesting that the interaction of ICAM-1 with the bilayer allows cells to 
spread and thus increase contact surface area. In this case, WAS DCs show a significantly 
reduced contact area at 15 and 30 minutes. Interestingly, there were also very few cells of 
either BL6 or WAS displaying the spike protrusions seen on the MHC only bilayer. 
The actin intensity of BL6 cells was significantly higher both compared to WAS DCs (Fig4.18) 
and compared to BL6 DCs on MHC only bilayers (Fig4.16). This may reflect more stable 
contacts as a result of ICAM-1 activation and increased actin polarisation. The appearance of 
podosome-like protrusions in BL6 cells may provide support for this, as discussed later. 
MHC area as a percentage of the total contact appears lower on bilayers containing both anti-
MHC and anti-ICAM compared to MHC only. This is in agreement with the increase in total 
contact area due to more widespread adhesion mediated by anti-ICAM-1. There is an 
interesting drop in % MHC area at 30minutes, which appears to reflect a contraction or 
compaction of the cSMAC, rather than increased cell spreading. MHC intensity, as before, 
increases over time in the BL6 DCs. This appears reduced in WAS DCs, perhaps as a result of 
poorer recruitment and concentration of MHCII molecules. 
The number of microclusters formed is lower in BL6 cells on bilayers containing anti-ICAM-1 in 
addition to anti-MHC, compared to anti-MHC only. This highlights the fact that these bilayers 
promote faster, more complete formation of the cSMAC. Interestingly, the number of 
microclusters is also reduced in WAS, suggesting that ICAM-1 ligation can increase cSMAC 
formation in WAS cells, albeit not to the same level as BL6, despite reduced actin 
polymerisation. 
Average synapse roundness, in agreement with other parameters above, also increases earlier 
compared to MHC only bilayers. The round central area of MHC is formed earlier and as 
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mentioned, there is little evidence of spikey cells at 15minutes upon ICAM-1 ligation. WAS DCs 
do not form the same circular, symmetric synapses at 30 and 60 minutes. 
As mentioned previously, control DCs formed striking rings of actin point protrusions, similar 
to the adhesive structures called podosomes. This has not been described previously in a 
synapse setting. Several concentrations of anti-ICAM-1 were tested in an attempt to determine 
whether the number and size of these structures was dose-dependent. The images in Figure 
4.17 represent bilayers with 0.125μg/ml anti-ICAM-1 and 0.5μg/ml anti-MHCII. While MHC 
ligation was kept constant, two other anti-ICAM-1 concentrations were tested - 0.25μg/ml and 
0.5μg/ml. Images from other concentrations are included in Appendix 2. Podosome-like 
protrusions were formed in a similar percentage of cells at all three concentrations of anti-
ICAM-1 tested (Figure 4.19). A significantly lower number of WAS DCs formed podosome-like 
structures. Those which did were not as prominent and did not organise in a ring pattern 
(Figure 4.17). A reduced ability to form podosomes has been well described in WASp-deficient 
cells (Monypenny et al., 2011, Calle et al., 2004, Olivier et al., 2006, Linder et al., 1999). 
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Figure 4.19 Podosome quantification on anti-MHCII and anti-ICAM-1 bilayers. Around 100 
cells were counted for each concentration at each time point and the number of cells 
containing actin protrusions was noted. Results represent a single experiment. 
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Further analysis was required to confirm the identity of these actin-rich protrusions. The 
diameter of these structures in BL6 cells was measured and found to be within the range 
quoted for podosome sizes in literature, 0.5-1μm (Linder and Aepfelbacher, 2003, Linder and 
Kopp, 2005).  
Podosomes are characteristically described as adhesion sites containing an actin-rich core 
surrounded by a ring of scaffold or actin-binding proteins, such as talin, vinculin and paxillin, as 
well as integrins. Beta-1 integrins have been shown to localise to the core, while β2 and β3 
integrins mainly localise to the outside ring (reviewed in (Linder and Kopp, 2005)). CD11a (also 
known as ITGAL or integrin alpha L) is major partner of the β2 chain and the heterodimer these 
form is more commonly known is LFA-1. 
Figure 4.20 shows a stain for CD11a in BL6 and WAS DCs. In BL6 DCs this appears to form rings 
around individual actin protrusions in a manner reminiscent of true podosomes. Relation to 
LFA-1 would have to be confirmed with a CD18 or β2 immunofluorescent stain. Representative 
images have been chosen from a 15minute time point, however, rings of CD11a were present 
in BL6 cells at all time intervals. 
 
  
Figure 4.20 Confirming podosome identity – CD11a. Bilayer chambers containing both 
anti-MHCII and anti-ICAM1 were fixed and permeabilised 15 minutes after cell seeding. A 
rat anti-CD11a antibody was used to detect murine CD11a; this was followed by an anti-
rat-564 secondary antibody. Scale Bar = 5μm. 
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A further stain for the alpha unit of human F-actin capping protein (CapZ) was included. 
Heterodimers of α and β subunits cap barbed ends of actin filaments to prevent 
polymerisation and depolymerisation. The role of capping proteins in podosome formation or 
stability is unclear. Figure 4.21 shows fixed and permeabilised DCs on bilayers containing both 
anti-MHC and anti-ICAM-1. The cells are stained with phalloidin, revealing the characteristic 
ring of podosomes. At all time points, 62.7 ± 4.76% (SEM; a total of 80 cells across all times 
were analysed) of cells showed colocalisation of capping protein with actin in the podosomes. 
Further, the images show that podosomes are initially situated within “clouds” of actin, as 
previously described in osteoclasts (Destaing et al., 2003). These must contain some F –actin 
components as they are detected by phalloidin. 
Finally, to investigate turnover of podosomes at the synapse, live imaging on lipid bilayers 
using TIRF microscopy was utilised. BL6 DCs were infected with a lentivirus containing a 
LIfeAct-mCherry construct in order to follow filamentous actin dynamics in real time. Two days 
post infection, cells were matured and added to bilayers containing both anti-MHC and anti-
ICAM-1. Imaging was initiated 5min after addition of cells and images were taken at 5 second 
intervals in both Cy5 (MHCII) and Cy3 (LifeAct-mCherry) channels for a total of 20minutes. 
Movie 4.5 shows MHCII gathering in the Cy5 channel. Unfortunately, actin labelling was diffuse 
which made it difficult to focus in the correct z-plane in TIRF mode for the duration of the 
imaging. Faint dots of actin can be seen from around 120seconds on. These appear to move 
and undergo constant fusion and fission suggesting that turnover of F-actin itself is faster than 
that of the podosomes. Although improved imaging is required for complete analysis, these 
podosomes appear dynamic, with a half-life of individual structures not significantly different 
from published data: a minimum of 2minutes in osteoclasts (Destaing et al., 2003), 1minute in 
macrophages (Evans et al., 2003), and between 30seconds and 10minutes in DCs (Calle et al., 
2004). Podosome clusters however, appears stable for up to 60 minutes.  
Movie 4.6 shows a migrating DC slowing down upon interaction with a T cell, leading to a final 
arrest. Although in this case the DC is interacting with a glass substrate rather than supported 
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planar bilayers, it is included as a comparison of migration-related podosomes and the ring 
structure seen in synaptic podosomes. 
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Figure 4.21 Confirming podosome identity – capping protein. Fixed and permeabilised cells 
were stained with phalloidin-488 (green) and a rabbit polyclonal antibody against capping 
protein, followed by a secondary anti-rabbit-633 antibody (purple). Areas of colocalisation 
appear white in the overlaid images. Scale bar = 5μm. 
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Anti -ICAM-1 only 
To test whether activation of ICAM-1 alone could induce podosome formation in DCs, 
biotinylated anti-ICAM-1 was added to lipid bilayers alone. Figure 4.22 shows representative 
images from these bilayers. DAPI was used to aid identification of individual cells; while 
phalloidin-488 was used to visualise polymerised actin. Similar to empty bilayers (Figure 4.13), 
cells which were stained with anti-MHCII after fixation on the bilayer (i.e. did not interact with 
anti-MHC during the experiment) do not form the characteristic MHCII microclusters and 
cSMACs. BL6 DCs formed podosomes in around 80-85% of cells, whereas WAS cell were unable 
to form similar structures. This suggests that activation of ICAM-1 alone is sufficient to induce 
podosome formation in mature DCs interacting with a lipid bilayer. 
Initially this appeared to be a synapse-independent process, which simply requires integrin 
adhesion. However, it was noted that BL6 cells interacting with anti-ICAM-1 only did not form 
rings of podosomes around the central MHC cluster as seen before. Instead podosomes 
appeared more disorganised and asymmetric and were often found in small clumps (Figure 
4.22).  
Although the function or mechanism behind podosome ring formation in DCs is unknown, 
rings were so prominent in cells interacting with anti-MHC anti-ICAM-1 bilayers that they 
appeared specifically localised to surround the central MHCII concentrated area. 
The number of BL6 cells displaying rings of podosomes was quantified as a percentage of the 
total number of cells containing podosome structures. This is shown in Figure 4.23. The 
percentage of cells forming podosome rings was significantly reduced when cells interact with 
either anti-MHCII or anti-ICAM-1 compared to interaction with both. This suggests that 
downstream signalling from both MHCII and ICAM-1 is required for the organisation of 
podosomes at the synapse interface of DCs. 
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Figure 4.22   
Anti-ICAM-1 only 
bilayers.  
Cells were fixed and 
permeabilised at 
specified intervals; 
and stained with 
DAPI, phalloidin-488 
and anti-MHCII-Cy5. 
Scale bar = 10μm. 
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Figure 4.23 Podosome quantification across different bilayer constituents. Over 150 
podosome-containing cells from two separate chambers were counted and scored for the 
presence of ring organisation. Significance was calculated using an unpaired t-test between 
two conditions. *p=0.01-0.05; **p=0.001-0.01. 
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4.3 Discussion 
This chapter aimed to investigate the differences in the dynamics of immune synapse 
formation between BL6 and WAS DCs. Initial results (Fig 4.1) showed that in DC: T cell 
cocultures fixed at different time points, WAS DC were unable to form as many conjugates 
with OT-II T cells, suggesting that their contacts were not as stable or long-lasting as BL6 DC 
conjugates. Live imaging was also used to show decreased stability and contact length in WAS 
DCs conjugates (Fig 4.2). Although a longer live imaging period would be beneficial for both 
BL6 and WAS samples; this form of live imaging was not sensitive enough to detect ICAM-1-
GFP polarisation towards the T cell interface and does not allow enough resolution to study 
the subtle molecular changes at the synapse. 
A number of techniques were optimised to study the cell-cell interface in more detail. Z-plane 
reconstructions suggested that a bull’s-eye organisation was formed in BL6 DC and this was 
incorrectly organised in the absence of WASp (Fig 4.9). Unfortunately, this could not be 
confirmed at higher resolution due to limitations of the micropit experiments for the DC: T cell 
system (Fig 4.11). A couple of different strategies could be adopted to optimise future 
experiments. Reducing the depth of the micropits used to 20μm (half the original depth) 
should reduce the time needed for DC seeding and may allow more efficient washing of 
unbound T cells from the substrates. Alternatively, micropits could be designed for T cell 
seeding. These would be much smaller in both depth and diameter in order to ensure only one 
T cell is present per pit. DCs could then be added to the top of the array substrate to allow 
interaction with seeded T cells.   
The FRAP results shown here highlight several crucial points. First, the cortex of primary 
murine DCs contains two subpopulations of actin filaments, as recently reported in cell lines 
(Fritzsche et al., 2013). Second, the proportions of the two different subpopulations are not 
altered in the cortex beneath the synapse interface; however, in BL6 cells actin recovery after 
photobleaching is slower implicating distinct regulatory mechanisms during formation of the 
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IS. Third, the absence of WASp in DCs has no effect on the proportion of each filament 
subpopulation, nor does it affect the recovery of actin in the steady-state cortex. It does, 
however, increase the recovery rate of actin in the synaptic cortex, suggesting reduced 
stability and regulation of the actin network here. This provides strong evidence for a role of 
WASp as a scaffolding adaptor, perhaps through interaction with other partners such as Nck, 
talin or Fyn. One could make the case that FRAP data showing faster actin recovery in WAS DCs 
confirms the less stable adhesion and lack of podosomes seen in WAS.  
Although these results provide useful insight into actin organisation at the synapse, there are 
limitations. FRAP across the synapse may encompass several types of actin networks, which 
would actually be spatially separate. For example, based on membrane protein composition, it 
has been suggested that the molecularly distinct areas of the synapse (cSMAC, pSMAC and 
dSMAC) are related to distinct regions in migrating T cells – the kinapse (lamellipodium, 
lamella and uropod) (Dustin, 2008b, Dustin, 2008a, Evans et al., 2009). More recently the 
model has gained momentum with recent publications showing distinct actin networks 
present in the comparable regions of the immune synapse and the migrating state of the T 
lymphocyte (Yi et al., 2012, Hammer and Burkhardt, 2013). Yi et al saw three zones with 
distinct actin content in Jurkat T cells interacting with supported planar bilayers – an outer, 
actin-rich zone, a middle zone formed of concentric arcs of F-actin and in inner/ central zone 
devoid of F-actin. Each of these networks should have different actin dynamics and thus 
different recovery rates after photobleaching. Although it is possible that the two different 
subpopulations identified in the FRAP experiments here correspond to the different actin 
networks described by Yi et al, the same spatial relationship cannot be inferred. The direction 
of imaging and bleaching in these experiments does not allow one to distinguish between 
these. The use of micropits or optical tweezers might make it possible to bleach different areas 
of the synapse and obtain good resolution of different actin networks. 
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Further, there is no evidence yet to suggest a similar organisation exists in DCs. Images of DCs 
on supported planar bilayers presented in this chapter do not show clear concentric arcs of F-
actin.  If these do exist on the DCs side of the synapse, they may be more difficult to image due 
to the much larger and less uniform cytoplasmic organisation in these cells, as well as the 
presence of podosome structures. Whether it is concentric arcs, podosomes, or both, the 
analysis of fluorescence recovery in the perpendicular direction to the synapse interface is 
complicated by the presence of distinct spatially regulated actin networks. It would be 
interesting to see whether future FRAP experiments can separate the contributions of 
different subpopulations in different areas of the synapse. Single molecule imaging would 
allow further characterisation of filaments at the synapse interface. 
The synapse/kinapse comparison may be relevant for DCs and, as a model, is not mutually 
exclusive with the presence of podosomes. In migrating cells, podosomes are situated at the 
border between the lamellipodium and lamellum and further back through the lamellum (Calle 
et al., 2006a). In direct comparison, podosomes in DCs interacting with anti-MHC and anti-
ICAM bilayers appear to form in a similar area (Fig 4.17, 4.20, 4.21). Thus although the 
podosome structures involved in these distinct cellular processes have different functions, the 
actin subpopulations and regulators involved may overlap. Questions remain about whether 
actin retrograde transport is involved on the DC side of the synapse, similarly to that described 
in T cells above,  and if so, how this interacts with actin networks responsible for podosomes. 
Live imaging has shown that retrograde flux in migrating fibroblasts is inversely proportional to 
migration, i.e. flux was increased when fibroblasts where immobilised (Guo and Wang, 2007). 
If a similar mechanism is present in DCs, it could integrate mechanosensing into the surface 
organisation mechanism and downstream signalling.  
F-actin intensities measured by confocal microscopy or flow cytometry suggest that WAS DCs 
contain less total polymerised actin. Taken together with the increased recovery rates of actin 
in FRAP, which suggest increased treadmilling and reduced stability, it is easy to see how a 
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deregulated, unstable actin network beneath the synapse would result in the poorer 
recruitment and concentration of MHC molecules seen in the bilayer experiments. This would 
be the case regardless of whether actin’s role in synapse organisation involves retrograde flow, 
size exclusion or simply providing stability for membrane protein clusters.  
The slower cSMAC formation seen in WAS DCs (Fig 4.14, 4.17, 4.18) might be expected to 
result in prolonged migration of microclusters through the pSMAC and thus increased 
signalling in the interacting T cell (Lee et al., 2003a, Ueda et al., 2011, Grakoui et al., 1999, 
Vardhana et al., 2010). It would be interesting to investigate this further by studying 
specifically phosphorylated proteins in the T cell activation pathway. An investigation of 
signalling on the DC side and the effects of slower cSMAC formation would also be beneficial. 
Anti-MHCII bilayers did not induce podosome formation (Fig 4.14); instead half of control cells 
formed actin-rich dots at the centre of the synapse. It is unclear whether these are related to 
the podosomes seen on anti-ICAM-1 bilayers or why they appear only at later time points. 
Could these be the remnants of unsuccessful podosomes initially induced by inside-out 
integrin signalling during synapse formation? 
The addition of anti-ICAM-1 alone was sufficient to induce podosomes, which is not as well 
described. It would be interesting to investigate the localisation of ICAM-1 itself in these 
structures; and also the specific necessity for ICAM-1 by testing whether podosomes form on 
bilayers targeting other ICAMs, integrins or costimulatory molecules. 
Most of what it known about the lack of podosomes in the absence of WASp comes from 
studies of DCs or macrophages seeded on glass or fibronectin-coated coverslips (Linder and 
Kopp, 2005, Humphries et al., 2006, Monypenny et al., 2011, Linder et al., 1999). It is essential 
to note that lack of WASp abrogates podosome formation in a different adhesion setting, 
suggesting that it is crucial for the basic process of podosome formation rather than an 
upstream signal.  
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The presence of podosome-mediated adhesion in BL6 DCs may explain the larger contact 
surface measured on supported bilayers (Fig 4.18). It also supports previous observations using 
3D EM reconstructions, which suggest that in a cell-cell system, BL6 DCs are able to induce 
much more extensive, intimate contacts (Fig 3.15 and 3.16). Protrusions from the DC into the T 
cell are quite commonly observed by EM. Although no prominent rings of these structures 
were noted during the EM imaging, these may be much more difficult to recognise in a cell-cell 
context compared to cell-bilayer interaction. 
Podosomes shown here were confirmed using their basic morphology and staining for CD11a 
and capping protein. Stains for β2 integrins and vinculin, which are normally used to 
characterise these structures (Linder and Kopp, 2005, Chou et al., 2006, Monypenny et al., 
2011, Marchisio et al., 1987), were unsuccessful in several bilayer stains, though they rarely fail 
with fibronectin-bound cells. While this may reflect technical limitations specific to the bilayer 
set up, there is a possibility that podosomes formed at the synapse use a different array of 
actin binding and bundling proteins and adaptors. it would be interesting to further investigate 
the localisation of other adaptors and integrins, as well as the dependence of these 
podosomes on disassembly by calpain for correct dynamic organisation, as has been described 
in other cells (Calle et al., 2006b). Conversely, the presence of capping protein in migration-
related podosomes has not been described; a recent paper showed no colocalisation of CapG 
to macrophage podosomes (De Clercq et al., 2013a). It would be interesting to see how this 
compares functionally with the colocalisation described here in synaptic podosomes.  
The ring formation observed here is reminiscent of podosomes at the osteoclast interface with 
bone, which define the sealing zone (Babb et al., 1997, Destaing et al., 2003, Jurdic et al., 
2006); with the exceptions of the pronounced outward ring expansion seen in osteoclasts at 
later time points. Whether formation of a fully functional sealing zone is dependent on 
podosomes is still under debate, though it has been suggested that podosomes evolve into a 
circular band of actin, which seals off the proteases secreted by actively resorbing osteoclasts 
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(Lakkakorpi et al., 1989, Vaananen et al., 2000). Similarly, although WAS DCs form some 
synapses, these are fewer and less organised and it would be interesting to investigate how 
their inability to form podosomes affects the function of the synapse. 
Finally, it is interesting to highlight that podosomes have been shown in immature DCs and 
maturation is associated with a decrease in podosome-mediated adherence (Burns et al., 
2004). DCs used for bilayer experiments were matured using LPS overnight and show 
characteristic maturation markers such as increased MHCII and CD80/86.  This suggests 
maturation status may be less important for the formation of synaptic podosomes. 
In summary, the decreased stability of the WAS DC actin cytoskeleton at the synapse interface 
results in smaller contacts, which are not as efficient in concentrating MHC molecules and 
show a less circular, symmetric organisation. 
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Chapter 5 – A disorganised 
immunological synapse is not sufficient 
for correct T cell activation 
 
 
5.1 Introduction 
 
The journey from a peripheral site of inflammation to the lymph node takes between 3-24 
hours in humans (Macatonia et al., 1987, Cumberbatch and Kimber, 1992, Roake et al., 1995). 
During this, DCs process and present antigen (Banchereau and Steinman, 1998) and upregulate 
surface MHC-peptide complexes to allow optimal interaction with T cells (Sallusto and 
Lanzavecchia, 1994). The formation of a stable and functional IS is a crucial step in T cell 
activation as it allows recognition of antigen and other costimulatory molecules on the surface 
of the DC by rare T cell clones. It is important for the general lymphoproliferative response, but 
also for guiding CD4+ T cells to a suitable effector cell fate. 
Results in previous chapters have shown that impaired actin polymerisation, caused by the loss 
of the actin regulator WASp, results in a malformed IS. This chapter aims to investigate 
whether this is sufficient to sustain intercellular signalling required for full T cell activation. T 
cell proliferation, surface marker expression (CD69) and IL-2 secretion were used as readouts 
of the DCs’ ability to activate T cells.  
As well as affecting signalling quantitatively, a malformed synapse may affect the quality of the 
message transduced to the T cell. Several groups have suggested that varying the strength of 
the contact, either through antigen dose or antigen affinity for TCR, can alter T helper 
differentiation (Hosken et al., 1995, Constant et al., 1995, Tao et al., 1997b) (see Introduction). 
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Data presented in the previous chapters has shown that WAS DC synapses are less stable, most 
likely due to incorrect actin and integrin organisation. How this affects T cell fate induction is 
investigated in this chapter using techniques including quantitative PCR, ELISA, microarray and 
in vivo models. 
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5.2 Results 
 
5.2.1 CD69 upregulation 
CD69 is a homodimeric cell surface protein and is one of the earliest markers of activation 
(reviewed in (Ziegler et al., 1994)). Previous work has shown that T cell activation results in 
rapid CD69 upregulation, with a peak around 8 hours post-stimulation, followed by decay and 
degradation. To test the ability of BL6 and WAS DCs to induce antigen-specific CD69 
upregulation in T cells, DCs and T cells were cocultured overnight. DCs which were previously 
pulsed with either full OVA protein or the ova 323-339 peptide (class II epitope recognised by 
OT-II T cells) induced antigen-specific upregulation of CD69, compared to DCs pulsed with LPS 
only. No significant difference was observed between BL6 and WAS DCs in their ability to 
induce CD69 upregulation. 
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Figure 5.1 No significant defect in CD69 upregulation in WAS DCs. DCs were matured by 
overnight stimulation with LPS, with or without the addition of OVA or OVA323-339 
antigen. 150 000 DCs were then cocultured with an equal number of T cells. CD69 
expression was analysed 15hours later by flow cytometry (gating on the CD4 positive 
subpopulation). The graph represents mean values of 4 separate experiments. A t test 
was used to compare populations. *p = 0.01-0.05, **p = 0.001-0.01, ** p< 0.001 
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The ability of WAS DCs to induce normal CD69 upregulation in OT-II cells, despite IS 
malformation shown in the previous chapters, may be due to the pathways controlling CD69 
expression. CD69 upregulation is a very early activation event, perhaps induced via TLR 
pathways and requiring very little stimulation. Flow cytometry analysis has shown that CD69 
upregulation occurs even at low doses of antigen or short periods of stimulation (Caruso et al., 
1997). Correct synapse formation may be unnecessary; the shorter, unstable and disorganised 
contacts formed with WAS DCs may be sufficient thus may not result in a functional defect in 
CD69 expression. 
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5.2.2 T cell proliferation 
T cell proliferation induced by control and WAS DCs was also compared. LPS-matured DCs 
induce no proliferation (grey and black filled histograms), while OVA-pulsed DCs form antigen-
specific contacts with OT-II cells and induce a large proliferative response (red and blue). There 
was no observable proliferation defect at a 1:1 cell ratio. At the 1:5 cell ratios, WAS DCs (red) 
consistently induced reduced antigen-specific proliferation in normal T cells compared to BL6. 
This was even more pronounced at lower DC: T cell ratios (1:8). 
 
 
 
 
Figure 5.2 Proliferation defect at lower levels of induction. CD4+ OT-II cells stained with 
CFSE were mixed with dendritic cells at three different cell ratios of DC: T cells (1:1, 1:5 
and 1:8). Cells were then co-cultured for 4 days, stained for CD3 and analysed on a CyAn 
ADP flow cytometer, gating on CD3+ cells only. Each peak represents a single cell 
division. 
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Proliferation ratios were calculated by dividing the number of daughter (proliferated) cells by 
the number of non-proliferated cells showing undiluted CFSE. This is quantified in Figure5.3 
Graph A. Due to large variation between experiments, the standard error means (SEM) appear 
very large and there was no significance between BL6 or WAS DC-induced T cell proliferation. 
The calculated ratios were then normalised relative to the BL6 OVA value of each respective 
experiment, effectively giving BL6 OVA a ratio of 1. Graph B shows the normalised results. 
Normalisation removed the variation arising from experimental differences and the 
significance of the different abilities of BL6 and WAS DCs to induce T cell proliferation becomes 
more apparent. 
 
 
  
Figure 5.3 Proliferation defect at lower levels of induction - normalised. Top: Average 
and SEM of proliferation ratios (proliferated/non-proliferated cells). Bottom: 
proliferation ratios were divided by the BL6 OVA for each respective experiment to 
normalise. Results from 5 separate experiments were averaged. Significance was 
calculated using a paired t test. *p = 0.01-0.05, **p = 0.001-0.01, ** p< 0.001. 
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5.2.3 IL-2 secretion 
T cell activation also results in IL-2 production and secretion, which occurs later than CD69 
upregulation and is necessary for T cell proliferation. WASp-deficient T cells exhibit reduced IL-
2 production when induced by APCs (Cannon and Burkhardt, 2004). Here, IL-2 production was 
tested in normal T cells induced by either BL6 or WAS DCs. 
 
 
 
 
 
 
 
 
 
 
OT-II cells induced by WASp-deficient DCs do not achieve the same level of IL-2 production at 
any of the tested ratios. BL6 DCs appear to have sufficient inductive capacity to overcome a 
population stimulation threshold, achieving maximum IL-2 production even at lower DC: T cell 
ratio (1:5), although this is reduced at the lowest ratio (1:10). IL-2 production at this lowest 
ratio is comparable to WAS samples at the highest ratio, suggesting that even at a 10-times 
higher number, WAS DCs are incapable of producing enough signal to induce normal T cell 
activation. 
Figure 5.4 Defective IL-2 production in T cells induced by WAS DCs. IL-2 concentration in 
DC: T cells coculture supernatants was measured by ELISA 48hours after coculture. Each 
bar represents the average and SEM for 3 separate experiments, where IL-2 
concentrations were measured in triplicate for each experiment. A two-tailed paired t-
test was used to compare BL6 and WAS data sets for each cell ratio. 
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5.2.4 QPCR 
Factors such as strength of antigen-induced TCR signalling and costimulatory molecules 
present (Murphy and Reiner, 2002) may affect CD4 T cells differentiation into different 
subsets. As these factors may be affected by synaptic duration and organisation, it was 
interesting to investigate whether the abnormal synapses seen in WAS DC conjugates affect 
subsequent T cell differentiation. LPS-matured BL6 or WAS DCs were either pulsed with OVA or 
used without specific antigen in cocultures with OT-II T cells. Taqman murine gene expression 
assay were used in QPCR experiments designed to test for expression of the master regulators 
of the 4 major T helper cell subtypes- Tbx21 (Th1), GATA3 (Th2), FoxP3 (Treg) and Rorc (Th17). 
Due to variation between experiments and thus large standard error means, the differences 
observed were not statistically significant. Further, fold changes calculated for FoxP3 and Rorc 
were very low. Several refinements of the experimental design, discussed later, may result in a 
more accurate and sensitive assay. 
 
  
Figure 5.5 T cell fate master regulators. DCs and T cells were cocultured at a cell ratio of 
1:5 for 48hrs. T cells were then purified using a murine CD4 isolation kit. Total mRNA was 
isolated, reverse transcribed and used, in triplicate, for real-time quantitative PCR. 
Replicate values were averaged; and results were normalised to murine GAPDH 
expression using ΔCT calculation (see Materials and Methods). Fold difference presented 
here shows mean and SEM from 4 separate experiments calculated relative to BL6 LPS 
value of each.  
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5.2.5 Cytokine ELISA 
The supernatants from cocultures used for mRNA isolation (i.e. 48hrs after DC: T cell 
cocultures in 96-well plate) were used to determine the amount of different cytokines 
secreted by ELISA. Tbx21 has been shown to promote IFNγ production (Szabo et al., 2000), 
which in turn induces further Tbx21 expression (Lighvani et al., 2001), making IFNγ a suitable 
readout of Th1 differentiation. IFNγ has also been shown to express Th2 differentiation (Seder 
et al., 1992). Conversely, IL-4 signals through STAT6 to promote Th2 differentiation (Shimoda 
et al., 1996, Takeda et al., 1996, Kaplan et al., 1996). The anti-inflammatory cytokine IL-10 has 
also been shown to promote Th2 responses and inhibit Th1; it has been shown to promote IL-4 
expression, and may itself be upregulated by IL-4 (Faith et al., 2012, Kosaka et al., 2011, 
Laouini et al., 2003, Moore et al., 2001, Schmidt-Weber et al., 1999).  Th17 cells were 
identified as a subset of T helper cells which produce IL-17 (Park et al., 2005, Harrington et al., 
2005, Bettelli et al., 2007). The graphs below show concentrations of these cytokines found in 
coculture supernatants.  
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Production or secretion of all cytokines was upregulated upon antigen-specific stimulation 
(OVA DCs) compared to LPS-only DCs. This suggests DCs are able to activate antigen-specific T 
cells in this in vitro model. Similar to Tbx21 expression, IFNγ production was reduced in T cells 
stimulated by WAS DCs compared to BL6; although the difference was not significant. GATA3, 
IL-4 and IL-10 presented a similar pattern, though again not statistically significant. 
Interestingly, while the Rorc signal was too low to detect any differences reliably, IL-17 showed 
robust, reproducible upregulation and this was significantly higher upon WAS DC-induced 
stimulation compared to control. 
As OT-II cells were harvested from the same mice for coculture with both types of DCs, there is 
no genetic or environmental difference arising from these cells that would influence cytokine 
secretion or transcription factor expression. Any differences seen are likely to be the result of 
different stimulation by the DCs. 
 
 
  
Figure 5.6 (previous page) T helper cell cytokines. Supernatants from DC: T cell 
cocultures were tested for the above cytokines using R&D systems ELISA kits. 
Concentrations were calculated using cytokine standard curves as per manufacturer’s 
instructions. Samples were tested in triplicate and the graphs represent mean and SEM 
from 4 separate experiments. A paired t test was used to calculate significance. 
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5.2.6 In vivo T cell fate induction 
Trends seen in vitro, may combine in vivo to produce a more severe defect in cytokine 
secretion through their feedback loops and effects on other cell types. To test this, a DC 
adoptive transfer experiment was designed to investigate the ability of antigen-specific BL6 
and WAS DCs to induce T cell activation and differentiation in vivo.  
DCs were matured with LPS or pulsed with or without OVA to induce antigen presentation. 
15hours later DCs were labelled with CFSE and 4x106 labelled cells were injected into the tail 
vein of OT-II mice. Two days after injection, mice were sacrificed and CD4+ cells were isolated 
from spleen and lymph nodes. CD4+ cells were incubated in PMA, ionomycin and brefeldin A 
for 5hours. Cells were washed and stained for several cytokines and analysed by flow 
cytometry. 
Previous studies have shown impaired migration of WAS Langerhans cells or DCs, in vitro and 
in vivo, using methods such as skin painting and subcutaneous injections (Snapper et al., 2005, 
de Noronha et al., 2005, Bouma et al., 2007). To avoid confounding influences of poor DC 
migration on T cell activation, DC migration to spleen and lymph nodes was tested following 
i.v. injection. Aliquots of the spleen and lymph node cell suspensions were used to estimate 
efficiency of DC migration by quantifying CFSE-positive cells. Cell suspensions were stained for 
CD11c to select for DCs. Gating on CD11c-positive cells, CFSE-positive cells were quantified. 
Figure 5.7 shows DCs present in spleen (top) and lymph nodes (bottom). CFSE positive cells 
were low as a percentage of the total number of DCs, but were easily detected. Their presence 
was also confirmed by allowing cell suspensions to settle in culture dishes and checking for 
bright CFSE cells on a fluorescent microscope. Similar numbers were found in OT-II mice 
injected with either BL6 or WAS DCs, suggesting that abnormal migration in WAS DC would not 
distort differences in T cell activation in these experiments. 
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Figure 5.7 No significant 
difference in migration 
between BL6 and WAS DCs 
following IV injection. BL6 
or WAS DCs were pulsed 
with LPS or LPS/OVA and 
stained with CFSE. The cells 
were injected i.v. into OT-II 
recipient mice. Two days 
post injection, cell 
suspensions from spleens 
and lymph nodes (LN) were 
immunostained for with 
anti-CD11c-PE and analysed 
by flow cytometry. Samples 
were gated for CD11c (A) 
and analysed for the 
presence of CFSE-positive 
cells in spleen (B) and 
lymph nodes (C). 
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Spleen and lymph node cell suspensions were mixed prior to T cell isolation. After the 
secondary stimulation (described above and in section 2.2.10), T cells were stained with 
fluorophore-conjugated antibodies CD3-FITC and either IL4-PE + IL-10-APC or IFNγ-APC + IL-17-
PE. The CD3-FITC positive gate, in Figure 5.9A, shows that compared to an isotype control 
(left), CD3-FITC staining suggests that efficient T cell isolation was achieved, reaching over 96% 
of CD3 positive cells. These were gated on and analysed for cytokine expression. Figure 5.9B 
shows IFNγ (x-axis) and IL-17 (y-axis). Quadrant gates were set according to isotype control 
stains. Results suggest a slight decrease in IFNγ and increase in IL-17 in OT-II mice injected with 
WAS DCs compared to BL6 DCs. Although not significant, the differences were seen across all 
mice in this experiment. These supported the IFNγ and IL-17 results seen with cytokine ELISA 
analysis of in vitro cocultures (Fig 5.6). 
Isotype controls for IL-4 and IL-10 showed higher than expected staining, making it difficult to 
set gates on positive cells. These were instead presented as histograms (Figure 5.9). No 
significant differences were seen between WAS and BL6 DC injections. Further, there was very 
little difference between the LPS and LPS+OVA conditions, suggesting either a technical error 
in the staining process or that OVA does not elicit a Th2 response in vivo. 
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Figure 5.8 IFNγ and IL-17 immunostaining. Two days after DC i.v. injection, OT-II 
recipients were sacrificed and total CD4+ T cells were isolated using a Miltenyi 
Mouse CD4 T cell isolation kit. T cells were stained for CD3 (FITC), IFNγ (APC) and IL-
17 (PE). CD3-positive cells were gated on (A) and analysed for IFNγ and IL-17 (B). 
Results are shown for one mouse in each condition, representative of one 
experiment. 
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Figure 5.9 IL-4 and IL-10 immunostaining. Two days after DC i.v. injection, OT-II recipients 
were sacrificed and total CD4+ T cells were isolated using a Miltenyi Mouse CD4 T cell 
isolation kit and a secondary stimulation was performed in PMA, ionomycin and brefeldin 
A. T cells were stained for CD3 (FITC), IL-10 (APC) and IL-4 (PE). CD3-positive cells were 
gated on and histograms show IL-10 and IL-4 staining within the CD3 gate. 
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5.2.7 Microarray analysis 
The data so far shows interesting trends though differences in T cell fate induction have been 
difficult to replicate, suggesting the responses involved may be more heterogeneous than 
expected. This led to the hypothesis that detecting differences in master regulators may not be 
sufficient to characterise such a complex immune response. Analysis of complete pathways 
should be more suited to this. Microarray analysis was chosen in order to build a more 
complete picture. 
Similar to QPCR experiments described above, 48hour DC: T cell cocultures were split using a 
Miltenyi CD4 Isolation kit and RNA was isolation from the T cell fraction as described in section 
2.2.8 of Materials and Methods. To check for potential RNA degradation or DNA 
contamination, samples were analysed on a Bioanalyser. This evaluates both RNA 
concentration and integrity. High quality RNA samples should show two strong peaks for the 
18S and 28S ribosomal RNA with few low molecular weight peaks. Ideally, the 28S:18S ratio 
should be around 2 and the RNA Integrity Number (RIN) should be above 7. A representative 
electropherogram of BL6 OVA sample 1 (BO1) is shown in Figure 5.10. Any samples of poor 
quality or concentration were repeated, together with corresponding controls. 
Samples were hybridised to an Affimetrix GeneChip Mouse Genome 2.0 Array. Data was 
imported into GeneSpring, where results were averaged for each condition and fold change 
analysis was performed (in collaboration with UCL Genomics facility). Fold change (FC) was 
calculated between pairs of data sets; gene lists were created of genes exhibiting a FC ≥ 1.3 at 
significance level of p ≤ 0.05. The number of genes differentially regulated to this level 
between different pairs of data sets are summarised in table 5.1 and presented as Venn 
diagrams in Figure 5.11. 
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Overall Results for sample 4: BO1 
RNA Concentration: 108ng/μl 
rRNA Ratio [28s / 18s]: 1.8 
RNA Integrity Number (RIN): 9  
 
 
 
 
Data set pair No of genes above cut off: 
FC1.3, p0.05 
BOvsBL 2913 
WOvsWL 4100 
WLvsBL 113 
WOvsBO 415 
  
Figure 5.10 Electropherograms of RNA samples. RNA quality was analysed on 2100 
Bioanalyser. Electropherograms are shown above with a summary of a representative 
sample BO1. Distinct 18s and 28s ribosomal RNA peaks can be seen. 
Table 5.1 
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Figure 5.11 Differentially regulated genes. Genes which show a change (top), 
downregulation (middle) or upregulation (bottom) at fold change (FC) ≥ 1.3 with p value 
≤0.05. Genes differentially regulated in BL6 OVA (BO) compared to BL6 LPS (BL) samples 
are indicated in red; WAS OVA (WO) compared to WAS LPS (WL) are in blue. 
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Figure 5.11 compares the differences in gene lists summarised in Table 5.1. There are 2913 
differentially expressed genes in BO compared to BL; and 4100 in WO compared to WL. The 
top Venn diagram in Figure 5.11 compares these two lists to illustrate that 1938 genes are 
shared, however there are differences in transcriptional regulation between antigen-specific 
stimulation by BL6 or WAS DCs. Of the 975 differentially regulated genes in BOvsBL, the 
majority (712) are downregulated (middle Venn diagram); while in WOvsWL, around two 
thirds of the differentially regulated genes (2162) are upregulated (bottom Venn diagram). 
Further, a Venn diagram comparing WLvsBL and WOvsBO clearly illustrates there is a larger 
difference in transcription upon OVA stimulation, confirming an antigen-specific response (Fig 
5.12). 
 
 
 
 
 
 
Gene lists (with FC values) were imported into Ingenuity Pathway Analysis (IPA) software. 
Differences between LPS and LPS/OVA samples mapped to several canonical pathways such as 
Cell Cycle Progression, EIF2 signalling and tRNA charging, confirming predicted increases in 
transcription, translation and proliferation upon antigen-specific T cell activation. 
Comparison between BL6 and WAS showed some differences in protein ubiquitination and 
DNA double strand break repair pathways; however, for the purpose of this investigation, one 
pathway was selected for further examination – T helper cell differentiation. This is shown for 
BOvsBL and WOvsWL in Figure 5.13. 
Figure 5.12 Differentially regulated genes – antigen-specific response. Venn diagram 
shows a comparison of total number of differentially regulated genes in WLvsBL 
compared to WOvsBO. 
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Figure 5.13 T helper cell 
differentiation. These two pages 
show the T helper cell 
differentiation pathway from the 
Ingenuity Pathway Analysis (IPA) 
database. This page represent 
BOvsBL (i.e. genes differentially 
regulated in BO compared to BL). 
Next page represent the same 
pathway highlighting genes 
differentially regulated in 
WOvsWL. The legend (adapted 
from Ingenuity Systems IPA8 
Legend) is shown on the next 
page. Red indicates upregulated 
genes (positive expression value); 
green indicates downregulated 
genes. The intensity of red or 
green correlates to the degree of 
up or down regulation (fold 
change value). 
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Several differences can be seen by comparing OVA responses from each cell type to their 
corresponding LPS only. For example, in BL6 there is upregulation of TNFα, and ICOS, which are 
either not present or are lower in the WAS response. ICOS (Inducible T cell costimulator) is 
upregulated in activated T cells and has been implicated in Th2 and TFH (follicular T helper 
cells) differentiation (Hutloff et al., 1999, Dong et al., 2001, Rudd and Schneider, 2003). It may 
also be important in initiating Th1 and Th2 responses in memory CD4 T cells (Khayyamian et 
al., 2002). Conversely, in WAS there is an increase in IL-5 and IL-13 cytokines, characteristic of a 
Th2 response (Mosmann et al., 2005, Wynn, 2003); and a  small increase in IL-21, which is 
implicated in the development of T follicular and Th17 cells (Chtanova et al., 2004, Wei et al., 
2007a).  
The differences described above are seen in ‘normalised’ antigen-specific responses, where 
BL6 and WAS OVA DC induction of T cells is expressed in the context of their respective LPS 
only DC induction. Thus, any differences between BL6 and WAS which are present in both LPS 
and LPS/OVA conditions are overlooked. The largest interleukin difference however, was 
observed in a comparison between WLvsBL and WOvsBO. IL-12 showed significantly decreased 
expression in WAS compared to BL6 in both antigen-specific and LPS only conditions, with a FC 
of -2.08 (Fig 5.14). IL-12 is involved in the differentiation of Th1 cells (Hsieh et al., 1993) and 
may have a role in preventing food allergies (Ternblay et al., 2007). This result confirms 
previous observations of reduced IL-12 in WAS DCs by flow cytometry (Bouma et al., 2011). 
Another report also provided evidence for the requirement of the WASp-activator Cdc42 in 
polarised IL-12 secretion and immune synapse formation (Pulecio et al., 2010). 
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Antigen 
Presenting Cell 
Figure 5.14 T helper cell differentiation 
- WOvsBO. Part of the pathway in Fig 
5.13, this pathway shows Th1 
differentiation induced by an APC. 
Green indicates downregulated genes 
in WO compared to BO.  
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5.2.8 DC conditional WAS knockout model 
To investigate the specific role of WASp in DCs, a cre-lox conditional WASp knockout mouse 
strain was created lacking WASp specifically in CD11c-positive cells (Baptista et al, manuscript 
submitted). WASp, flanked by LoxP sites, was removed by crossing animals with a CD11c-cre 
strain. This model can be used to study the role of DCs, and in particular their actin 
cytoskeleton, in several in vivo experiments. One of the clinical characteristics of WAS is 
autoimmunity and autoantibodies are present in both patients and WAS knockout mice 
(Schurman and Candotti, 2003, Nikolov et al., 2010).  
To test whether DCs play a role in the development of this autoimmunity, serum was collected 
from 25-week old mice and an autoantibody array chip was used to detect IgG and IgM isotype 
antibodies against 73 different autoantigens, as previously described (Ternblay et al., 2007). 
Results are shown in Figure 5.15. Serum from the DC conditional WAS KO (DCcWKO) showed 
autoimmune responses, similar to WAS for IgG, and less severe for IgM though significantly 
higher than normal BL6. Particularly striking is the response to single- and double-stranded 
DNA (ssDNA and dsDNA). This suggests there may be a difference in plasmacytoid DC (PDC) 
responses, which express toll-like receptors (TLRs), specific in particular for ssDNA. Further 
investigation is required; however, this idea would support recent findings in the group using 
an LCMV infection model, which highlighted a defect in PDCs’ ability to produce IFNα (K Lang, 
A Thrasher, personal communication). 
The difference in IgG and IgM levels is also interesting. Different conditional WAS KO models 
show slightly different IgG and IgM patterns, for example, WAS KO specifically in Treg cells 
shows a less severe autoantibody response, with higher readouts for IgG than IgM (L 
Notarangelo, personal communication). This may reflect perturbations in a delicate balance, 
which would normally control B cell subtype polarisation, similar to T helper cell fluctuations. 
Thus, differences in antibody subsets produced during autoimmunity in different models may 
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be a read out of altered cytokine milieu. This assay highlighted the involvement of WAS and 
actin regulation specifically in DCs in preventing autoimmune disease. 
IgG 
SLE BL6 DCcWKO WAS Figure 5.15 Serum autoimmune 
antibody levels. Mice were bled 
by cardiac puncture and blood 
was allowed to clot. Sera from 4 
control, 5 WAS, and 10 DCcWKO 
mice were tested. Sera from 
lupus-prone MRL/NZM mouse 
(SLE rows) served as a positive 
control. At least 3 negative 
control samples were averaged 
for each, antigen ratios were 
calculated between each sample 
and the average of the negative 
controls. Yellow indicates a five-
fold increase of autoantibody 
titre compared to average 
negative control sample 
detection. IgG is presented here, 
IgM on the following page. 
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5.2.9 Dynabead IP assay 
In order to unravel the molecular pathway involved, an assay was developed using magnetic 
beads coated with anti-MHC class II and anti-ICAM-1. These were designed to mimic DC 
interaction with an antigen-specific primary T cell, using antibodies tested in bilayer 
experiments in Chapter 4. The model was validated by analysing cell-bead interactions by 
confocal microscopy.  
As seen in Figure 5.16, BL6 DCs show a regular actin cytoskeleton around the cell cortex and an 
actin ring at the bead contact area, with an actin-free area in the centre. In contrast, WAS DCs 
exhibit abnormal, disorganised actin polymerisation. The frequency of normal cortical actin 
staining is quantified showing a significant reduction in WAS DCs (p=0.0154). 
 
 
 
 
 
 
 
 
 
As the beads revealed a defect in actin organisation in WAS DCs, it was agreed they provided a 
reasonable model to replicate the defect seen in synapse formation. A further advantage of 
the bead model is the ability to isolate the interacting cells using a magnet; to lyse these and 
perform immunoprecipitation assays.  
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Figure 5.16 Magnetic bead model. DCs were incubated with beads coated with anti-MHCII 
and anti-ICAM-1 for 30min. The cell-bead suspension was resuspended gently and added to 
poly-L-lysine coated slides. These were fixed, stained using phalloidin-633 and analysed by 
confocal microscopy. Percentages of DCs showing actin rings beneath the bead were 
converted into arcsin values and a t test was performed. A minimum of 80 cells were 
examined in each of two experiments. *p=0.0154 Scale bars = 5μm. 
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The first row in Fig 5.16 shows strong, specific pull down of WASp in IP samples compared to 
its level in whole cell lysates (around 63kDa). The second row however, highlights the presence 
of N-WASp in all samples (similar size). This does not seem to be specifically concentrated in IP 
samples, suggesting the α-WASp antibody used for IP has a higher affinity for WASp than N-
WASp and is able to concentrate WASp to a greater extent. The presence of N-WASp however 
is worrying due to its homology with WASp and the overlap in interacting proteins. It would be 
difficult to distinguish between protein populations interacting with one or the other actin 
nucleator. For example, Nck (~47kDa), in the bottom panel, shows stronger pull down in BL6 
compared to WAS samples, however it has also been described to interact with N-WASp 
(Donnelly et al., 2013) (and is present in WAS IP samples below), suggesting that the IP is not 
detecting synapse-specific interactions. It is possible that N-WASp may be recruited to the 
synapse, which may be able to bind some Nck, although not to the same level as BL6. 
However, the differences seen so far in IS structure, actin dynamics and function suggest N-
WASp is unable to compensate for the lack of functional WASp. 
WIP has recently been shown to link Nck and N-WASp during actin polymerisation (Donnelly et 
al., 2013); however, WIP does not appear to interact with WASp and N-WASp in the same way. 
It has been shown that WIP protects WASp from degradation as knockdown or overexpression 
of WIP results in decreased or increased levels of WASp respectively (Chou et al., 2006, Worth 
et al., 2013). This has not been seen for N-WASp (de la Fuente et al., 2007). IP samples probed 
for WIP, in Fig 5.16, show WIP (third panel; ~55kDa) interacts with WASp in BL6 cells (first two 
lanes), but no WIP is present in WAS IP samples. This may suggest WIP does not interact with 
N-WASp in these cells or this particular process. It could also reflect the reduced total WIP 
levels seen in whole cell lysates of WAS DCs (last two lanes). This contradicts previously 
published data, which suggests WIP levels are normal in WASp -/- cells (Chou et al., 2006, 
Worth et al., 2013). 
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While the bead model is useful for highlighting difference in actin organisation between BL6 
and WAS DCs, further optimisation is needed in order to use the cell: bead interactions to 
investigate WASp binding partners during IS formation. 
 
  
Figure 5.17 Magnetic bead optimisation for immunoprecipitation. DCs were incubated with 
beads coated with anti-MHCII and anti-ICAM-1 for 30min. The cell-bead suspension was 
resuspended gently and bead-bound cells were harvested using a Dynabead magnet. Cells 
were lysed and IP was performed according to protocol described in section 2.2.4. Denaturing 
elution was performed and samples were separated on a NUPAGE gel. Proteins were 
transferred to PVDF membranes, which were blocked in 5% milk and probed with antibodies 
against WASp, N-WASp, WIP and Nck. PreStained Page Ruler Protein ladder is used as size 
marker.  
IP  WASp, IB  WASp 
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5.3 Discussion 
This chapter aimed to investigate differences in DC capacity to induce T cell activation between 
BL6 and WAS DCs. Flow cytometry and IL-2 ELISA were used to show that WAS DCs were 
unable to induce the same level of T cell activation (Fig5.3 and 5.4). The greater difference in 
proliferation and IL-2 secretion at lower DC: T cell ratios suggest the DC actin cytoskeleton is 
especially important in conditions with lower DC-induced stimulation. 
Results in the previous chapter showed slower “cSMAC” formation in WAS DCs compared to 
BL6. If this corresponds to slower cSMAC formation in an interacting T cell, might be expected 
to result in increased signalling in the T cell, due to prolonged TCR residence in the signalling-
competent pSMAC rather than signal-terminating cSMAC (Lee et al., 2003a). Reduced 
proliferation and IL-2 production in WAS DC-induced T cells, however, suggest the opposite. It 
is unclear whether the cSMAC has a similar role in DCs, i.e. whether receptor uptake and 
degradation or recycling occurs in the same way in DCs. There is some evidence for MHCII-
peptide complex recycling via a dynamin- and clathrin-independent pathway (Walseng et al., 
2008). In this model, peptide-loaded MHCII molecules are quickly recycled back to the surface 
from early endocytic compartments, in a pathway distinct from that of newly-synthesised 
MHCII. However, it is unclear from this work whether this MHCII recycling is active at cell: cell 
synapses; and if so, where in the symmetric synapse structure the peptide-MHCII complexes 
would be targeted to. Further, in cell: cell contacts, both membranes are deformable and 
contain other surface molecules. Consequently, in vivo it is likely that other forces and 
interactions contribute to the control of downstream signalling. For example, the reduced 
number of microclusters, reduced MHC and lower cell spreading seen in WAS DCs (Fig 4.18) 
may all have confounding effects. Further optimisation of the micropit experiments shown in 
Chapter 4 may shed light on how signals for cSMAC formation are integrated from both sides 
of the IS. 
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The disorganised WAS synapse may affect T cell fate induction in several ways. If the strength 
of primary stimulation is important for fate induction, an asymmetric synapse may result in an 
imbalance between signalling microclusters and receptor uptake and recycling, resulting in 
inappropriate amplification or cessation of the signal. Maldonado et al, for example, show that 
co-polarisation of IFNγ receptor with the TCR to the IS leads to a Th1 response (Maldonado et 
al., 2004). Tao et al suggest that the strength of the primary signal stimulation determines 
whether CD28 ligation is required for inducing Th2 differentiation ((Tao et al., 1997a)). 
Alternatively, if fate induction is dependent on activation of different costimulatory receptors, 
such as LFA-1, CD28 or CTLA-4 (Salomon and Bluestone, 1998, Smits et al., 2002, Tao et al., 
1997b, Purvis et al., 2010), abnormal spatial and/or temporal organisation of these could 
affect downstream signalling. For example, numerous studies have highlighted a role for LFA-1 
ligation in Th1/Th2 balance (Salomon and Bluestone, 1998, Smits et al., 2002, Perez et al., 
2003). Perez et al showed that LFA-1 induced downstream signalling through JAB-1 and 
cytohesin-1 (Perez et al., 2003) and it would be interesting to see how these are affected by 
the improper organisation of LFA-1 in T cells activated by WAS DCs. Some groups have shown 
CD28 is important for inducing Th2 cell fate (Rodriguez-Palmero et al., 1999, Tao et al., 1997a). 
Others have shown a role for further surface factors, for example, Amsen et al express 
different Notch ligands to induce either Th1 or Th2 differentiation, with Delta inducing Th1 
cells and Jagged inducing Th2 cell fate, independently of IL-4/STAT6 (Amsen et al., 2004). It 
would be interesting to investigate how these ligands are organised at the IS. Thus, although 
the exact intercellular signalling determinants of T cell fate are unknown, it is easy to see how 
an unstable DC actin network may not be able to stabilise the necessary interactions.  
QPCR and DC adoptive transfer experiments showed very small differences in the master 
regulators of T cell fates between T cell induced by BL6 or WAS DCs. In the in vivo experiments 
in particular, there were very small differences between LPS only and OVA-pulsed DCs. Several 
attempts were made at improving the protocol, including increasing the number of DCs 
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injected or the ovalbumin dose, or testing different time points post-injection. Most of these 
were unsuccessful, with several animals dying, thus an insufficient number for statistical 
analysis. CFSE staining of live cells is a well-established protocol. Although it is unlikely the 
CFSE staining of the DCs affected their function, it has previously been noted in the lab that 
some CFSE staining protocols result in a type of anergy in T cells where cells remained viable 
but did not proliferate in antigen-specific settings for 4 days (own observations). One further 
improvement to the experimental design for DC adoptive transfer may be to use DCs from 
control or WAS-deficient mice expressing a reporter, instead of relying on CFSE staining to 
follow migration. One such model is the DC-GLOWS mouse strain, which is WASp-deficient and 
expresses YFP under the CD11c promoter. A control, WASp-expressing CD11c-YFP, mouse 
strain is also available. 
Using QPCR, any significant differences were difficult to replicate, suggesting that a complex or 
heterogeneous response was involved and detection of master regulator differences alone 
would not be sufficient to describe the complex response. Microarrays should compile data 
from different genes and detect pathways involved in different T helper cell differentiation. 
Even using this technique, only small differences in T cell activation and differentiation were 
observed and these are highlighted in Fig 5.13. In vivo, one reason for this may be the fact that 
a very small proportion of T cells show a strong cytokine response, as seen in the FACS plots in 
Fig 5.8, so the response may be quickly diluted across the population. 
To test the initial hypothesis fully, it would be advantageous to test standard responses to a 
variety of pathogens or peptides that polarise T cell responses to each of the different effector 
T cell fates; then investigate how these differ in the context of WAS. Furthermore, 
characterisation of FYN DC’s capacity for T cell inductions would shed light on the requirement 
of WASp phosphorylation for a functional, signalling-competent synapse. 
Despite limitations, and although Rorc upregulation was too low to detect reliably above LPS 
signal, the significant increase in IL-17 secreted in vitro agree with increased IL-17 production 
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observed in vivo. This is also supported by recent findings in the lab using an antigen-induced 
arthritis model. Arthritis appears to be exacerbated in WAS knockout mice, with a significant 
increase in Th17 (CD4+IL17+) cells (Bouma, personal communication). Further, the severity of 
the disease correlates with increased Th17 and decreased Treg and Breg cell numbers. 
The differences seen here, although small, highlight interesting trends and point to defects in 
IS function in WAS DCs. In WAS patients, all immune cells are WASp-deficient, which results in 
even poorer cell-cell communication and a lower capacity to induce the correct immune 
response. Data presented here highlights the essential role DCs, and in particular the DC actin 
cytoskeleton, play in functionally relevant cell-cell communication. 
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Chapter 6 – Abnormal actin regulation in 
novel primary immunodeficiencies 
 
 
6.1 Introduction 
Correct actin structure and function depends on a delicate balance of feedback mechanisms 
and regulators. Its importance is highlighted by the existence of several actin regulating 
proteins exclusively expressed in cells of the immune system; and by the fact that several 
primary immunodeficiencies are caused by defects in actin regulation.  
It was hypothesised that lack of functional actin regulating proteins results in abnormal basic 
cellular processes, which could be the result of both increased or decreased actin 
polymerisation. First, the state of the actin cytoskeletal network was investigated in two novel 
Primary Immunodeficiencies (PIDs). 
Megakaryoblastic acute leukemia 1 (MAL; also termed MKL-1, MRTF-A, BSAC) was originally 
identified due to its involvement in acute megakaryoblastic leukaemias, resulting from a 
chromosome translocation which produced the oncogenic RBM15-MKL-1 fusion protein (Ma et 
al., 2001, Mercher et al., 2001). 
MKL-1 belongs to the MRTF (myocardin-related transcription factors) family of transcription 
factors, with conserved domains for actin binding, dimerisation and transcriptional activation. 
Unlike myocardin, which is specifically expressed in the heart, MKL-1 is ubiquitously expressed 
and thus could be a common regulator of growth factor-induced immediate-early genes (Ma et 
al., 2001, Mercher et al., 2001, Wang et al., 2002). 
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MKL-1 has been shown to interact with serum response factor (SRF) to activate transcription of 
a number of genes with a role in actin organisation (Cen et al., 2003, Selvaraj and Prywes, 
2003, Miralles et al., 2003). SRF activity is related to cellular G actin content and changes in 
actin dynamics by Rho GTPase result in SRF activation (Hill et al., 1995, Sotiropoulos et al., 
1999). Expression of dominant negative forms of actin nucleators, or overexpression of wild-
type or non-polymerisable actin, inhibit SRF activation (Geneste et al., 2002, Grosse et al., 
2003, Posern et al., 2002). These results suggested that actin polymerisation or stabilisation, 
and thus G actin pool depletion, enhances SRF activity. 
The precise mechanism between G-actin and MKL-1 activation is unclear. Loss of MKL-1 
expression has been shown to affect megakaryocyte migration and platelet formation (Gilles et 
al., 2009). Its effects on other cellular functions have not been studied and the experiments 
shown in this chapter aimed to investigate the effect of MKL-1 mutation on total cellular actin 
and consequently myeloid cell adhesion, spreading and podosome formation. 
The second novel immunodeficiency was found to be caused by a previously undescribed 
mutation in Actin-Interacting Protein (AIP1). In a yeast two-hybrid screen, AIP1 was originally 
identified as an actin-interacting protein (Amberg et al., 1995). It has been shown to interact 
with ADF (actin-depolymerising factor)/cofilin by affinity chromatography (Okada et al., 1999) 
and yeast two-hybrid systems (Rodal et al., 1999). Cofilin severs actin filaments by changing 
the conformation of the filament and weakening forces of the lateral contacts within filaments 
(McGough et al., 1997, Galkin et al., 2001). Although, it severs filaments, it does not cap their 
ends, thus increasing the availability of free filament ends for further polymerisation or 
depolymerisation (Mabuchi, 1983, Hawkins et al., 1993, Hayden et al., 1993, Blanchoin and 
Pollard, 1999, Ichetovkin et al., 2000). Consequently, it plays a crucial role in actin filament 
turnover (Bamburg et al., 1999, Maciver and Hussey, 2002).  
AIP1 alone has no significant effect on actin filaments; however, it has been shown to 
accelerate cofilin’s severing activity on actin filaments by capping severed filament ends to 
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prevent elongation or reannealing (Okada et al., 1999, Aizawa et al., 1999, Okada et al., 2002) 
and weakening interactions between actin monomers within a filament. Although cofilin and 
AIP1 have been shown to be important for migration, in Drosophila as well as Dictyostelium, 
very little is known about how this is regulated (Konzok et al., 1999, Ono, 2003, Chen et al., 
2001, Zhang et al., 2011). The mutation of the mammalian homologue of AIP1, WDR1, has 
been shown to result in cytoskeletal defects in neutrophils (Kile et al., 2007). Although 
complete loss of function of WDR1 is embryonically lethal, hypomorphic mutations result in 
macrothrombocytopaenia and autoinflammatory disease (Kile et al., 2007). 
A non-synonymous base change in WDR1 was identified in a pair of siblings with episodes of 
unprovoked inflammation and thrombocytopaenia. The experiments presented here aimed to 
investigate how this mutation in WDR1 affects the cellular actin network. 
Finally, DOCK8 was investigated as another player in the Arp2/3 actin polymerisation pathway. 
Mutations in the gene DOCK8 (dedicator of cytokinesis 8) have recently been shown to be the 
cause of a human immunodeficiency associated with recurrent viral infections, allergic disease, 
malignancy and hyper IgE previously known as autosomal hyper IgE syndrome. This suggests 
that at the cellular level, DOCK8 patients have multiple abnormalities in all lineages of the 
immune system. This includes reduced numbers of T cells (both CD4 and CD8) which 
deteriorates with age, with some loss of B and NK cells. Furthermore, these cells fail to 
proliferate in response to antigen with a reduction in the production of antiviral cytokines. In 
addition, antibody levels are often abnormal with elevated IgE and low IgM (Su, 2010, 
Moulding et al., 2013). 
DOCK8 is a member of a family of guanine nucleotide exchange factors (GEFs), many of which 
interact with CDC42 to facilitate the switching between GDP and GTP bound forms. CDC42 is a 
Rho GTPase known to be important for regulation of the actin cytoskeleton, including WASp 
activation (see Introduction). Actin’s crucial role in the formation of the DC immune synapse is 
highlighted in the previous chapters. DOCK8 has been shown to be important in the formation 
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of B cell and NK cell immunological synapses (Ham et al., 2013). DOCK8 NK cells showed 
defective conjugate formation and impaired polarisation of F-actin, LFA-1 and cytolytic granule 
towards target cells. Further, DOCK8 was shown to interact directly with WASp and the 
integrin regulator talin, and contribute to their polarisation towards the IS (Ham et al., 2013). 
Little is known about how mutations in DOCK8 affect dendritic cell (DC) function during 
synapse formation.  
This part of the project aimed to use a DOCK8 mutant murine model (Randall et al., 2009) to 
investigate the role in actin regulation in dendritic cells and its functional effect on the DC: T 
cell immune synapse.  
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6.2 Results 
6.2.1 Megakaryoblastic leukaemia (MKL-1) 
 A girl born to second cousin consanguineous parents presented in the first year of life with 
Pseudomonas septic shock associated with meningitis, otitis media, and multiple subcutaneous 
abscesses. Whole exome sequencing identified a mutation in Megakaryoblastic leukemia 1 
(MKL-1), a co-factor of the transcription serum-response factor (SRF) that binds to the 
promoters of several actin-regulating genes. Therefore the role of MKL-1 in actin-mediated 
functions of immune cells was investigated.  
An EBV-immortalised B cell line was made from patient cells and lysates were made for 
Western blot analysis. MKL-1 is predicted to have a size of around 160kDa although on 4-12% 
percent acrylamide gel it appears to migrate to 140kDa (as previously published (Gilles et al., 
2009)). As Figure 6.1 shows, MKL-1 expression was severely reduced in patient cells. An 
antibody against the N-terminus, which also appeared to recognise MKL-2, showed no 
difference in MKL-2 (~118kDa) expression between patient and control cells (not shown). This 
suggests MKL-2 is unable to compensate for the lack of MKL-1 function in the immune system. 
 
 
 
 
 
 
 
 
Figure 6.1 Mutation in MKL-1 resulting in loss of protein expression. Using two separate 
antibodies (left = Sigma; right = SantaCruz), lysates from control and patient EBV-immortalised 
B cell lines were separated by SDS-PAGE and probed for MKL-1. 
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Peripheral blood mononuclear cells (PBMCs) were isolated from control or patient blood and a 
CD14-selection was performed. CD14-positive monocytic cells were cultured for 5 days in the 
presence of IL-4 and GM-CSF to induce DC differentiation. Figure 6.2 shows the morphology of 
DCs after 5 days in culture. Control DCs showed good adhesion to culture dishes, spreading 
and polarisation. Patient DCs remained rounded and showed a severely reduced ability to 
adhere, spread and polarise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 DC morphology 5 days post isolation. Over 500 cells were observed and 
characterised as either adhered, spread and polarised or rounded and floating. This is 
quantified in the graph. Scale bar = 20μm. 
control MKL-1 
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CD14-positive myeloid cells and the remaining (CD14-) lymphoid fraction were assessed for 
total F-actin content. As phalloidin staining can be very variable and it binds to filamentous 
actin stoichiometrically, to directly assess the total actin content, control and patient cells 
were stained together as a mixed sample population. Patient cells were stained with CFSE and 
washed twice to prevent dye transfer to other cells. They were then mixed with an equal 
number of control cells, fixed, permeabilised and stained with 647-conjugated Phalloidin. 
Figure 6.3 shows analysis of these by both flow cytometry and confocal microscopy. These 
histograms indicate that control cells contain more total polymerised actin; which can also be 
seen in the confocal images where CFSE-positive (green) patient cells stained less brightly with 
phalloidin-647 than unstained control cells. The dot plot represents MFIs of individual cells, 
calculated by measuring the average intensity of each cell in the phalloidin channel of confocal 
images. This shows that control cells contain significantly more total polymerised actin. Similar 
results were obtained when CFSE-stained control cells were mixed with unstained patient cells. 
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Figure 6.3. Total polymerised actin is reduced in MKL-1 patient cells. Mixed population phalloidin stains were performed on cells of both the myeloid and 
lymphoid lineages. Patient cells are CFSE stained in the FACS histograms and confocal images. Confocal images show control and patient lymphocyte 
populations. Scale bar = 8μm. MFI of individual cells were calculated in ImageJ. Significance level was calculated using an unpaired t test. *** p< 0.0001 
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To further investigate MKL-1 deficiency, a monocytic THP1 knockdown (KD) cell line was 
created. THP1 were infected with lentivirus encoding either scrambled (SCR) control shRNA or 
a shRNA sequence previously described to specifically silence MKL-1. After 3 days in culture, 
the cells were sorted for high GFP expression and a stable cell line was propagated. 
Knockdown of MKL-1 at protein level was confirmed by western (Figure 6.4a). 
To confirm the actin defects seen in patient cells, THP1 cell lines were stained for phalloidin 
using a similar mixed population protocol, substituting CFSE with a far red DDAO dye. In Figure 
6.4b, MKL-1 KD THP1 are DDAO-positive and SCR THP1 are unstained. Phalloidin-564 staining 
shows MKL-1 KD results in decreased amount of total polymerised actin. 
The THP1 cell line was cultured in the presence of rhIL-4 (10ng/ml) and rhGM-CSF (10ng/ml) to 
induce differentiation into DCs (THP1DCs). Figure 6.4d shows these GFP-positive, shRNA-
expressing THP1 cells after 5 days in culture. MKL-1 knockdown cells exhibit reduced spreading 
and adhesion compared to SCR. This is quantified in Figure 6.4c. 
Consistent with the adhesion and spreading defect, MKL-1 knockdown THP1DCs were unable 
to form podosomes when seeded on fibronectin (Figure 6.4e). This was also observed in 
primary monocytes from the patient (D Moulding, personal communication). This suggests 
that MKL-1 plays an important role in podosome formation or maintenance, which is likely to 
have a severe adverse impact on immune function given the importance of podosomes for cell 
migration in vivo (Calle et al., 2006b, Chou et al., 2006, Linder and Aepfelbacher, 2003, Klos 
Dehring et al., 2011, Isaac et al., 2010). 
These experiments show that a mutation which disrupts MKL-1 expression reduces the 
amount of total polymerised actin and affects myeloid cell adhesion, spreading and podosome 
formation. 
 
 
 Chapter 6 
215 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 MKL-1 knockdown THP1 cell line. A) Western showing reduced MKL-1 (~98kDa) 
protein expression in cells treated with MKL-1 specific shRNA compared to SCR control 
shRNA. B) Mixed population actin stain showing decreased polymerised actin in MKL-1 cells. C 
and D) THP1 at day 5 of DC differentiation culture. Spread and rounded cells quantified as 
before. E) THP1DCs seeded on fibronectin to analyse podosome formation. Scale bars = 
10μm. 
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6.2.2 Actin-interacting protein 1 (AIP1) 
A non-synonymous base change in WDR1 was identified in a pair of siblings with episodes of 
unprovoked inflammation and thrombocytopaenia (N Klein and P Brogan, personal 
communication). Western blot analysis has revealed the presence of a smaller sized protein, 
however, it is unclear whether the mutation results in a truncated protein or expression of a 
splice variant (A Standing, personal communication). The following experiments aimed to 
determine the effect of this mutation on the actin cytoskeleton of immune cells. 
As before, Ficoll and CD14 magnetic cell purification was performed on patient and control 
peripheral blood samples. CD14-negative PBMCs were stained with phalloidin-647 in a mixed 
population sample and analysed by flow cytometry. The forward scatter (FS)/ side scatter (SS) 
plot showed several populations with distinct differences between control and patient cells 
(Fig 6.5a). To characterise these further, cells were stained for surface markers for T cells 
(CD3), B cells (CD20) and NK cells (CD56), before fixing, permeabilising and staining for actin. 
CD3-positive cells show no difference in total polymerised actin between control and patient; 
however, in both CD20- and CD56-positive populations, patient cells were more strongly 
stained for phalloidin than control cells (Fig 6.5b). This suggests the WDR1 mutation results in 
increased actin polymerisation in B and NK cell populations. 
 
  
  
Figure 6.5 WDR1 patient lymphocyte actin. Patient B cells and NK cells contain more 
total polymerised actin. Patient lymphocytes were stained with CFSE and mixed with 
unstained control lymphocytes. A) The mixed population was permeabilised and stained 
with phalloidin. B) Cells were first stained for surface CD3, CD20 or CD56 with PE-
conjugated antibodies, followed by fixing and permeabilisation. 
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CD14-positive cells were differentiated into DCs and also stained with phalloidin in a mixed 
population sample. Figure 6.6 shows that patient cells (black line) from the myeloid lineage 
also contain more polymerised actin than control cells at steady state. Further, upon activation 
with LPS or LPS/ATP for 4 hours, actin polymerisation in patient cells appears to be 
upregulated to a much greater extent than in control cells, as illustrated by their mean 
fluorescent intensities (MFI). Patient cell MFIs are double those of control cells. Stains for each 
treatment were performed in a mixed population sample; however, comparison of MFIs across 
treatments is not valid as untreated cells were stained separately and may have been stained 
for longer, which could explain the elevated phalloidin intensity in these cells compared to 
cells post treatment. Results for separate treatments were normalised against control and 
presented in the bar graph. 
  
Figure 6.6 Total polymerised actin in DCs. Grey histogram represents untreated 
patient and control DCs, permeabilised and stained for phalloidin in a mixed 
population sample. On the right, the table summarises MFIs of cell populations 
following LPS or LPS/ATP treatment. MFIs from two separate experiments are 
normalised against control values in the bar chart. An unpaired t test was performed. 
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To investigate whether the WDR1 mutation affects cell adhesion, patient and control DCs were 
seeded on fibronectin-coated coverslips and stained (Fig 6.7). Actin and vinculin stains showed 
patient cells formed podosomes which, unlike WAS or MKL-1, appeared larger than control cell 
podosomes in both the xy and the z plane. To take into account both dimensions, podosome 
volumes were measured using threshold and measurement functions in Volocity. These are 
shown in Figure 6.8. Although the number of podosomes per cell was not significantly 
Control 
Actin         Vinculin       AIP   merge 
Figure 6.7 Podosome formation. Patient and control cells were seeded on fibronectin-
coated coverslips for 4 hours, fixed and stained for actin (phalloidin-488), vinculin and 
WDR1. Coverslips were mounted on glass slides and analysed by confocal microscopy. 
Scale bars = 10µm 
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different, podosomes formed by patient cells were significantly larger than control. This 
suggests that the mutation in WDR1 either increases actin polymerisation at podosome 
structures or results in decreased podosome turnover through stabilisation or reduced 
depolymerisation. 
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A THP1 WDR1 knockdown cell line was created to investigate the effect of lack of WDR1 
protein expression. The Western blot in Figure 6.9 shows WDR1 expression in untransduced 
THP1s and those infected with SCR control virus. WDR1 expression is severely decreased in 
THP1s expressing hairpin (HP) 4 or 5 shRNA constructs.  
WDR1 knockdown was unable to reproduce the abnormalities seen in patient cells, including 
increased F-actin and increased podosome volumes (not shown), as well as altered cell 
migration (J Record, personal communication). This suggests that defects seen in patient cells 
result from the abnormal regulation or localisation of the splice variant or truncated protein 
expressed, rather than complete loss of its function. It would be interesting the further 
Figure 6.8 Podosome volumes. Podosomes in patient and control cells were counted 
and size was analysed using Threshold and Measure functions in Volocity. A minimum of 
10 cells were measured from each sample. An unpaired t test was used to test for 
significance. 
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investigate the nature of the mutation and introduce this mutated WDR1 into the knockdown 
cell line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 6.9 WDR1 knockdown cell line. Prestained PageRuler Protein ladder was used as 
a size marker. PVDF membrane was probed with a rabbit anti-WDR1 antibody, followed 
by an anti-rabbit-HRP conjugated secondary. GAPDH is used as a loading control to 
show similar loading in all samples. GFP expression confirms shRNA construct 
expression. 
 
U
n
tr
an
sd
u
ce
d
 
H
P
4
 
H
P
5
 
H
P
6
/S
C
R
 140 
115 
 
80 
70 
 
 
50 
 
40 
 
30 
 
25 
 
 
15 
α-WDR1 (goat) 
α-GFP 
α-GAPDH 
 Chapter 6 
222 
 
6.2.3 Dedicator of cytokinesis (DOCK) 8 
DOCK8 is a guanine nucleotide exchange factor, which has been shown to interact with several 
Rho GTPases, including Cdc42 (Ruusala and Aspenstrom, 2004). WASp, as the best understood 
effector of the Rho GTPase pathway, can be regulated by Cdc42 (Thrasher and Burns, 2010). 
The following experiments aimed to investigate how disrupting the function of DOCK8, an 
upstream member of this pathway, affects immune synapse formation described in Chapter 3. 
Dock8 deficient mice (Randall et al., 2009) were bred in house, bone marrow was isolated from 
femurs and cells were cultured in 20ng/ml GMCSF to generate BMDCs. As previously described 
for WAS DCs, these were matured and pulsed with OVA; and cocultured with OTII CD4 cells. To 
investigate the stability of the DOCK8 DC synapses, conjugate numbers were analysed by 
confocal microscopy.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10 Stable conjugate formation and polarisation of synapse markers. DC: T cell 
cocultures, seeded on poly-L-lysine slides, were stained for ICAM-1, actin and TCR. These 
were analysed by confocal microscopy and DCs forming conjugates were quantified as a 
percentage of total DC number. Percentages from 2 separate experiments were converted 
to arcsin numbers and a paired t test was used to analyse significance. Polarisation ratios 
were calculated as described before in Fig3.8. 
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DOCK8 DCs form fewer stable conjugates than BL6, as seen in Fig 6.10 (top left). This suggests 
that disrupting Cdc42-mediated pathways affects the stability of cell: cell contacts. 
Interestingly, unlike WAS DC conjugates, in DOCK8 DCs polarisation of ICAM-1 appears normal, 
suggesting that this integrin is regulated normally and is not responsible for the differences in 
stable synapse numbers. Due to the variability of these results (large SEM on the dot plots in 
Fig6.10) it would be beneficial to repeat these with a larger number of cells. 
Similar to the WAS conjugates, immunofluorescent staining for γ-tubulin showed that the T cell 
MTOC did not polarise towards the IS interface (Fig 6.11). This was almost as severe as the 
defect seen in T cells contacting WAS DCs; the mean distance between the T cell MTOC and 
the IS was 2.55µm in Dock8 and 2.86µm in WAS conjugates. 
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Figure 6.11 MTOC polarisation. DC: T cell 
cocultures, seeded on poly-L-lysine slides, were 
stained for TCR (red), γ-tubulin (green) and the 
nucleus (DAPI; blue). These were analysed by 
confocal microscopy and the distance between 
the T cell MTOC and the DC interface was 
measured in ImageJ. Scale bar = 5μm. A 
minimum of 10 cells was and an unpaired t test 
was used to analyse significance. 
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Although no differences in integrin localisation were observed, the reduced number of stable 
conjugates and severely disrupted MTOC translocation induced by DOCK8 DCs suggest there 
may still be quantitative and qualitative abnormalities in functional IS formation as a result of 
DOCK8 deficiency. To investigate this, concentrations of secreted cytokines in DC: T cell 
coculture supernatants were measured by ELISA.  
Figure 6.12 shows the results from IL-2, IFNγ and IL-17 ELISA analyses, which previously 
showed the largest differences in WAS DC cocultures compared to BL6 (Fig 5.4- 5.6). DOCK8 
DCs were unable to induce the same IL-2 secretion as BL6 at a 1:1 cell ratio, similar to what 
was observed in WAS. At 1:5 ratio however, both types of DCs induced less IL-2 production and 
there was no significant difference between them. It would be interesting to investigate 
whether these differences reflect altered T cell proliferation. 
IFNγ secretion was significantly lower in T cells induced by DOCK8 DCs, compared to BL6, at 
both cell ratios. Similar to the difference seen in WAS, this suggests there may be a defect in 
Th1 cell fate specification. However, IL-17 secretion appeared normal in T cells induced by 
DOCK8 DCs, suggesting Th17 development is normal. Further QPCR or in vivo cytokine assays 
are required to confirm these differences.  
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Figure 6.12 Coculture cytokine secretion. BL6 or Dock8 BMDCs were pulsed with OVA and 
cocultured with T cells at 1:1 and 1:5 DC: T cell ratios. 48hrs after coculture, supernatants 
were collected and analysed using R&D systems ELISAs. Each graph represents an average 
from 3 separate experiments, each of which was measured in triplicate. A paired t test was 
used to determine significance. *p=0.01-0.05 
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6.3 Discussion 
This chapter aimed to investigate the role of several actin regulators in the steady state 
maintenance of the actin cytoskeleton, as well as during adhesion and synapse formation as 
described for WASp in previous chapters. 
First, two novel PIDs were described, MKL-1 and WDR1; both of which result from mutations in 
actin-regulating proteins. Loss of MKL-1 expression, in patient and THP1 knockdown cells, 
resulted in significant loss of cellular polymerised actin. This resulted in poor cellular adhesion, 
spreading and migration (not shown, J Record). The reduction in F-actin would be expected to 
affect other fundamental processes, such as cell division. Indeed, the MKL-1 THP1 cell line 
appeared to expand slower in culture, compared to SCR cell lines. A separate investigation of 
actin dynamics throughout the cell cycle in the context of MKL-1 would be interesting, 
including live imaging of MKL-1-deficient cells during cell division. Abnormal cell division may 
correlate with some clinical findings, such as neutropenia. 
In terms of MKL-1’s role in transcription regulation, the planned future work for this project 
includes a complete transcriptome analysis using RNA Sequencing. For example, some of the 
genes known to be regulated by MKL-1 are the myosin heavy and light chains (Sun et al., 2006, 
Gilles et al., 2009). Myosin has a role in both migration and podosome formation (Bhuwania et 
al., 2012, Vicente-Manzanares et al., 2009). Thus defects seen above may be the result of 
perturbed non-muscle myosin function. However, a full transcriptional analysis is important as 
it is likely that the complex disease results from the abnormal regulation of several actin 
modulators, including vinculin and N-WASp (Gilles et al., 2009). 
The second immunodeficiency described was shown to be related to a homozygous mutation 
in WDR1. This was shown to result in an increase in polymerised actin, abnormal podosome 
formation and impaired phagocytosis by dendritic cells (A Standing). Thus, similar to the 
effects of decreased F-actin described above, an increase in F-actin also has detrimental effects 
on basic cell processes. This highlights the crucial role of actin regulators in controlling the 
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delicate balance between actin assembly and disassembly, particularly in the immune system. 
As the defects are present in several cell lineages, it is likely that these regulators play similar 
roles across a number of cell types. Many questions remain unanswered. The precise nature of 
the WDR1 patient mutation is still unknown and characterising this may allow expression of 
the variant protein in a THP1 cell line in order to reconstitute the defect more completely on a 
cellular level. The increased podosome volume phenotype also needs further characterisation. 
Increased F-actin content has been described for the constitutively active WASp-I294T 
(Moulding et al., 2007), however podosomes in these cells, although deregulated, were not 
significantly larger. This highlights the importance of filament severing and depolymerisation, 
as well as nucleation, in the maintenance of podosomes. Live imaging and FRAP should provide 
useful insight into the turnover dynamics of these altered adhesion structures. As the loss of 
functional WDR1 results in an increased F-actin network, the results presented here agree with 
previous findings using electron microscopy showing that AIP1 and cofilin increase the 
population of short filaments (Okada et al., 1999, Aizawa et al., 1999). Characterisation of the 
distinct actin subpopulations, similar to that conducted for WAS DCs in Chapter 4, would be 
valuable. 
Imaging migration in vivo or cell adhesion under flow, for example using flow chambers, may 
be helpful for both MKL-1 and WDR1 studies, to provide more physiologically relevant 
quantification of these processes. Further, mouse models, such as the MKL1-/- model 
developed by Li et al (Li et al., 2006), would be useful for more regular investigations into other 
cellular processes, including NK or CD8 cell killing, macrophage phagocytosis, humoral 
immunity, as well as antigen presentation and IS formation. 
Finally, Dock8 deficiency is the best described of the three immunodeficiencies presented in 
this chapter. In 2009, DOCK8 was independently described as the cause of severe immune 
deficiency in both humans and mice (Randall et al., 2009, Zhang et al., 2009, Engelhardt et al., 
2009). Initially, yeast two-hybrid screens showed DOCK8 interaction with Cdc42 (Ruusala and 
 Chapter 6 
228 
 
Aspenstrom, 2004). More recently, this has been confirmed using pull down experiments and 
was shown to be important for DC migration (Harada et al., 2012). As Cdc42 is a potential 
WASp activator, DOCK8 deficiency is interesting to study as an example of an upstream defect 
or disruption in the Arp2/3-dependent actin polymerisation pathway.  
In contrast to WAS conjugates, in which ICAM-1 polarisation was defective (Fig 3.11), in DOCK8 
DCs this was shown to be normal, albeit in very few cells (Fig 6.10). This suggests that WASp is 
essential for ICAM-1 localisation; however WASp, or Cdc42, may be activated via a DOCK8-
independent pathway. For example, Cdc42 could be activated by other GEFs such as Dbl and 
Vav1 (Schmidt and Hall, 2002), or WASp activation may be unnecessary for correct ICAM-1 
polarisation. The latter argument supports results obtained from FYN DC in Chapter 3, where it 
appears the presence of WASp alone, without activation through phosphorylation, is enough 
to restore most ICAM-1 polarisation (see Chapter 3 discussion).  
Furthermore, although the Dock8 DCs show normal ICAM-1 polarisation, they are unable to 
induce correct T cell MTOC polarisation in the interacting T cell. This suggests that the ICAM-1-
LFA-1 interaction is not essential for this process, although an LFA-1 stain of the Dock8 
conjugates would be required to confirm that ICAM-1 polarisation in Dock8 DCs leads to LFA-1 
polarisation in T cells, similar to that seen in BL6 conjugates. Although LFA-1 has been 
suggested to play a role in MTOC docking (De Clercq et al., 2013b), results presented here 
show there is some uncoupling between the ICAM-1-LFA-1 interaction and MTOC 
translocation. This is the case in Dock8 DCs in this chapter; as well as FYN DCs in Chapter 3, 
which polarise ICAM-1 correctly but show only limited recovery of MTOC polarisation (Fig 3.11, 
3.12). 
Despite correct ICAM-1 localisation, Dock8 DCs do form fewer conjugates with T cells in vitro 
(Fig 6.10), suggesting there is some defect in the stability of the conjugates. It would be 
interesting to examine this further using serial block face SEM (similar to WAS in Fig 3.15) to 
determine whether the size of the adhesion area between the two cells is affected. Further, 
 Chapter 6 
229 
 
since ICAM-1 polarisation, and presumably its synapse function, are normal in Dock8 DCs, it 
would also be intriguing to study their interaction with lipid bilayers to see if ICAM-1-
dependent podosomes are formed and organised as described for BL6. 
In summary, the data presented here provides strong support for the crucial role of actin 
regulators in the immune system. The MKL-1 patient presented with Pseudomonas septic 
shock associated with meningitis, otitis media, and multiple cutaneous and subcutaneous 
abscesses. The WDR1 mutation appears to lead to episodes of unprovoked inflammation and 
thrombocytopaenia. The defective cytoskeletal function in both these patients results in 
abnormal migration, cell-cell interaction and phagocytosis, all of which can be related to the 
clinical symptoms observed. 
The clinical characteristics of Dock8 deficiency include severe food or environmental allergies, 
otitis media, pneumonia or bronchitis and cutaneous viral infections (Zhang et al., 2009, Chu et 
al., 2012). Susceptibility to viral infections is also seen in other PIDs such as WAS (Modiano et 
al., 1995, Saijo et al., 1998, Artac et al., 2010). As in WAS, the increased susceptibility to viral 
infections could be the result of a combination of factors including defective skin barrier, 
reduced numbers of T cell, impaired T cell proliferation and antiviral cytokine production, and 
abnormal migration into infected tissues (Zhang et al., 2010). Other symptoms described in 
Dock8 deficiency, such as rash, elevated IgE and susceptibility to autoimmunity, are very 
similar to those described in WAS (Thrasher and Burns, 2010). Similar to WAS, the disease 
pathology is likely to be the result of a combination of cellular defects including the inability of 
B cells to generate high-affinity antibodies; the absence of T cell memory; defects in DC 
migration and capacity to prime T cells; as well as reduced NK cell cytotoxicity. As an effector 
of the Rho GTPase Cdc42, WASp presumably acts downstream of DOCK8 and the similar 
clinical manifestations may reflect the overlapping signalling pathways. While WASp function 
may also be diminished in DOCK8 patients, this cannot explain the complete phenotype of 
DOCK8 patients and data presented in this chapter suggests that WASp can be activated by 
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Dock8-independent pathways. Unlike WAS, DOCK8 expression is not restricted to the 
haematopoietic system, it would be interesting to see whether reconstitution of the immune 
system would correct disease pathology. Further, in mice DOCK8 mutations replicate many of 
the cellular defects described while the animals show no obvious clinical phenotype, similar to 
WAS knockout animals (Snapper et al., 1998, Zhang et al., 1999).  
Deficiencies in all three major components of Rho GTPase signalling have been described: the 
effectors, such as WASp, the GTPases, such as Rac2, and the upstream modulators, such as 
DOCK8 (actin-related PIDs reviewed in (Moulding et al., 2013)). While this pathway appears 
essential, novel immunodeficiencies have been described to results from mutations in other 
pathways, such as MKL-1 and WDR1 presented here. These two actin regulating proteins, 
through their roles in controlling actin dynamics, are crucial to the normal functioning of 
immune cells and themselves provide unique opportunities for research to better understand 
the role of the actin cytoskeleton in immunity. 
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Chapter 7 – Discussion 
 
 
Our knowledge of the immunological synapse and its role in T cell activation has improved 
greatly over the last couple of decades (Smith-Garvin et al., 2009). How cells form stable 
interactions, which have a role in intercellular signalling, is an important question in cell 
biology and the field of immunology in particular. The actin and microtubule arms of the 
cytoskeleton play key roles in IS formation in the obligatorily mobile immune cells. Most 
studies have focused on the T cell side and several groups have shown the importance of the 
actin cytoskeleton in this process (Bunnell et al., 2001, Babich et al., 2012, Beemiller et al., 
2012). Although many of the cytoskeletal regulators are conserved, their precise interactions, 
effectors and functions may differ between cell types.  
 
WASp deficiency results in a more fluid, unstable DC synapse 
In T cells, it has been suggested that L-plastin, a leukocyte-specific actin bundling protein, 
interacts with LFA-1 and through its recruitment to the IS and F-actin bundling activities is able 
to stabilise and cluster LFA-1 at this site. Disrupting L-plastin function led to a decrease in LFA-1 
phosphorylation and synaptic localisation; thus leading to abnormal MTOC docking, IL-2 
secretion and proliferation (De Clercq et al., 2013b). This supported previous evidence that L-
plastin plays a crucial role in recruitment of LFA-1 and full T cell activation (Wang et al., 2010, 
Wabnitz et al., 2010). De Clercq et al suggest that L-plastin may be involved in converting the 
diffuse cSMAC cytoskeleton into the longer-filament, tightly-bundled network required in the 
pSMAC (De Clercq et al., 2013b). L-plastin phosphorylation enhances its bundling activity, 
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resulting in an increasingly ‘opaque’ actin network, which increases LFA-1 stabilisation and 
activation (De Clercq et al., 2013b). In agreement with this, they show a reduction in IS length 
and surface area in T cells with disrupted L-plastin function, suggesting that T cells are unable 
to generate a normal pSMAC. The authors however, do not investigate distinct c- and p-SMAC 
compositions in these synapses.  
Their results are remarkably similar to the reduced LFA-1 polarisation and decreased IS contact 
area in WAS DCs, presented here in Chapter 3. Similarly functional differences, including MTOC 
docking, IL-2 secretion and proliferation, were also seen as a result of poor IS formation by 
WAS DC, as described in Chapter 5. This clearly highlights a role for LFA-1 in the correct 
organisation of the synapse interface during T cell activation; incorrect localisation of LFA-1, 
whether through a cell-intrinsic mechanism (L-plastin dysregulation) or an external driving 
force (incorrect ICAM-1 localisation) leads to abnormal synapse formation and function. 
It is possible that the two pathways interact across the cell interface. If WASp-deficiency 
disrupts ICAM-1 localisation in the DC and this results in fewer, less organised LFA-1 
interactions, less L-plastin may be recruited on the T cell side of the synapse leading to a less 
bundled actin and less LFA-1 clustering and stabilisation. Results presented in Chapter 4 only 
consider the dynamics of the actin cytoskeleton in the dendritic cell though it would be 
interesting to further investigate cytoskeletal dynamics in the WAS DC-induced T cells. As LFA-
1 has been highlighted as a crucial player in both adhesion and signalling between T cells and 
APCs, for example through JAB-1 and cytohesin-1 (Perez et al., 2003), it would also be 
beneficial to study the integrity of these pathways in T cells induced by WAS DCs. 
The results in Chapter 3 confirm previous observations from the group. WAS DCs were shown 
to form shorter-lasting contacts with OT-II T cells and induce less proliferation and calcium 
fluctuation of T cells compared to control BL6 DCs (Fig 4.2, 5.2, (Bouma et al., 2011)). Some 
differences in MTOC polarisation were also previously observed (Bouma et al., 2011), though 
these were not significant. Improved staining protocols in this thesis have confirmed this 
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difference and allowed analysis of statistical significance (Fig 3.12). The decreased IL-12 
production by WAS DCs reported by FACS (Bouma et al., 2011) has also been confirmed using 
microarray analysis (Fig 5.14); though the paper also considers IL-12 in FYN DC samples, which 
was not analysed by microarrays here. Finally, the defects in LFA-1 polarisation and bulls eye 
pattern formation were also affirmed (Fig 3.9, 4.9 and (Bouma et al., 2011)).  
Further to these findings, results in Chapter 3 show defective ICAM-1 polarisation in WAS DCs 
(Fig 3.11), which is implicated in the abnormal organisation of its ligand LFA-1 and the 
symmetric IS interface. Experiments in Chapter 3 also utilised electron microscopy to improve 
imaging resolution and allow the quantification of contact surface area between the T cell and 
DC, which is severely reduced in WAS (Fig 3.16). 
The reduced contact area and defect in integrin polarisation towards the synapse in WAS DCs 
are in agreement with a less stable actin network (as shown by FRAP, Fig 4.8) and the inability 
of WAS DCs to form stable adhesion structures using dynamic podosomes (Fig 4.20). On a 
molecular level, these results suggest that WASp stabilises the actin cytoskeleton upon IS 
formation, in a manner exhibiting dynamics distinct from the steady state cortex (see FRAP 
results and discussion). This of course could translate into defects in macromolecular 
organisation in WAS DCs, for example, an inability of this fluid, disorganised actin network to 
stabilise molecular complexes and clusters required for signal transduction. Eventually, at the 
cellular level, this could result in reduced adhesion forces (due to decreased integrin 
clustering) and/or reduced signalling (due to lower local concentration and stability of peptide-
MHC complexes or costimulatory molecules). 
As discussed in Chapter 3, LFA-1 may also play a role in MTOC polarisation towards the IS (Yi et 
al., 2013), both of which are abnormal in T cells contacting WAS DCs. In contact with FYN DCs 
however, T cells are able to polarise LFA-1 and form extensive contacts with the DC, yet MTOC 
polarisation is not recovered completely, suggesting an LFA-1-independent mechanism may 
also be required.  
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It should be noted that CD4 cells also show some directional secretion, similar to CD8 and NK 
cells (Huse et al., 2006). IFNγ secretion was microtubule-dependent and polarised towards the 
synapse; this may serve to activate APC in antigen-specific manner (Boehm et al., 1997). By 
contrast, TNF secretion was multidirectional as TNF can act on a range of cell types to induce 
an inflammatory response (Locksley et al., 2001). The directional secretion pathway may be 
regulated by MTOC docking. WASp-deficient Th1 cells (which are unable to polarise their 
MTOC towards the IS) have been shown to secrete chemokines but not IFNγ (Morales-Tirado 
et al., 2004). It would be interesting to see if this is also the case in T cells where lack of MTOC 
polarisation is not the result of intrinsic WASp deficiency but that of irregular IS organisation. 
Combined, these results highlight a synapse-specific link between the actin and microtubule 
cytoskeletons.  
Despite slower ‘cSMAC’ formation by WAS DCs (Fig 4.14, 4.17, 4.18), their T cell inductive 
capacity was lower. T cell induced by WAS DCs exhibited less proliferation and IL-2 secretion 
(Fig 5.3 and 5.4), suggesting lower levels of successful TCR activation and downstream 
signalling, though specific signalling complexes or phosphorylation were not investigated. This 
may be the result of asymmetric pSMAC organisation, or the macromolecular interface 
instability and fluidity discussed earlier. If one assumes that TCR organisation mirrors that of 
peptide-MHC observed, these results confirm that speed of TCR microcluster translocation, or 
their maintenance in the periphery are not the only determinants of downstream signalling. 
Further, differences in IS organisation clearly have a functional impact on T cell activation; and 
show small but measurable effects on T helper cell differentiation (Chapter 5). 
 
Novel adhesive structures at the IS 
The presence of podosomes in the DC: bilayer model interface was unexpected. Podosomes 
are cylindrical protrusions, formed on the ventral side of adherent cells. They are around 0.2-
1um in diameter with a central core of F-actin and a characteristic ring of vinculin, talin and β2 
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or β3 integrins (Gavazzi et al., 1989, DeFife et al., 1999, Linder and Aepfelbacher, 2003). These 
structures are known to be highly dynamic, with a turnover rate measured in seconds or 
minutes (Stickel and Wang, 1987, Kanehisa et al., 1990). Their precise function is less clear 
though they have been implicated in cell adhesion to some substrates, providing friction forces 
to allow migration, or linking intracellular cytoskeletal components to ECM and cell-cell 
adhesions (Gaidano et al., 1990, Burns et al., 2004). Although, podosomes have mainly been 
described in cells of the myeloid lineage, such as macrophages, DCs and osteoclasts; it is likely 
that in vivo, these structures have much more varied roles, in a large range of cell lineages. For 
example, lymphocytes have been shown to form podosomes, both in vitro and in vivo, 
followed by more extensive “invasive podosomes”, which were required for transcellular 
diapedesis (through individual microvascular endothelial cells) (Carman et al., 2007). Although, 
it could be argued that these are similar to invadopodia, their average size as well as highly 
dynamic assembly and disassembly (tens of seconds) is more consistent with podosomes. It is 
unclear whether podosomes have a precursor role in invadopodia formation, or whether 
podosomes are required at the site of invadopodia formation (perhaps to stabilise cell-cell 
interaction while the invading cell finds the path of least resistance for pore formation and 
diapedesis). The authors suggest that the sizes of protrusions exhibit a continuous rather than 
bimodal distribution, which would suggest a “continuum of related protrusive structures 
rather than the existence of categorically distinct ones” (Carman et al., 2007). 
Carman et al also found an enrichment of vesicles in endothelial cells adjacent to sites of 
podosome formation (Carman et al., 2007). It is possible that podosome formation, and the 
subsequent downstream signalling e.g. tyrosine phosphorylation (Gavazzi et al., 1989), may 
play a role in vesicle transport or recruitment/ activation of fusogenic proteins. Vesicles, in 
turn, may play distinct roles in different cell-cell contacts, for example, increasing plasma 
membrane surface area to allow pore formation during diapedesis. It would be interesting to 
investigate where similar vesicle clustering occurs beneath the DC synapse interface and 
whether these are involved in the release of cytokines for optimal T cell activation. 
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Confocal imaging studies of DC: T cell conjugates presented here do not provide evidence for 
the existence of podosomes at the interface, though this may be explained by the insufficient 
resolution achieved by z-stack interface reconstructions. There is evidence however, for 
extensive “invasive podosomes” from the T cell into the DC (own EM data, (Ueda et al., 2011). 
One possibility is that this type of adhesion is more common than expected and is in fact what 
mediates the initial contact for several cell-cell interactions, including the immunological 
synapse. Further signals such as, costimulatory receptors and cytokines may be responsible for 
organising the final functional structure. Cell: cell contacts may not require formation of a 
stabilising podosome structure in vitro; which may be crucial for cell interactions between DCs 
and T cells migrating through the lymphatics and lymph node structures. Alternatively, 
podosomes may not be required in vivo but may be an artefact of interaction with a non-
deformable membrane. Optimisation of imaging techniques including micropits, optical 
tweezers or multi-photon microscopy may shed light on the relevance of these structures in 
vivo (or in vitro in cell: cell contacts).  
Microtubules have been implicated in the regulation of podosome formation and patterning 
(Linder et al., 2000, Babb et al., 1997, Destaing et al., 2003). Destaing et al suggest that 
microtubules promote stability of the mature podosome belt in osteoclasts but are not 
required for the initial podosome ring or cluster formation (Destaing et al., 2003). The authors 
use reversible nocodazole-mediated microtubule disruption to show podosome belt collapse 
but do not investigate the localisation of the osteoclast MTOC. It is interesting to note that the 
DC MTOC does not polarise towards the IS in DC: T cell conjugates. Future experiments could 
probe MTOC localisation in DCs interacting with supported bilayers, or the effects of 
nocodazole treatment on synaptic podosome rings. 
The synapse/ kinapse model has been a key to understanding how migrating T cells reorganise 
their cytoskeleton and surface receptors to produce symmetric contact interfaces (Dustin, 
2007). In keeping with this model, Dock2 has been shown to play a role both at the leading 
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edge, during leukocyte migration (Fukui et al., 2001, Nishikimi et al., 2009), and at the IS, 
during T cell activation (Le Floc'h et al., 2013). Interestingly, the different mechanisms have 
been proposed for Dock2 accumulation at the two distinct locations. At the leading edge, 
Dock2 is regulated by phosphatidic acid (Nishikimi et al., 2009), while at the IS, the majority of 
Dock2 recruitment is through interaction with PIP3. This is one example of different activators 
or signal transducers used to differentiate between cellular processes that may use similar 
pathways or effectors. A similar strategy may be at play on the DC side, where talin and 
vinculin rings (characteristic of adhesive podosomes) did not show the same organisation in 
the synapse (Chapter 4). As podosomes may be crucial for both migration and adhesion during 
IS formation, their structural proteins may be the same (actin, WASp, β2 integrins), but their 
activators or binding partners (e.g. vinculin) may differ. Podosomes at the IS have a different, 
annular organisation compared to the clusters found at the leading edge, which is consistent 
with the formation of a symmetrical structure. 
As discussed earlier, podosomes have been described primarily in the context of myeloid cells, 
however, there is evidence for their existence in other cells, including primary lymphocytes 
(Carman et al., 2007) and B cell lines (Redondo-Munoz et al., 2006). Further investigation is 
required into the structure, dynamics, regulators, effectors and other components of these 
podosomes. Based on podosomal structures seen at the synapse, these results strongly 
suggest that podosomes are more versatile in structure and function that originally expected 
and that they may be differentially regulated depending on the cell lineage, environment cues 
or cellular context and other surface molecules or downstream signalling present. 
Several groups have reported that organised assembly of podosome components is strongly 
dependent on WASp (Linder et al., 1999, Burns et al., 2001, Jones et al., 2002, Calle et al., 
2004, Linder and Aepfelbacher, 2003, Olivier et al., 2006). In agreement with this, no 
podosomes were observed in WAS-deficient primary murine DCs on supported lipid bilayers. 
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More to achieve at the IS 
In an organism, T cell motility is most likely irregular and not as uniform as predicted; some T 
cells may meet a DC presenting sufficient antigen and form a stable attachment immediately, 
others may remain dynamic for a much longer time. The precise interactions are most likely 
dependent on many factors including the initial speed of T cell migration, the number of 
specific TCRs present on its surface, the polarity/orientation of the T cell, the number of 
pMHCs available, the flexibility of the DC membrane, integrin activation status, the location 
within the lymph node and the cytokine milieu. Such a heterogeneous response may explain 
why different studies observe different interactions or requirements over time both in vitro 
and in vivo.  
A complete picture of immunological synapses would require the localisation of many other 
actin-regulating proteins such as capping or severing proteins, bundling proteins, 
polymerisation and depolymerisation regulators. Further, most IS studies consider actin as 2D 
network, for example focusing on filaments running in the plane of the interface only, which 
does not take into account the dynamics or function of other actin subpopulations. 
Improvements in super resolution microscopy allow researchers to probe these more deeply 
and investigate actin directionality or the contribution or different molecular populations to 
overall structure and function (Smith et al., 2013b, Oddos et al., 2008, Williamson et al., 2011). 
Further investigation of lipid composition is also required. The involvement of lipid messengers 
in IS organisation is apparent, for example the DAG-dependent polarisation of the MTOC or 
the recruitment of Dock2 by PIP3 (Quann et al., 2009, Le Floc'h et al., 2013). These 
mechanisms can provide quick gradients of the messenger required, which are sensitive to 
change and thus ideal for regulating dynamic cytoskeletal structures. 
More questions remain regarding the MTOC polarisation and docking signals as well as the 
cooperation between the actin and microtubule cytoskeletons at the IS. It is clear however 
that many dynamic regulators are involved to achieve spatial and temporal regulation. 
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Wiskott-Aldrich syndrome 
The IS has been described as a ‘knowledge’ transfer facility, which can transfer information 
through its structure, its dynamics and the context (Xie et al., 2013). Results presented here 
strongly support this idea and show that the transfer of information is disrupted as a result of 
deregulated actin in WAS cells. 
Although it is helpful and necessary to focus on individual cell-cell contacts, it is important to 
remember that the immune system involves a complicated range of different cell interactions 
(previously described as ‘immunological circuits’ – (Gerard et al., 2013)). There is evidence for 
autocrine and paracrine stimulation of T cells, B cells and DCs (Sabatos et al., 2008, Tadokoro 
et al., 2006, Okada et al., 2005, Itano et al., 2003). This suggests many other cell-cell 
interactions are involved in determining the overall immune response.  
Deregulated DC actin and poorly formed conjugates are also likely to affect T cell repriming 
directly, as well as T cell clustering, T:T communication or downregulation of T cell responses. 
If WAS DCs are unable to stably interact with several T cells and cluster these as seen in normal 
DCs (Bousso and Robey, 2003), T:T cell interactions may have altered efficiency or capacity for 
activation. T:T synapses are considered to play a role in T cell expansion, activation and 
differentiation; as well as the regulation of a balanced immune response by inducing T cell 
suppression or apoptosis (Thummler et al., 2010, Collison et al., 2009, Helft et al., 2008, 
Lenardo, 1991, Mempel et al., 2006). 
Other cells also play a role in augmenting the response. It is known that innate signals are 
crucial for both optimal activation and pathogen-specific priming of DCs , which in turn 
determines the precise adaptive immune response initiated (Kapsenberg, 2003, Corthay, 
2006). As WASp-deficiency affects both the innate and adaptive arms of an immune response, 
it is likely that many cell-intrinsic and externally-activated pathways are disturbed, resulting in 
the complex disease. Thus the reduced priming capacity of WAS DCs, resulting in poor 
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activation and disturbed helper cell fate balance of T cells is only one component of the 
deregulated circuit. 
Cellular defects in WAS are often not clear cut in vitro. Phagocytosis, particular antigen 
presentation and humoral immunity are all decreased but not abolished (Leverrier et al., 2001, 
Westerberg et al., 2003, Westerberg et al., 2005). Similarly, in this thesis, WAS DCs are shown 
to form some synapses, albeit fewer, shorter and more disorganised. This suggests there may 
be some redundancy in regulatory pathways, for example, some functions may be 
compensated by proteins such as N-WASp; however this is insufficient to restore individual cell 
function and, as discussed above, small cellular defects would be compounded in the whole 
organism immune response. 
Reconstitution of WASp expression in several cell lineages, including T, NKT and B cells but not 
myeloid cells, has been shown to confer a selective survival or homing advantage to the WASp-
expressing cells compared to their deficient counterparts (Meyer-Bahlburg et al., 2008, 
Westerberg et al., 2008). Studies into the myeloid functions of WAS therefore are crucial as 
they may have important consequences for patients who show limited myeloid reconstitution 
after gene therapy or bone marrow transplants. 
 
Actin in the immune system 
The importance of actin in the immune system is highlighted by the number of actin-related 
immunodeficiencies and by the fact that several actin regulators or adhesion proteins are 
expressed exclusively in immune cells.  
Deficiencies in all three major components of Rho GTPase signalling pathway have been 
described: the effectors, such as WASp, the GTPases, such as Rac2, and the upstream 
modulators, such as DOCK8 (Moulding et al., 2013). The murine Dock8 deficiency investigated 
in Chapter 6 shows many cellular defects similar to WAS. Dock8 DCs form fewer stable 
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conjugates and are unable to induce T cell MTOC polarisation. In contrast to WAS DCs, cells 
deficient in this upstream regulator are able to polarise ICAM-1 to the IS, suggesting that 
WASp, or Cdc42, in these cells may be activated by a different mechanism. Alternatively, 
ICAM-1 polarisation may require WASp expression but not its function in actin nucleation. 
Although Dock8 DCs show normal ICAM-1 polarisation, and T cell LFA-1 polarisation would be 
expected to mimic this, MTOC migration is not restored, suggesting the requirement of an LFA-
1-independent mechanism in this process. 
Although much remains to be characterised in the Dock8-deficient mice, results here show 
that, similar to WAS, the abnormal synapse formed by Dock8 DCs results in perturbed cytokine 
secretion, in particular affecting IL-2 and IFNγ. This highlights a role for DCs in correct synapse 
organisation and function, which depends on actin regulation through the WASp and Rho 
GTPase pathway. 
Chapter 6 also presents results from two other actin-related immune defects – MKL-1 and 
AIP1. These have shown that actin deregulation, whether through increased or decreased total 
F-actin content, can have very severe adverse effects on basic immune cell functions. These 
mutations highlight the large number and diversity of actin-regulating pathways involved in 
dendritic cell migration and adhesion; and provide useful models for studying actin dynamics 
and contribution to many other cellular processes. 
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1. Constructs  
LNT_mCherry-Actin
LNT mCherry-actin
10156 bp
mcherry
actin
U3 (HIV-LTR)
5'LTR (Lenti-WT)
SFFV
SV40 enhancer
AmpR
Acc65I (1915)
AgeI (5824)
ApaI (6403)
AscI (10114)
AvrII (5334)
BamHI (1903)
ClaI (9626)
DraIII (7637)
EcoRI (9643)
HpaI (7122)
KpnI (1919)
NruI (8258)
PmlI (7715)
SalI (49)
SbfI (422)
SciI (39)
XbaI (2223)
XhoI (37)
AatII (3023)
AatII (6303)
AfeI (1553)
AfeI (2610)
AflIII (4830)
AflIII (5577)
AleI (709)
AleI (8998)
EagI (1209)
EagI (8569)
MfeI (7109)
MfeI (8610)
NaeI (57)
NaeI (2517)
NheI (2482)
NheI (9731)
NotI (1209)
NotI (8569)
NsiI (5084)
NsiI (5156)
PciI (4830)
PciI (5577)
SacII (1385)
SacII (1463)
ScaI (3461)
ScaI (7740)
SexAI (5101)
SexAI (5813)
XcmI (753)
XcmI (7329)
ZraI (3021)
ZraI (6301)
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LNT_LifeAct-mCherry 
LNT/sffv LifeAct-Cherry
9738 bp
gpt (OFR-frame shift)
Amp. Res.
LTR HIV-1
LTR-HIVdelU3
3' SFFV LTR
RRE-Rev responsive element
WPRE
cPPT
SFFV fwd primer
rev seq primer
SV40 promoter-enhancer
Afe I (692)
Apa I (4485)
Asc I (8194)
Avr II (3416)
Bae I (3904)
Bcl I (8279)
Bsp EI (5815)
BspMI (9102)
Dra III (5719)
Fsp I (1801)
Hpa I (5204)
Mlu I (9066)
MscI (8365)
Nru I (6340)
Pml I (5797)
Psh AI (4246)
Psp OMI (4481)
Pvu I (1655)
Sac II (9634)
San DI (7437)
Sci I (8243)
Sfi I (3369)
Sse 8647I (8080)
Tth 111I (8216)
Xho I (8241)
Age I (3906)
Age I (8322)
Ahd I (2024)
Ahd I (8529)
Alo I (8028)
Alo I (8683)
Bam HI (8231)
Bam HI (8316)
Bcg I (542)
Bcg I (1486)
Bfr BI (3164)
Bfr BI (3236)
Bgl I (1906)
Bgl I (3369)
Bmt I (568)
Bmt I (7815)
Bsa BI (4345)
Bsa BI (5103)
Bsm BI (987)
Bsm BI (1029)
BsrGI (403)
BsrGI (9035)
BstBI (8255)
BstBI (8291)
Eco NI (822)
Eco NI (6673)
Eco RI (7723)
Eco RI (8257)
Mfe I (5191)
Mfe I (6692)
Nae I (599)
Nae I (9645)
Ngo MIV (597)
Ngo MIV (9643)
Nhe I (564)
Nhe I (7811)
Nsi I (3166)
Nsi I (3238)
Pci I (2912)
Pci I (3659)
Pfo I (985)
Pfo I (9404)
Ppi I (1396)
Ppi I (2206)
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LNT_ICAM-1-EGFP 
  
LNT SFFV IC AM-1 GFP	11350
11350 bp
Ampicillin
ORF frame 2
GFP(v ariant)
cPPT
U3PPT
delta U3
HIV-1 5 LTR
truncHIV-1 3 LTR
Sp6 primer
pBRrev Bam primer
pGEX 3 primer
pBABE 3 primer
SV40 enhancer
SV40pro F primer
SV40 int
SV40 3 splice
EBV rev  primer
HIV-1 5 LTR
truncHIV-1 3 LTR
HIV-1 psi pack
RRE
cPPT
GFP R primer
GFPfusionREV primer
GFP F primer
WPRE
AmpR promoter
SV40 promoter
SV40 promoter
pBR322 origin
SV40 origin
SV40 PA terminator
BamHI (8231)
EcoRI (7723)
EcoRI (8240)
SmaI (7953)
SmaI (8225)
XmaI (7951)
XmaI (8223)
ClaI (7706)
ClaI (10738)
ClaI (11333)
NcoI (3323)
NcoI (9653)
NcoI (10101)
ApaLI (855)
ApaLI (1352)
ApaLI (2598)
ApaLI (10952)
PstI (7733)
PstI (7820)
PstI (9558)
PstI (10711)
AvaI (5802)
AvaI (7430)
AvaI (7951)
AvaI (7993)
AvaI (8157)
AvaI (8223)
AvaI (8460)
HindIII (198)
HindIII (3432)
HindIII (6038)
HindIII (6594)
HindIII (7178)
HindIII (7711)
HindIII (9365)
HindIII (10719)
HindIII (10731)
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2. Anti-MHCII +  Anti-ICAM-I (0.25µg/ml) bilayer 
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